IMAC Holdings, Inc. BACK Financial Statement Data


2025 Q2

Submissions

Field Row 1 Row 2 Row 3 Row 4
adsh 0001641172-25-017193 0001641172-25-017216 0001641172-25-017196 0001641172-25-004643
cik 1729944 1729944 1729944 1729944
name IMAC HOLDINGS, INC. IMAC HOLDINGS, INC. IMAC HOLDINGS, INC. IMAC HOLDINGS, INC.
sic 8093 8093 8093 8093
countryba US US US US
stprba TN TN TN TN
cityba FRANKLIN FRANKLIN FRANKLIN FRANKLIN
zipba 37067 37067 37067 37067
bas1 3401 MALLORY LANE 3401 MALLORY LANE 3401 MALLORY LANE 3401 MALLORY LANE
bas2 SUITE 100 SUITE 100 SUITE 100 SUITE 100
baph 844-266-4622 844-266-4622 844-266-4622 844-266-4622
countryma US US US US
stprma TN TN TN TN
cityma FRANKLIN FRANKLIN FRANKLIN FRANKLIN
zipma 37067 37067 37067 37067
mas1 3401 MALLORY LANE 3401 MALLORY LANE 3401 MALLORY LANE 3401 MALLORY LANE
mas2 SUITE 100 SUITE 100 SUITE 100 SUITE 100
countryinc US US US US
stprinc DE DE DE DE
ein 473579961 473579961 473579961 473579961
former IMAC HOLDINGS LLC IMAC HOLDINGS LLC IMAC HOLDINGS LLC IMAC HOLDINGS LLC
changed 20180131 20180131 20180131 20180131
afs 4-NON 4-NON 4-NON 4-NON
wksi 0 0 0 0
fye 1231 1231 1231 1231
form 10-Q/A 10-K/A 10-Q/A 10-K
period 20240630 20241231 20240930 20241231
fy 2024 2024 2024 2024
fp Q2 FY Q3 FY
filed 20250630 20250630 20250630 20250415
accepted 2025-06-30 17:17:00.0 2025-06-30 17:31:00.0 2025-06-30 17:19:00.0 2025-04-14 18:59:00.0
prevrpt 0 0 0 0
detail 1 1 1 1
instance form10-qa_htm.xml form10-ka_htm.xml form10-qa_htm.xml form10-k_htm.xml
nciks 1 1 1 1
aciks

Description
Field Name Field Description
adsh Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission.
cik Central Index Key (CIK). Ten digit number assigned by the SEC to each registrant that submits filings.
name Name of registrant. This corresponds to the name of the legal entity as recorded in EDGAR as of the filing date.
sic Standard Industrial Classification (SIC). Four digit code assigned by the SEC as of the filing date, indicating the registrant’s type of business.
countryba The ISO 3166-1 country of the registrant's business address.
stprba The state or province of the registrant’s business address, if field countryba is US or CA.
cityba The city of the registrant's business address.
zipba The zip code of the registrant’s business address.
bas1 The first line of the street of the registrant’s business address.
bas2 The second line of the street of the registrant’s business address.
baph The phone number of the registrant’s business address.
countryma The ISO 3166-1 country of the registrant's mailing address.
stprma The state or province of the registrant’s mailing address, if field countryma is US or CA.
cityma The city of the registrant's mailing address.
zipma The zip code of the registrant’s mailing address.
mas1 The first line of the street of the registrant’s mailing address.
mas2 The second line of the street of the registrant’s mailing address.
countryinc The ISO 3166-1 country of incorporation for the registrant.
stprinc The state or province of incorporation for the registrant, if countryinc is US or CA.
ein Employee Identification Number, 9 digit identification number assigned by the Internal Revenue Service to business entities operating in the United States.
former Most recent former name of the registrant, if any.
changed Date of change from the former name, if any.
afs Filer status with the SEC at the time of submission:
1-LAF=Large Accelerated, 2-ACC=Accelerated, 3-SRA=Smaller Reporting Accelerated, 4-NON=Non-Accelerated, 5-SML=Smaller Reporting Filer, NULL=not assigned.
wksi Well Known Seasoned Issuer (WKSI). An issuer that meets specific SEC requirements at some point during a 60-day period preceding the date the issuer satisfies its obligation to update its shelf registration statement.
fye Fiscal Year End Date, rounded to nearest month-end.
form The submission type of the registrant’s filing.
period Balance Sheet Date, rounded to nearest month-end.
fy Fiscal Year Focus (as defined in the EDGAR XBRL Guide Ch. 3.1.8).
fp Fiscal Period Focus (as defined in the EDGAR XBRL Guide Ch. 3.1.8) within Fiscal Year.
filed The date of the registrant’s filing with the Commission.
accepted The acceptance date and time of the registrant’s filing with the Commission.
prevrpt Previous Report – TRUE indicates that the submission information was subsequently amended.
detail TRUE indicates that the XBRL submission contains quantitative disclosures within the footnotes and schedules at the required detail level (e.g., each amount).
instance The name of the submitted XBRL Instance Document. The name often begins with the company ticker symbol.
nciks Number of Central Index Keys (CIK) of registrants (i.e., business units) included in the consolidating entity’s submitted filing.
aciks Additional CIKs of co-registrants included in a consolidating entity’s EDGAR submission, separated by spaces. If there are no other co-registrants (i.e., nciks=1), the value of aciks is NULL. For a very small number of filers, the entire list of co-registrants is too long to fit in the field. Where this is the case, users should refer to the complete submission file for all CIK information.

Numbers

adsh ddate tag value uom qtrs version segments coreg footnote
0001641172-25-004643 20231231 Accounts Payable And Accrued Liabilities Current 454055.0000 USD 0 us-gaap/2024
0001641172-25-004643 20241231 Accounts And Other Receivables Net Current USD 0 us-gaap/2024
0001641172-25-004643 20231231 Accounts Receivable Net Current USD 0 us-gaap/2024
0001641172-25-004643 20231231 Adjustments To Additional Paid In Capital Dividend In Excess Of Retained Earnings USD 4 0001641172-25-004643 Equity Components= Retained Earnings;
0001641172-25-004643 20241231 Adjustments To Additional Paid In Capital Dividend In Excess Of Retained Earnings 1120979.0000 USD 4 0001641172-25-004643 Equity Components= Additional Paid In Capital;
0001641172-25-004643 20241231 Adjustments To Additional Paid In Capital Dividend In Excess Of Retained Earnings USD 4 0001641172-25-004643 Equity Components= Preferred Stock;
0001641172-25-004643 20241231 Adjustments To Additional Paid In Capital Dividend In Excess Of Retained Earnings USD 4 0001641172-25-004643 Equity Components= Retained Earnings;
0001641172-25-004643 20231231 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations 221511.0000 USD 0 us-gaap/2024
0001641172-25-004643 20231231 Cost Of Revenue USD 4 us-gaap/2024
0001641172-25-004643 20241231 Cost Of Revenue 305248.0000 USD 4 us-gaap/2024
0001641172-25-004643 20231231 Discontinued Operation Income Loss From Discontinued Operation Before Income Tax -1707342.0000 USD 4 us-gaap/2024
0001641172-25-004643 20231231 Dividends Payable Current 130000.0000 USD 0 us-gaap/2024
0001641172-25-004643 20231231 Gain Loss On Disposition Of Assets1 -1475289.0000 USD 4 us-gaap/2024
0001641172-25-004643 20231231 Gains Losses On Extinguishment Of Debt 94346.0000 USD 4 us-gaap/2024
0001641172-25-004643 20231231 General And Administrative Expense 2941624.0000 USD 4 us-gaap/2024
0001641172-25-004643 20241231 General And Administrative Expense 5390069.0000 USD 4 us-gaap/2024
0001641172-25-004643 20241231 General And Administrative Expense 162956.0000 USD 4 us-gaap/2024 Consolidation Items= Operating Segments;
0001641172-25-004643 20231231 Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest -6475358.0000 USD 4 us-gaap/2024 Consolidation Items= Operating Segments;
0001641172-25-004643 20231231 Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interests -6475358.0000 USD 4 0001641172-25-004643
0001641172-25-004643 20241231 Increase Decrease In Prepaid Deferred Expense And Other Assets -33360.0000 USD 4 us-gaap/2024
0001641172-25-004643 20231231 Increase Decrease In Right Of Use Lease Liability 346770.0000 USD 4 0001641172-25-004643
0001641172-25-004643 20241231 Interest Expense Debt 640000.0000 USD 4 us-gaap/2024
0001641172-25-004643 20231231 Liabilities 200000.0000 USD 0 us-gaap/2024 Consolidated Entities= Variable Interest Entities;
0001641172-25-004643 20241231 Liabilities Current 7983001.0000 USD 0 us-gaap/2024
0001641172-25-004643 20231231 Net Cash Provided By Used In Financing Activities 4023751.0000 USD 4 us-gaap/2024
0001641172-25-004643 20241231 Net Cash Provided By Used In Operating Activities -3162090.0000 USD 4 us-gaap/2024
0001641172-25-004643 20231231 Net Cash Provided By Used In Operating Activities Continuing Operations 153076.0000 USD 4 us-gaap/2024
0001641172-25-004643 20241231 Net Cash Provided By Used In Operating Activities Continuing Operations -414041.0000 USD 4 us-gaap/2024
0001641172-25-004643 20231231 Net Income Loss USD 4 us-gaap/2024 Equity Components= Common Stock;
0001641172-25-004643 20241231 Net Income Loss -9045827.0000 USD 4 us-gaap/2024
0001641172-25-004643 20231231 Net Income Loss Available To Common Stockholders Basic -9548585.0000 USD 4 us-gaap/2024
0001641172-25-004643 20231231 Net Income Losses -9418585.0000 USD 4 0001641172-25-004643
0001641172-25-004643 20241231 Nonoperating Income Expense -674511.0000 USD 4 us-gaap/2024
0001641172-25-004643 20231231 Payments To Acquire Notes Receivable 3000000.0000 USD 4 us-gaap/2024
0001641172-25-004643 20241231 Preferred Stock Dividends Income Statement Impact 1250979.0000 USD 4 us-gaap/2024
0001641172-25-004643 20241231 Preferred Stock Shares Outstanding 1276.0000 shares 0 us-gaap/2024 Class Of Stock= Series C Two Preferred Stock;
0001641172-25-004643 20241231 Proceeds From Issuance Of Common Stock USD 4 us-gaap/2024
0001641172-25-004643 20231231 Proceeds From Notes Payable USD 4 us-gaap/2024
0001641172-25-004643 20231231 Revenue From Contract With Customer Excluding Assessed Tax USD 4 us-gaap/2024
0001641172-25-004643 20241231 Revenue From Contract With Customer Excluding Assessed Tax 72050.0000 USD 4 us-gaap/2024 Consolidation Items= Operating Segments;
0001641172-25-004643 20241231 Settlement Of Notes Receivable In Connection With Asset Purchase Agreement 1044000.0000 USD 4 0001641172-25-004643
0001641172-25-004643 20221231 Stockholders Equity 4651256.0000 USD 0 us-gaap/2024
0001641172-25-004643 20231231 Stockholders Equity -752647.0000 USD 0 us-gaap/2024
0001641172-25-004643 20231231 Stockholders Equity 5.0000 USD 0 us-gaap/2024 Equity Components= Preferred Stock;
0001641172-25-004643 20231231 Stockholders Equity -55938325.0000 USD 0 us-gaap/2024 Equity Components= Retained Earnings;
0001641172-25-004643 20241231 Stockholders Equity -6393980.0000 USD 0 us-gaap/2024
0001641172-25-004643 20241231 Stockholders Equity 1168.0000 USD 0 us-gaap/2024 Equity Components= Common Stock;
0001641172-25-004643 20231231 Stock Issued During Period Shares New Issues 2725.0000 shares 4 us-gaap/2024 Equity Components= Common Stock;
0001641172-25-004643 20241231 Stock Issued During Period Value Conversion Of Convertible Securities USD 4 us-gaap/2024
0001641172-25-004643 20241231 Stock Issued During Period Value Conversion Of Convertible Securities USD 4 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001641172-25-004643 20231231 Stock Issued During Period Value Reverse Stock Splits USD 4 0001641172-25-004643 Equity Components= Retained Earnings;
0001641172-25-004643 20241231 Accounts Payable And Accrued Liabilities Current 2714102.0000 USD 0 us-gaap/2024
0001641172-25-004643 20231231 Assets 3900000.0000 USD 0 us-gaap/2024 Consolidated Entities= Variable Interest Entities;
0001641172-25-004643 20241231 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations 504189.0000 USD 0 us-gaap/2024
0001641172-25-004643 20241231 Cash Provided By Used In Operating Activities Discontinued Operations -2748049.0000 USD 4 us-gaap/2024
0001641172-25-004643 20241231 Common Stock Par Or Stated Value Per Share 0.0010 USD 0 us-gaap/2024
0001641172-25-004643 20231231 Common Stock Shares Outstanding 1148321.0000 shares 0 us-gaap/2024
0001641172-25-004643 20231231 Depreciation Depletion And Amortization 403593.0000 USD 4 us-gaap/2024
0001641172-25-004643 20231231 Earnings Per Share Basic -8.4700 USD 4 us-gaap/2024
0001641172-25-004643 20241231 Gain Loss On Disposition Of Assets USD 4 us-gaap/2024 Consolidation Items= Operating Segments;
0001641172-25-004643 20241231 Gain Loss On Disposition Of Assets1 USD 4 us-gaap/2024
0001641172-25-004643 20241231 Gross Profit -233198.0000 USD 4 us-gaap/2024 Consolidation Items= Operating Segments;
0001641172-25-004643 20231231 Income Tax Expense Benefit USD 4 us-gaap/2024
0001641172-25-004643 20241231 Increase Decrease In Deferred Compensation USD 4 us-gaap/2024
0001641172-25-004643 20241231 Increase Decrease In Right Of Use Lease Liability USD 4 0001641172-25-004643
0001641172-25-004643 20241231 Investment Income Interest 3470.0000 USD 4 us-gaap/2024
0001641172-25-004643 20231231 Liabilities 1896766.0000 USD 0 us-gaap/2024
0001641172-25-004643 20231231 Liabilities And Stockholders Equity 1144119.0000 USD 0 us-gaap/2024
0001641172-25-004643 20231231 Nonoperating Income Expense -99850.0000 USD 4 us-gaap/2024
0001641172-25-004643 20241231 Payments To Acquire Notes Receivable 375000.0000 USD 4 us-gaap/2024
0001641172-25-004643 20241231 Payments To Acquire Property Plant And Equipment 1100000.0000 USD 4 us-gaap/2024 Type Of Arrangement= Settlement And Release Agreement;
0001641172-25-004643 20231231 Preferred Stock Par Or Stated Value Per Share 0.0010 USD 0 us-gaap/2024
0001641172-25-004643 20231231 Preferred Stock Shares Authorized 5000000.0000 shares 0 us-gaap/2024
0001641172-25-004643 20241231 Preferred Stock Shares Outstanding 50502.0000 shares 0 us-gaap/2024
0001641172-25-004643 20231231 Preferred Stock Value 5.0000 USD 0 us-gaap/2024
0001641172-25-004643 20230731 Proceeds From Issuance Of Preferred Stock And Preference Stock 4300000.0000 USD 0 us-gaap/2024 Type Of Arrangement= Securities Purchase Agreement;
0001641172-25-004643 20241231 Provision For Doubtful Accounts USD 4 us-gaap/2024
0001641172-25-004643 20241231 Repayments Of Debt And Capital Lease Obligations 1724.0000 USD 4 us-gaap/2024
0001641172-25-004643 20241231 Retained Earnings Accumulated Deficit -64984152.0000 USD 0 us-gaap/2024
0001641172-25-004643 20241231 Revenue From Contract With Customer Excluding Assessed Tax 72050.0000 USD 4 us-gaap/2024
0001641172-25-004643 20241231 Stockholders Equity -64984152.0000 USD 0 us-gaap/2024 Equity Components= Retained Earnings;
0001641172-25-004643 20231231 Stock Issued During Period Preferred Stock Value 4045001.0000 USD 4 0001641172-25-004643
0001641172-25-004643 20241231 Stock Issued During Period Shares Conversion Of Convertible Securities 864846.0000 shares 4 us-gaap/2024 Equity Components= Common Stock;
0001641172-25-004643 20241231 Stock Issued During Period Value Conversion Of Convertible Securities -2.0000 USD 4 us-gaap/2024 Equity Components= Preferred Stock;
0001641172-25-004643 20241231 Stock Issued During Period Value New Issues 4490058.0000 USD 4 us-gaap/2024
0001641172-25-004643 20241231 Stock Issued During Period Value New Issues USD 4 us-gaap/2024 Equity Components= Common Stock;
0001641172-25-004643 20231231 Stock Issued During Period Value Reverse Stock Splits 38.0000 USD 4 0001641172-25-004643 Equity Components= Common Stock;
0001641172-25-004643 20231231 Stock Issued During Period Value Share Based Compensation Gross 42890.0000 USD 4 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001641172-25-004643 20241231 Stock Issued During Period Value Share Based Compensation Gross 35415.0000 USD 4 us-gaap/2024
0001641172-25-004643 20241231 Accrued Dividends 1251000.0000 USD 4 0001641172-25-004643
0001641172-25-004643 20231231 Adjustments To Additional Paid In Capital Issuance Of Employee Stock Option USD 4 0001641172-25-004643 Equity Components= Common Stock;
0001641172-25-004643 20241231 Asset Impairment Charges 2300000.0000 USD 4 us-gaap/2024 Adjustments For New Accounting Pronouncements= Accounting Standards Update201613;
0001641172-25-004643 20231231 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect -541700.0000 USD 4 us-gaap/2024
0001641172-25-004643 20241231 Commitments And Contingencies USD 0 us-gaap/2024
0001641172-25-004643 20231231 Cost Of Revenue USD 4 us-gaap/2024 Consolidation Items= Operating Segments;
0001641172-25-004643 20241231 Earnings Per Share Basic -5.7600 USD 4 us-gaap/2024
0001641172-25-004643 20231231 Earnings Per Share Diluted -8.4700 USD 4 us-gaap/2024
0001641172-25-004643 20241231 Gross Profit -233198.0000 USD 4 us-gaap/2024
0001641172-25-004643 20231231 Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest -6475358.0000 USD 4 us-gaap/2024
0001641172-25-004643 20231231 Income Loss From Discontinued Operations Net Of Tax -2943227.0000 USD 4 us-gaap/2024
0001641172-25-004643 20241231 Income Loss From Discontinued Operations Net Of Tax Per Diluted Share -1.7500 USD 4 us-gaap/2024
0001641172-25-004643 20241231 Income Tax Expense Benefit USD 4 us-gaap/2024
0001641172-25-004643 20231231 Increase Decrease In Accounts Payable And Accrued Liabilities -388467.0000 USD 4 us-gaap/2024
0001641172-25-004643 20241231 Increase Decrease In Accounts Payable And Accrued Liabilities 5063810.0000 USD 4 us-gaap/2024
0001641172-25-004643 20231231 Interest Expense Debt USD 4 us-gaap/2024
0001641172-25-004643 20231231 Liabilities Current 1896766.0000 USD 0 us-gaap/2024
0001641172-25-004643 20231231 Net Income Loss -9418585.0000 USD 4 us-gaap/2024 Equity Components= Retained Earnings;
0001641172-25-004643 20241231 Net Income Loss USD 4 us-gaap/2024 Equity Components= Common Stock;
0001641172-25-004643 20241231 Operating Expenses 5390069.0000 USD 4 us-gaap/2024
0001641172-25-004643 20231231 Other Nonoperating Income Expense -2040.0000 USD 4 us-gaap/2024
0001641172-25-004643 20241231 Other Nonoperating Income Expense USD 4 us-gaap/2024 Consolidation Items= Operating Segments;
0001641172-25-004643 20231231 Preferred Stock Converstion USD 4 0001641172-25-004643
0001641172-25-004643 20231231 Preferred Stock Dividends Income Statement Impact 130000.0000 USD 4 us-gaap/2024
0001641172-25-004643 20231231 Preferred Stock Shares Outstanding 1905.0000 shares 0 us-gaap/2024 Class Of Stock= Series B Two Preferred Stock;
0001641172-25-004643 20241231 Preferred Stock Shares Outstanding 450.0000 shares 0 us-gaap/2024 Class Of Stock= Series F Preferred Stock;
0001641172-25-004643 20241231 Preferred Stock Shares Outstanding 4676.0000 shares 0 us-gaap/2024 Class Of Stock= Series G Preferred Stock;
0001641172-25-004643 20241231 Prepaid Expense And Other Assets Current 152122.0000 USD 0 us-gaap/2024
0001641172-25-004643 20241231 Proceeds From Issuance Of Preferred Stock And Preference Stock 2221492.0000 USD 4 us-gaap/2024
0001641172-25-004643 20241231 Proceeds From Issuance Of Preferred Stock And Preference Stock 2200000.0000 USD 4 us-gaap/2024 Class Of Stock= Series G Preferred Stock;
0001641172-25-004643 20241231 Proceeds From Sale Of Property Plant And Equipment USD 4 us-gaap/2024
0001641172-25-004643 20231231 Revenue From Contract With Customer Excluding Assessed Tax USD 4 us-gaap/2024 Consolidation Items= Operating Segments;
0001641172-25-004643 20241231 Share Based Compensation 35415.0000 USD 4 us-gaap/2024
0001641172-25-004643 20221231 Stockholders Equity 1098.0000 USD 0 us-gaap/2024 Equity Components= Common Stock;
0001641172-25-004643 20230731 Stock Issued During Period Shares New Issues 2500.0000 shares 0 us-gaap/2024 Class Of Stock= Series A One Convertible Preferred Stock; Type Of Arrangement= Securities Purchase Agreement;
0001641172-25-004643 20231231 Stock Issued During Period Value New Issues 16650.0000 USD 4 us-gaap/2024
0001641172-25-004643 20241231 Stock Issued During Period Value New Issues USD 4 us-gaap/2024 Equity Components= Retained Earnings;
0001641172-25-004643 20241231 Stock Issued During Period Value Share Based Compensation Gross USD 4 us-gaap/2024 Equity Components= Preferred Stock;
0001641172-25-004643 20231231 Weighted Average Number Of Diluted Shares Outstanding 1111844.0000 shares 4 us-gaap/2024
0001641172-25-004643 20241231 Weighted Average Number Of Shares Outstanding Basic 1569627.0000 shares 4 us-gaap/2024
0001641172-25-017193 20240630 Accounts Payable And Accrued Liabilities Current USD 0 us-gaap/2024 Restatement= Revision Of Prior Period Reclassification Adjustment;
0001641172-25-004643 20241231 Additional Paid In Capital 58588953.0000 USD 0 us-gaap/2024
0001641172-25-004643 20231231 Adjustments To Additional Paid In Capital Dividend In Excess Of Retained Earnings USD 4 0001641172-25-004643 Equity Components= Common Stock;
0001641172-25-004643 20241231 Adjustments To Additional Paid In Capital Dividend In Excess Of Retained Earnings USD 4 0001641172-25-004643 Equity Components= Common Stock;
0001641172-25-004643 20231231 Asset Impairment Charges 3519322.0000 USD 4 us-gaap/2024
0001641172-25-004643 20231231 Assets 1144119.0000 USD 0 us-gaap/2024
0001641172-25-004643 20241231 Cash 504189.0000 USD 0 us-gaap/2024
0001641172-25-004643 20241231 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect 282678.0000 USD 4 us-gaap/2024
0001641172-25-004643 20231231 Cash Provided By Used In Operating Activities Discontinued Operations -2943227.0000 USD 4 us-gaap/2024
0001641172-25-004643 20231231 Common Stock Par Or Stated Value Per Share 0.0010 USD 0 us-gaap/2024
0001641172-25-004643 20231231 Common Stock Par Or Stated Value Per Share 4.2900 USD 0 us-gaap/2024 Title Of Individual= Board Of Directors Chairman;
0001641172-25-004643 20231231 Common Stock Shares Authorized 120000000.0000 shares 0 us-gaap/2024
0001641172-25-004643 20241231 Common Stock Shares Authorized 120000000.0000 shares 0 us-gaap/2024
0001641172-25-004643 20230131 Common Stock Shares Issued 2725.0000 shares 0 us-gaap/2024
0001641172-25-004643 20241231 Dividends Payable Current 1250979.0000 USD 0 us-gaap/2024
0001641172-25-004643 20241231 Earnings Per Share Diluted -5.7600 USD 4 us-gaap/2024
0001641172-25-004643 20241231 Gain Loss On Disposition Of Assets USD 4 us-gaap/2024
0001641172-25-004643 20241231 Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest -6297778.0000 USD 4 us-gaap/2024
0001641172-25-004643 20241231 Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest -6297778.0000 USD 4 us-gaap/2024 Consolidation Items= Operating Segments;
0001641172-25-004643 20241231 Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interests -6297778.0000 USD 4 0001641172-25-004643
0001641172-25-004643 20231231 Income Loss From Discontinued Operations Net Of Tax Per Diluted Share -2.6500 USD 4 us-gaap/2024
0001641172-25-004643 20231231 Increase Decrease In Accounts Receivable -1449569.0000 USD 4 us-gaap/2024
0001641172-25-004643 20231231 Increase Decrease In Security Deposits 205389.0000 USD 4 us-gaap/2024
0001641172-25-004643 20241231 Net Cash Provided By Used In Investing Activities -375000.0000 USD 4 us-gaap/2024
0001641172-25-004643 20241231 Net Income Loss Available To Common Stockholders Basic -10296806.0000 USD 4 us-gaap/2024
0001641172-25-004643 20241231 Operating Income Loss -5623267.0000 USD 4 us-gaap/2024
0001641172-25-004643 20241231 Preferred Stock Shares Outstanding 2564.0000 shares 0 us-gaap/2024 Class Of Stock= Series C One Preferred Stock;
0001641172-25-004643 20241231 Preferred Stock Shares Outstanding 24172.0000 shares 0 us-gaap/2024 Class Of Stock= Series E Preferred Stock;
0001641172-25-004643 20241231 Proceeds From Notes Payable 1600000.0000 USD 4 us-gaap/2024 Title Of Individual= Lenders;
0001641172-25-004643 20250331 Proceeds From Notes Payable 1000000.0000 USD 1 us-gaap/2024 Debt Instrument= Two Thousand Twenty Five Notes; Subsequent Event Type= Subsequent Event; Title Of Individual= Lenders;
0001641172-25-004643 20231231 Proceeds From Repayments Of Notes Payable -10350.0000 USD 4 us-gaap/2024
0001641172-25-004643 20231231 Proceeds From Sale Of Practices 224700.0000 USD 4 0001641172-25-004643
0001641172-25-004643 20231231 Proceeds From Sale Of Property Plant And Equipment 1000000.0000 USD 4 us-gaap/2024
0001641172-25-004643 20231231 Property Plant And Equipment Net USD 0 us-gaap/2024
0001641172-25-004643 20231231 Provision For Doubtful Accounts 431671.0000 USD 4 us-gaap/2024
0001641172-25-004643 20231231 Repayments Of Debt And Capital Lease Obligations 27549.0000 USD 4 us-gaap/2024
0001641172-25-004643 20231231 Retained Earnings Accumulated Deficit -55938325.0000 USD 0 us-gaap/2024
0001641172-25-004643 20231231 Share Based Compensation 83031.0000 USD 4 us-gaap/2024
0001641172-25-004643 20221231 Shares Outstanding shares 0 us-gaap/2024 Equity Components= Preferred Stock;
0001641172-25-004643 20221231 Stockholders Equity -46519740.0000 USD 0 us-gaap/2024 Equity Components= Retained Earnings;
0001641172-25-004643 20231231 Stock Issued During Period Preferred Stock Value 4044996.0000 USD 4 0001641172-25-004643 Equity Components= Additional Paid In Capital;
0001641172-25-004643 20231231 Stock Issued During Period Preferred Stock Value 5.0000 USD 4 0001641172-25-004643 Equity Components= Preferred Stock;
0001641172-25-004643 20241231 Stock Issued During Period Shares New Issues 1276.0000 shares 4 us-gaap/2024 Class Of Stock= Series C Two Preferred Stock;
0001641172-25-004643 20231231 Stock Issued During Period Value New Issues 3.0000 USD 4 us-gaap/2024 Equity Components= Common Stock;
0001641172-25-017193 20240630 Accrued Dividends 114000.0000 USD 2 0001641172-25-017193
0001641172-25-017193 20240630 Adjustments To Additional Paid In Capital Dividends In Excess Of Retained Earnings USD 1 us-gaap/2024 Equity Components= Preferred Stock;
0001641172-25-017193 20240630 Adjustments To Additional Paid In Capital Dividends In Excess Of Retained Earnings USD 2 us-gaap/2024 Equity Components= Retained Earnings;
0001641172-25-017193 20231231 Assets Current 1144119.0000 USD 0 us-gaap/2024
0001641172-25-017193 20230630 Capitalized Dividends USD 2 0001641172-25-017193
0001641172-25-017193 20240630 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations USD 0 us-gaap/2024 Restatement= Revision Of Prior Period Reclassification Adjustment;
0001641172-25-017193 20240630 Cost Of Revenue 72002.0000 USD 1 us-gaap/2024
0001641172-25-017193 20240630 Depreciation Depletion And Amortization 34795.0000 USD 2 us-gaap/2024 Restatement= Scenario Previously Reported;
0001641172-25-017193 20240630 Earnings Per Share Basic -1.7200 USD 1 us-gaap/2024
0001641172-25-017193 20240630 Earnings Per Share Diluted -2.1600 USD 2 us-gaap/2024
0001641172-25-017193 20230630 General And Administrative Expense 2131944.0000 USD 2 us-gaap/2024
0001641172-25-017193 20240630 Income Loss From Continuing Operations Per Basic Share -2.2200 USD 2 us-gaap/2024
0001641172-25-017193 20240630 Income Loss From Discontinued Operations Net Of Tax 29702.0000 USD 1 us-gaap/2024
0001641172-25-017193 20230630 Income Loss From Discontinued Operations Net Of Tax Per Basic Share -2.4000 USD 2 us-gaap/2024
0001641172-25-017193 20240630 Income Taxes Paid Net USD 2 us-gaap/2024 Restatement= Scenario Previously Reported;
0001641172-25-017193 20230630 Income Tax Expense Benefit USD 2 us-gaap/2024
0001641172-25-017193 20240630 Increase Decrease In Accounts Payable And Accrued Liabilities 882079.0000 USD 2 us-gaap/2024
0001641172-25-017193 20230630 Interest Expense Debt USD 2 us-gaap/2024
0001641172-25-017193 20240630 Interest Expense Debt 14444.0000 USD 2 us-gaap/2024
0001641172-25-017193 20240630 Interest Expense Nonoperating 52426.0000 USD 2 us-gaap/2024
0001641172-25-017193 20240630 Interest Paid Net USD 2 us-gaap/2024 Restatement= Scenario Previously Reported;
0001641172-25-017193 20230630 Investment Income Interest 1.0000 USD 1 us-gaap/2024
0001641172-25-017193 20231231 Liabilities Current 1896766.0000 USD 0 us-gaap/2024
0001641172-25-017193 20240630 Liabilities Current -525075.0000 USD 0 us-gaap/2024 Restatement= Revision Of Prior Period Reclassification Adjustment;
0001641172-25-017193 20240630 Net Cash Provided By Used In Investing Activities USD 2 us-gaap/2024 Restatement= Revision Of Prior Period Reclassification Adjustment;
0001641172-25-017193 20230630 Net Income Loss USD 1 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001641172-25-017193 20240630 Net Income Loss -1383404.0000 USD 1 us-gaap/2024
0001641172-25-017193 20240630 Net Income Loss USD 1 us-gaap/2024 Equity Components= Preferred Stock;
0001641172-25-017193 20230630 Operating Expenses 1137682.0000 USD 1 us-gaap/2024
0001641172-25-017193 20240630 Operating Expenses 1754322.0000 USD 2 us-gaap/2024
0001641172-25-017193 20240630 Payments To Acquire Notes Receivable 375000.0000 USD 2 us-gaap/2024 Restatement= Scenario Previously Reported;
0001641172-25-017193 20230630 Preferred Dividends Accrued USD 2 0001641172-25-017193
0001641172-25-017193 20230630 Preferred Stock Dividends Income Statement Impact USD 1 us-gaap/2024
0001641172-25-017193 20240630 Preferred Stock Dividends Income Statement Impact 648116.0000 USD 1 us-gaap/2024
0001641172-25-017193 20240630 Preferred Stock Par Or Stated Value Per Share 0.0010 USD 0 us-gaap/2024
0001641172-25-017193 20240630 Preferred Stock Shares Authorized 5000000.0000 shares 0 us-gaap/2024
0001641172-25-017193 20240630 Preferred Stock Shares Issued 3864.0000 shares 0 us-gaap/2024 Class Of Stock= Series C One Preferred Stock; Restatement= Revision Of Prior Period Reclassification Adjustment;
0001641172-25-017193 20240630 Preferred Stock Shares Issued 1276.0000 shares 0 us-gaap/2024 Class Of Stock= Series C Two Preferred Stock;
0001641172-25-017193 20240630 Preferred Stock Shares Issued 1276.0000 shares 0 us-gaap/2024 Class Of Stock= Series C Two Preferred Stock; Restatement= Revision Of Prior Period Reclassification Adjustment;
0001641172-25-017193 20240630 Preferred Stock Shares Issued 24172.0000 shares 0 us-gaap/2024 Class Of Stock= Series E Preferred Stock; Restatement= Revision Of Prior Period Reclassification Adjustment;
0001641172-25-017193 20231231 Preferred Stock Shares Outstanding 1905.0000 shares 0 us-gaap/2024 Class Of Stock= Series B Two Preferred Stock;
0001641172-25-017193 20240630 Proceeds From Issuance Of Preferred Stock And Preference Stock 975951.0000 USD 2 us-gaap/2024 Restatement= Scenario Previously Reported;
0001641172-25-017193 20240630 Property Plant And Equipment Net 1009066.0000 USD 0 us-gaap/2024
0001641172-25-017193 20240630 Settlement Of Notes Receivable In Connection With Asset Purchase Agreement 1083000.0000 USD 2 0001641172-25-017193
0001641172-25-017193 20240630 Settlement Of Notes Receivable In Connection With Asset Purchase Agreement USD 2 0001641172-25-017193 Restatement= Revision Of Prior Period Reclassification Adjustment;
0001641172-25-017193 20230331 Stockholders Equity 996955.0000 USD 0 us-gaap/2024
0001641172-25-017193 20230331 Stockholders Equity 1101.0000 USD 0 us-gaap/2024 Equity Components= Common Stock;
0001641172-25-017193 20240630 Stock Issued During Period Shares Conversion Of Preferred Stock Into Common Shares -886.0000 shares 1 0001641172-25-017193 Equity Components= Preferred Stock;
0001641172-25-017193 20240630 Stock Issued During Period Shares New Issues 17364.0000 shares 2 us-gaap/2024 Class Of Stock= Series D Preferred Stock;
0001641172-25-017193 20240630 Stock Issued During Period Shares New Issues 24172.0000 shares 2 us-gaap/2024 Class Of Stock= Series E Preferred Stock;
0001641172-25-017193 20240630 Stock Issued During Period Shares New Issues 24172.0000 shares 2 us-gaap/2024 Class Of Stock= Series E Preferred Stock; Type Of Arrangement= Settlement And Release Agreement;
0001641172-25-017193 20240630 Stock Issued During Period Shares New Issues 450.0000 shares 2 us-gaap/2024 Class Of Stock= Series F Preferred Stock;
0001641172-25-017193 20240630 Stock Issued During Period Value Conversion Of Preferred Stock Into Common Shares USD 1 0001641172-25-017193
0001641172-25-017193 20240630 Stock Issued During Period Value Conversion Of Preferred Stock Into Common Shares -1.0000 USD 2 0001641172-25-017193 Equity Components= Preferred Stock;
0001641172-25-017193 20240630 Stock Issued During Period Value Preferred Stock Net Of Issuance Costs USD 1 0001641172-25-017193 Equity Components= Retained Earnings;
0001641172-25-017193 20240630 Stock Issued During Period Value Preferred Stock Net Of Issuance Costs 975909.0000 USD 2 0001641172-25-017193 Equity Components= Additional Paid In Capital;
0001641172-25-017193 20230630 Weighted Average Number Of Shares Outstanding Basic 1100568.0000 shares 1 us-gaap/2024
0001641172-25-017196 20240930 Accounts Receivable Net Current 41700.0000 USD 0 us-gaap/2024 Restatement= Scenario Previously Reported;
0001641172-25-017196 20240930 Adjustments To Additional Paid In Capital Capitalized Dividends 1062777.0000 USD 1 0001641172-25-017196
0001641172-25-017196 20240930 Adjustments To Additional Paid In Capital Capitalized Dividends USD 3 0001641172-25-017196 Equity Components= Common Stock;
0001641172-25-017196 20240930 Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition USD 1 us-gaap/2024 Equity Components= Preferred Stock;
0001641172-25-017196 20240930 Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition 3562.0000 USD 3 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001641172-25-017196 20240930 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect USD 3 us-gaap/2024 Restatement= Revision Of Prior Period Reclassification Adjustment;
0001641172-25-017196 20240930 Common Stock Shares Outstanding 2013199.0000 shares 0 us-gaap/2024
0001641172-25-017196 20240930 Cost Of Revenue 194079.0000 USD 3 us-gaap/2024
0001641172-25-017196 20230930 Depreciation Depletion And Amortization 386847.0000 USD 3 us-gaap/2024
0001641172-25-017196 20240930 Preferred Stock Value 46.0000 USD 0 us-gaap/2024
0001641172-25-017196 20240930 Depreciation Depletion And Amortization USD 3 us-gaap/2024 Restatement= Revision Of Prior Period Reclassification Adjustment;
0001641172-25-017196 20240930 Earnings Per Share Basic -3.6400 USD 3 us-gaap/2024 Restatement= Scenario Previously Reported;
0001641172-25-017196 20240930 Earnings Per Share Diluted -4.1600 USD 3 us-gaap/2024
0001641172-25-017196 20230930 Gain Loss On Disposition Of Assets -2568608.0000 USD 3 us-gaap/2024
0001641172-25-017196 20240930 Gain Loss On Disposition Of Assets USD 3 us-gaap/2024 Restatement= Revision Of Prior Period Reclassification Adjustment;
0001641172-25-017196 20230930 General And Administrative Expense 996592.0000 USD 1 us-gaap/2024
0001641172-25-017196 20240930 Gross Profit -122029.0000 USD 3 us-gaap/2024 Restatement= Scenario Previously Reported;
0001641172-25-017196 20240930 Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest -3963279.0000 USD 3 us-gaap/2024 Restatement= Scenario Previously Reported;
0001641172-25-017196 20230930 Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interests -5763227.0000 USD 3 0001641172-25-017196
0001641172-25-017196 20230930 Income Loss From Continuing Operations Per Basic Share -5.2800 USD 3 us-gaap/2024
0001641172-25-017196 20240930 Income Loss From Continuing Operations Per Basic Share -4.1400 USD 3 us-gaap/2024
0001641172-25-017196 20240930 Income Loss From Continuing Operations Per Diluted Share -3.6200 USD 3 us-gaap/2024 Restatement= Scenario Previously Reported;
0001641172-25-017196 20240930 Income Loss From Discontinued Operations Net Of Tax USD 3 us-gaap/2024 Restatement= Revision Of Prior Period Reclassification Adjustment;
0001641172-25-017196 20230930 Income Loss From Discontinued Operations Net Of Tax Per Diluted Share -2.0000 USD 3 us-gaap/2024
0001641172-25-017196 20240930 Income Loss From Discontinued Operations Net Of Tax Per Diluted Share USD 3 us-gaap/2024 Restatement= Restatement Adjustment;
0001641172-25-017196 20230930 Income Tax Expense Benefit USD 1 us-gaap/2024
0001641172-25-017196 20240930 Income Tax Expense Benefit USD 1 us-gaap/2024
0001641172-25-017196 20240930 Increase Decrease In Accounts Receivable 41700.0000 USD 3 us-gaap/2024 Restatement= Scenario Previously Reported;
0001641172-25-017196 20240930 Interest Expense Nonoperating USD 3 us-gaap/2024 Restatement= Revision Of Prior Period Reclassification Adjustment;
0001641172-25-017196 20240930 Liabilities And Stockholders Equity 1467611.0000 USD 0 us-gaap/2024 Restatement= Scenario Previously Reported;
0001641172-25-017196 20231231 Liabilities Current 1896766.0000 USD 0 us-gaap/2024
0001641172-25-017196 20240930 Net Cash Provided By Used In Financing Activities 2374227.0000 USD 3 us-gaap/2024 Restatement= Scenario Previously Reported;
0001641172-25-017196 20230930 Net Income Loss -7959631.0000 USD 3 us-gaap/2024
0001641172-25-017196 20240930 Net Income Loss USD 1 us-gaap/2024 Equity Components= Common Stock;
0001641172-25-017196 20240930 Net Income Loss USD 3 us-gaap/2024 Restatement= Revision Of Prior Period Reclassification Adjustment;
0001641172-25-017196 20240930 Net Income Loss Available To Common Stockholders Basic -3363425.0000 USD 1 us-gaap/2024
0001641172-25-017196 20240930 Net Income Loss Available To Common Stockholders Basic -725347.0000 USD 1 us-gaap/2024 Restatement= Revision Of Prior Period Reclassification Adjustment;
0001641172-25-017196 20240930 Net Income Losses -3995271.0000 USD 3 0001641172-25-017196 Restatement= Scenario Previously Reported;
0001641172-25-017196 20240930 Operating Expenses USD 3 us-gaap/2024 Restatement= Revision Of Prior Period Reclassification Adjustment;
0001641172-25-017196 20230930 Operating Income Loss -5697144.0000 USD 3 us-gaap/2024
0001641172-25-017196 20240930 Operating Income Loss -3806665.0000 USD 3 us-gaap/2024
0001641172-25-017196 20240930 Preferred Stock Par Or Stated Value Per Share 0.0010 USD 0 us-gaap/2024
0001641172-25-017196 20240930 Preferred Stock Shares Issued 45826.0000 shares 0 us-gaap/2024
0001641172-25-017196 20240930 Preferred Stock Shares Outstanding 450.0000 shares 0 us-gaap/2024 Class Of Stock= Series F Preferred Stock;
0001641172-25-017196 20240930 Preferred Stock Value 46.0000 USD 0 us-gaap/2024 Restatement= Scenario Previously Reported;
0001641172-25-017196 20230930 Proceeds From Issuance Of Common Stock 64032.0000 USD 3 us-gaap/2024
0001641172-25-017196 20240930 Property Plant And Equipment Net 956873.0000 USD 0 us-gaap/2024
0001641172-25-017196 20240930 Repayments Of Debt And Capital Lease Obligations 1724.0000 USD 3 us-gaap/2024
0001641172-25-017196 20240930 Retained Earnings Accumulated Deficit USD 0 us-gaap/2024 Restatement= Revision Of Prior Period Reclassification Adjustment;
0001641172-25-017196 20230930 Shares Outstanding 1109335.0000 shares 0 us-gaap/2024 Equity Components= Common Stock;
0001641172-25-017196 20240630 Shares Outstanding 47126.0000 shares 0 us-gaap/2024 Equity Components= Preferred Stock;
0001641172-25-017196 20240930 Shares Outstanding 2013167.0000 shares 0 us-gaap/2024 Equity Components= Common Stock; Restatement= Scenario Previously Reported;
0001641172-25-017196 20240930 Stockholders Equity 55894475.0000 USD 0 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001641172-25-017196 20240930 Stockholders Equity 1151.0000 USD 0 us-gaap/2024 Equity Components= Common Stock; Restatement= Scenario Previously Reported;
0001641172-25-017196 20240930 Stock Issued During Period Shares New Issues 1276.0000 shares 3 us-gaap/2024 Class Of Stock= Series C Two Preferred Stock;
0001641172-25-017196 20241031 Stock Issued During Period Shares New Issues 4676.0000 shares 0 us-gaap/2024 Class Of Stock= Series G Preferred Stock; Subsequent Event Type= Subsequent Event;
0001641172-25-017196 20240930 Stock Issued During Period Shares Preferred Stock Net Of Issuance Costs 43462.0000 shares 3 0001641172-25-017196 Equity Components= Preferred Stock;
0001641172-25-017196 20240930 Stock Issued During Period Value Conversion Of Series C1 Preferred Stock Into Common Shares 28886.0000 USD 1 0001641172-25-017196
0001641172-25-017196 20240930 Stock Issued During Period Value Conversion Of Series C1 Preferred Stock Into Common Shares 2.0000 USD 3 0001641172-25-017196 Equity Components= Common Stock;
0001641172-25-017196 20230930 Stock Issued During Period Value Preferred Stock Net Of Issuance Costs 4300000.0000 USD 1 0001641172-25-017196
0001641172-25-017196 20230930 Weighted Average Number Of Diluted Shares Outstanding 1107134.0000 shares 1 us-gaap/2024
0001641172-25-017196 20230930 Weighted Average Number Of Diluted Shares Outstanding 1102738.0000 shares 3 us-gaap/2024
0001641172-25-017196 20240930 Weighted Average Number Of Shares Outstanding Basic 1909588.0000 shares 1 us-gaap/2024 Restatement= Scenario Previously Reported;
0001641172-25-017216 20241231 Accounts And Other Receivables Net Current USD 0 us-gaap/2024 Restatement= Scenario Previously Reported;
0001641172-25-017216 20231231 Accounts Payable And Accrued Liabilities Current 454055.0000 USD 0 us-gaap/2024
0001641172-25-017216 20241231 Accounts Receivable Net Current 28030.0000 USD 0 us-gaap/2024
0001641172-25-017216 20241231 Accounts Receivable Net Current 28030.0000 USD 0 us-gaap/2024 Restatement= Scenario Previously Reported;
0001641172-25-017216 20231231 Adjustments To Additional Paid In Capital Issuance Of Employee Stock Option 40131.0000 USD 4 0001641172-25-017216
0001641172-25-017216 20231231 Adjustments To Additional Paid In Capital Issuance Of Employee Stock Option 40131.0000 USD 4 0001641172-25-017216 Equity Components= Additional Paid In Capital;
0001641172-25-017216 20231231 Adjustments To Additional Paid In Capital Issuance Of Employee Stock Option USD 4 0001641172-25-017216 Equity Components= Common Stock;
0001641172-25-017216 20241231 Assets Current USD 0 us-gaap/2024 Restatement= Revision Of Prior Period Reclassification Adjustment;
0001641172-25-017216 20221231 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations 763211.0000 USD 0 us-gaap/2024
0001641172-25-017216 20241231 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations 504189.0000 USD 0 us-gaap/2024 Restatement= Scenario Previously Reported;
0001641172-25-017216 20231231 Common Stock Shares Issued 1148321.0000 shares 0 us-gaap/2024
0001641172-25-017216 20231231 Common Stock Shares Outstanding 1148321.0000 shares 0 us-gaap/2024
0001641172-25-017216 20231231 Common Stock Value 42900.0000 USD 0 us-gaap/2024 Title Of Individual= Board Of Directors Chairman;
0001641172-25-017216 20241231 Depreciation Depletion And Amortization 139182.0000 USD 4 us-gaap/2024
0001641172-25-017216 20241231 Depreciation Depletion And Amortization USD 4 us-gaap/2024 Restatement= Revision Of Prior Period Reclassification Adjustment;
0001641172-25-017216 20241231 Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest -6297778.0000 USD 4 us-gaap/2024 Restatement= Scenario Previously Reported;
0001641172-25-017216 20231231 Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest -6475358.0000 USD 4 us-gaap/2024
0001641172-25-017216 20241231 Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest USD 4 us-gaap/2024 Restatement= Revision Of Prior Period Reclassification Adjustment;
0001641172-25-017216 20241231 Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interests -6297778.0000 USD 4 0001641172-25-017216
0001641172-25-017216 20231231 Income Loss From Continuing Operations Per Basic Share -5.8200 USD 4 us-gaap/2024
0001641172-25-017216 20241231 Income Loss From Continuing Operations Per Basic Share -6.0100 USD 4 us-gaap/2024
0001641172-25-017216 20241231 Income Loss From Continuing Operations Per Diluted Share -6.0100 USD 4 us-gaap/2024
0001641172-25-017216 20241231 Income Loss From Continuing Operations Per Diluted Share -4.0100 USD 4 us-gaap/2024 Restatement= Scenario Previously Reported;
0001641172-25-017216 20241231 Income Loss From Discontinued Operations Net Of Tax Per Basic Share -1.7500 USD 4 us-gaap/2024
0001641172-25-017216 20231231 Income Loss From Discontinued Operations Net Of Tax Per Diluted Share -2.6500 USD 4 us-gaap/2024
0001641172-25-017216 20241231 Increase Decrease In Prepaid Deferred Expense And Other Assets -33360.0000 USD 4 us-gaap/2024 Restatement= Scenario Previously Reported;
0001641172-25-017216 20241231 Interest Expense Debt 640000.0000 USD 4 us-gaap/2024 Restatement= Scenario Previously Reported;
0001641172-25-017216 20231231 Interest Expense Nonoperating 325585.0000 USD 4 us-gaap/2024 Consolidation Items= Operating Segments;
0001641172-25-017216 20231231 Investment Income Interest 27156.0000 USD 4 us-gaap/2024 Consolidation Items= Operating Segments;
0001641172-25-017216 20241231 Liabilities 7227546.0000 USD 0 us-gaap/2024
0001641172-25-017216 20241231 Liabilities 2900000.0000 USD 0 us-gaap/2024 Consolidated Entities= Variable Interest Entities;
0001641172-25-017216 20241231 Liabilities Current -755455.0000 USD 0 us-gaap/2024 Restatement= Revision Of Prior Period Reclassification Adjustment;
0001641172-25-017216 20241231 Liabilities Current 7983001.0000 USD 0 us-gaap/2024 Restatement= Scenario Previously Reported;
0001641172-25-017216 20241231 Liabilities Of Disposal Group Including Discontinued Operation Current 4017920.0000 USD 0 us-gaap/2024
0001641172-25-017216 20241231 Liabilities Of Disposal Group Including Discontinued Operation Current USD 0 us-gaap/2024 Restatement= Revision Of Prior Period Reclassification Adjustment;
0001641172-25-017216 20241231 Net Cash Provided By Used In Financing Activities USD 4 us-gaap/2024 Restatement= Revision Of Prior Period Reclassification Adjustment;
0001641172-25-017216 20231231 Net Cash Provided By Used In Operating Activities -2790151.0000 USD 4 us-gaap/2024
0001641172-25-017216 20241231 Net Cash Provided By Used In Operating Activities -3162090.0000 USD 4 us-gaap/2024 Restatement= Scenario Previously Reported;
0001641172-25-017216 20241231 Net Cash Provided By Used In Operating Activities Continuing Operations -414041.0000 USD 4 us-gaap/2024 Restatement= Scenario Previously Reported;
0001641172-25-017216 20241231 Net Income Loss -9045827.0000 USD 4 us-gaap/2024 Equity Components= Retained Earnings;
0001641172-25-017216 20241231 Net Income Loss Available To Common Stockholders Basic -12178477.0000 USD 4 us-gaap/2024
0001641172-25-017216 20241231 Nonoperating Income Expense -674511.0000 USD 4 us-gaap/2024 Restatement= Scenario Previously Reported;
0001641172-25-017216 20231231 Operating Income Loss -6375508.0000 USD 4 us-gaap/2024 Consolidation Items= Operating Segments;
0001641172-25-017216 20241231 Operating Income Loss -5623267.0000 USD 4 us-gaap/2024
0001641172-25-017216 20231231 Other Nonoperating Income Expense -2040.0000 USD 4 us-gaap/2024 Consolidation Items= Operating Segments;
0001641172-25-017216 20231231 Payments To Acquire Property Plant And Equipment USD 4 us-gaap/2024
0001641172-25-017216 20241231 Payments To Acquire Property Plant And Equipment USD 4 us-gaap/2024
0001641172-25-017216 20241231 Preferred Dividends Accrued C1 And C2 306000.0000 USD 4 0001641172-25-017216 Restatement= Revision Of Prior Period Reclassification Adjustment;
0001641172-25-017216 20241231 Preferred Stock Converstion 2.0000 USD 4 0001641172-25-017216 Restatement= Scenario Previously Reported;
0001641172-25-017216 20240930 Preferred Stock Shares Issued 4550.0000 shares 0 us-gaap/2024
0001641172-25-017216 20241231 Preferred Stock Shares Outstanding 2564.0000 shares 0 us-gaap/2024 Class Of Stock= Series C One Preferred Stock;
0001641172-25-017216 20241231 Prepaid Expense And Other Assets Current USD 0 us-gaap/2024 Restatement= Revision Of Prior Period Reclassification Adjustment;
0001641172-25-017216 20231231 Proceeds From Issuance Of Common Stock 16650.0000 USD 4 us-gaap/2024
0001641172-25-017216 20241231 Proceeds From Issuance Of Preferred Stock And Preference Stock USD 4 us-gaap/2024 Restatement= Revision Of Prior Period Reclassification Adjustment;
0001641172-25-017216 20241231 Proceeds From Notes Payable 1600000.0000 USD 4 us-gaap/2024 Title Of Individual= Lenders;
0001641172-25-017216 20231231 Proceeds From Sale Of Property Plant And Equipment 1000000.0000 USD 4 us-gaap/2024
0001641172-25-017216 20231231 Provision For Doubtful Accounts 431671.0000 USD 4 us-gaap/2024
0001641172-25-017216 20241231 Repayments Of Debt And Capital Lease Obligations 1724.0000 USD 4 us-gaap/2024
0001641172-25-017216 20241231 Revenue From Contract With Customer Excluding Assessed Tax 72050.0000 USD 4 us-gaap/2024 Restatement= Scenario Previously Reported;
0001641172-25-017216 20241231 Settlement Of Notes Receivable In Connection With Asset Purchase Agreement 1044000.0000 USD 4 0001641172-25-017216 Restatement= Scenario Previously Reported;
0001641172-25-017216 20221231 Shares Outstanding 1097843.0000 shares 0 us-gaap/2024 Equity Components= Common Stock;
0001641172-25-017216 20241231 Shares Outstanding 50502.0000 shares 0 us-gaap/2024 Equity Components= Preferred Stock; Restatement= Scenario Previously Reported;
0001641172-25-017216 20221231 Stockholders Equity 51169898.0000 USD 0 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001641172-25-017216 20221231 Stockholders Equity -46519740.0000 USD 0 us-gaap/2024 Equity Components= Retained Earnings;
0001641172-25-017216 20241231 Stockholders Equity 51.0000 USD 0 us-gaap/2024 Equity Components= Preferred Stock;
0001641172-25-017216 20241231 Stockholders Equity 755455.0000 USD 0 us-gaap/2024 Restatement= Revision Of Prior Period Reclassification Adjustment;
0001641172-25-017216 20241231 Stockholders Equity -6393980.0000 USD 0 us-gaap/2024 Restatement= Scenario Previously Reported;
0001641172-25-017216 20231231 Stock Issued During Period Preferred Stock Value 5.0000 USD 4 0001641172-25-017216 Equity Components= Preferred Stock;
0001641172-25-017216 20241231 Stock Issued During Period Shares Conversion Of Convertible Securities -2186.0000 shares 4 us-gaap/2024 Equity Components= Preferred Stock;
0001641172-25-017216 20230731 Stock Issued During Period Shares New Issues 1800.0000 shares 0 us-gaap/2024 Class Of Stock= Series A Two Convertible Preferred Stock; Type Of Arrangement= Securities Purchase Agreement;
0001641172-25-017216 20231231 Stock Issued During Period Shares Reverse Stock Splits 37753.0000 shares 4 us-gaap/2024 Equity Components= Common Stock;
0001641172-25-017216 20231231 Stock Issued During Period Shares Share Based Compensation Gross 10000.0000 shares 4 us-gaap/2024 Equity Components= Common Stock;
0001641172-25-004643 20231231 Accrued Dividends 130000.0000 USD 4 0001641172-25-004643
0001641172-25-004643 20231231 Adjustments To Additional Paid In Capital Dividend In Excess Of Retained Earnings USD 4 0001641172-25-004643 Equity Components= Preferred Stock;
0001641172-25-004643 20231231 Common Stock Shares Issued 10000.0000 shares 0 us-gaap/2024 Title Of Individual= Board Of Directors Chairman;
0001641172-25-004643 20241231 Discontinued Operation Gain Loss On Disposal Of Discontinued Operation Net Of Tax -100041.0000 USD 4 us-gaap/2024
0001641172-25-004643 20241231 Discontinued Operation Income Loss From Discontinued Operation Before Income Tax -2648008.0000 USD 4 us-gaap/2024
0001641172-25-004643 20231231 Gain Loss On Disposition Of Assets 3433884.0000 USD 4 us-gaap/2024 Consolidation Items= Operating Segments;
0001641172-25-004643 20241231 Income Loss From Continuing Operations Per Basic Share -4.0100 USD 4 us-gaap/2024
0001641172-25-004643 20231231 Income Loss From Discontinued Operations Net Of Tax Per Basic Share -2.6500 USD 4 us-gaap/2024
0001641172-25-004643 20231231 Income Taxes Paid Net USD 4 us-gaap/2024
0001641172-25-004643 20241231 Income Taxes Paid Net USD 4 us-gaap/2024
0001641172-25-004643 20241231 Increase Decrease In Accounts Receivable 28030.0000 USD 4 us-gaap/2024
0001641172-25-004643 20231231 Increase Decrease In Deferred Compensation 196121.0000 USD 4 us-gaap/2024
0001641172-25-004643 20241231 Increase Decrease In Security Deposits USD 4 us-gaap/2024
0001641172-25-004643 20241231 Interest Paid Net USD 4 us-gaap/2024
0001641172-25-004643 20241231 Liabilities 7983001.0000 USD 0 us-gaap/2024
0001641172-25-004643 20241231 Liabilities And Stockholders Equity 1589021.0000 USD 0 us-gaap/2024
0001641172-25-004643 20241231 Net Cash Provided By Used In Financing Activities 3819768.0000 USD 4 us-gaap/2024
0001641172-25-004643 20231231 Net Income Loss -9418585.0000 USD 4 us-gaap/2024
0001641172-25-004643 20241231 Other Nonoperating Income Expense USD 4 us-gaap/2024
0001641172-25-004643 20231231 Preferred Stock Shares Issued 2645.0000 shares 0 us-gaap/2024 Class Of Stock= Series B One Preferred Stock;
0001641172-25-004643 20231231 Prepaid Expense And Other Assets Current 94711.0000 USD 0 us-gaap/2024
0001641172-25-004643 20241231 Proceeds From Repayments Of Notes Payable USD 4 us-gaap/2024
0001641172-25-004643 20231231 Stockholders Equity 55184524.0000 USD 0 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001641172-25-004643 20231231 Stockholders Equity 1149.0000 USD 0 us-gaap/2024 Equity Components= Common Stock;
0001641172-25-004643 20241231 Stock Issued During Period Shares New Issues 24172.0000 shares 4 us-gaap/2024 Class Of Stock= Series E Preferred Stock;
0001641172-25-004643 20241231 Stock Issued During Period Shares New Issues 24172.0000 shares 4 us-gaap/2024 Class Of Stock= Series E Preferred Stock; Type Of Arrangement= Settlement And Release Agreement;
0001641172-25-004643 20241231 Stock Issued During Period Shares New Issues 4676.0000 shares 4 us-gaap/2024 Class Of Stock= Series G Preferred Stock;
0001641172-25-004643 20241231 Stock Issued During Period Value Conversion Of Convertible Securities 2.0000 USD 4 us-gaap/2024 Equity Components= Common Stock;
0001641172-25-004643 20231231 Stock Issued During Period Value Reverse Stock Splits -38.0000 USD 4 0001641172-25-004643 Equity Components= Additional Paid In Capital;
0001641172-25-004643 20231231 Stock Issued During Period Value Share Based Compensation Gross 42900.0000 USD 4 us-gaap/2024
0001641172-25-004643 20231231 Stock Issued During Period Value Share Based Compensation Gross USD 4 us-gaap/2024 Equity Components= Retained Earnings;
0001641172-25-004643 20241231 Stock Issued During Period Value Share Based Compensation Gross 17.0000 USD 4 us-gaap/2024 Equity Components= Common Stock;
0001641172-25-004643 20241231 Stock Issued During Period Value Share Based Compensation Gross USD 4 us-gaap/2024 Equity Components= Retained Earnings;
0001641172-25-004643 20241231 Accounts Receivable Net Current 28030.0000 USD 0 us-gaap/2024
0001641172-25-004643 20231231 Adjustments To Additional Paid In Capital Dividend In Excess Of Retained Earnings 130000.0000 USD 4 0001641172-25-004643
0001641172-25-004643 20231231 Adjustments To Additional Paid In Capital Dividend In Excess Of Retained Earnings 130000.0000 USD 4 0001641172-25-004643 Equity Components= Additional Paid In Capital;
0001641172-25-004643 20241231 Assets 1589021.0000 USD 0 us-gaap/2024
0001641172-25-004643 20231231 Assets Of Disposal Group Including Discontinued Operation Current 96830.0000 USD 0 us-gaap/2024
0001641172-25-004643 20231231 Common Stock Shares Issued 1148321.0000 shares 0 us-gaap/2024
0001641172-25-004643 20241231 Common Stock Value 1168.0000 USD 0 us-gaap/2024
0001641172-25-004643 20241231 Depreciation Depletion And Amortization 139182.0000 USD 4 us-gaap/2024
0001641172-25-004643 20231231 Gross Profit USD 4 us-gaap/2024 Consolidation Items= Operating Segments;
0001641172-25-004643 20241231 Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest -6297778.0000 USD 4 us-gaap/2024
0001641172-25-004643 20231231 Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest -6475358.0000 USD 4 us-gaap/2024
0001641172-25-004643 20241231 Income Loss From Continuing Operations Per Diluted Share -4.0100 USD 4 us-gaap/2024
0001641172-25-004643 20241231 Increase Decrease In Patient Deposits USD 4 0001641172-25-004643
0001641172-25-004643 20231231 Interest Expense Nonoperating 325585.0000 USD 4 us-gaap/2024 Consolidation Items= Operating Segments;
0001641172-25-004643 20231231 Proceeds From Issuance Of Common Stock 16650.0000 USD 4 us-gaap/2024
0001641172-25-004643 20241231 Proceeds From Sale Of Practices USD 4 0001641172-25-004643
0001641172-25-004643 20231231 Investment Income Interest 27156.0000 USD 4 us-gaap/2024
0001641172-25-004643 20241231 Liabilities Of Disposal Group Including Discontinued Operation Current 4017920.0000 USD 0 us-gaap/2024
0001641172-25-004643 20231231 Net Cash Provided By Used In Investing Activities -1775300.0000 USD 4 us-gaap/2024
0001641172-25-004643 20231231 Net Income Loss USD 4 us-gaap/2024 Equity Components= Preferred Stock;
0001641172-25-004643 20241231 Net Income Loss -9045827.0000 USD 4 us-gaap/2024 Equity Components= Retained Earnings;
0001641172-25-004643 20231231 Nonoperating Income Expense -99850.0000 USD 4 us-gaap/2024 Consolidation Items= Operating Segments;
0001641172-25-004643 20241231 Nonoperating Income Expense -674511.0000 USD 4 us-gaap/2024 Consolidation Items= Operating Segments;
0001641172-25-004643 20231231 Operating Income Loss -6375508.0000 USD 4 us-gaap/2024 Consolidation Items= Operating Segments;
0001641172-25-004643 20231231 Payments To Acquire Property Plant And Equipment USD 4 us-gaap/2024
0001641172-25-004643 20241231 Preferred Stock Par Or Stated Value Per Share 0.0010 USD 0 us-gaap/2024
0001641172-25-004643 20241231 Preferred Stock Shares Authorized 5000000.0000 shares 0 us-gaap/2024
0001641172-25-004643 20231231 Preferred Stock Shares Outstanding 2645.0000 shares 0 us-gaap/2024 Class Of Stock= Series B One Preferred Stock;
0001641172-25-004643 20231231 Settlement Of Notes Receivable In Connection With Asset Purchase Agreement USD 4 0001641172-25-004643
0001641172-25-004643 20241231 Shares Outstanding 2029832.0000 shares 0 us-gaap/2024 Equity Components= Common Stock;
0001641172-25-004643 20221231 Stockholders Equity USD 0 us-gaap/2024 Equity Components= Preferred Stock;
0001641172-25-004643 20241231 Stockholders Equity 58588953.0000 USD 0 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001641172-25-004643 20231231 Stock Issued During Period Preferred Stock Shares 4550.0000 shares 4 0001641172-25-004643 Equity Components= Preferred Stock;
0001641172-25-004643 20231231 Stock Issued During Period Preferred Stock Value USD 4 0001641172-25-004643 Equity Components= Retained Earnings;
0001641172-25-004643 20230731 Stock Issued During Period Shares New Issues 1800.0000 shares 0 us-gaap/2024 Class Of Stock= Series A Two Convertible Preferred Stock; Type Of Arrangement= Securities Purchase Agreement;
0001641172-25-004643 20241231 Stock Issued During Period Shares New Issues 17364.0000 shares 4 us-gaap/2024 Class Of Stock= Series D Preferred Stock;
0001641172-25-004643 20231231 Stock Issued During Period Shares Reverse Stock Splits 37753.0000 shares 4 us-gaap/2024 Equity Components= Common Stock;
0001641172-25-004643 20241231 Stock Issued During Period Shares Share Based Compensation Gross 16665.0000 shares 4 us-gaap/2024 Equity Components= Common Stock;
0001641172-25-004643 20241231 Stock Issued During Period Value Conversion Of Convertible Securities USD 4 us-gaap/2024 Equity Components= Retained Earnings;
0001641172-25-004643 20231231 Stock Issued During Period Value New Issues USD 4 us-gaap/2024 Equity Components= Preferred Stock;
0001641172-25-004643 20231231 Stock Issued During Period Value Reverse Stock Splits USD 4 0001641172-25-004643
0001641172-25-004643 20241231 Weighted Average Number Of Diluted Shares Outstanding 1569627.0000 shares 4 us-gaap/2024
0001641172-25-004643 20231231 Weighted Average Number Of Shares Outstanding Basic 1111844.0000 shares 4 us-gaap/2024
0001641172-25-017216 20241231 Stock Issued During Period Value Conversion Of Convertible Securities USD 4 us-gaap/2024 Equity Components= Retained Earnings;
0001641172-25-017216 20231231 Stock Issued During Period Value Reverse Stock Splits 38.0000 USD 4 0001641172-25-017216 Equity Components= Common Stock;
0001641172-25-004643 20231231 Additional Paid In Capital 55184524.0000 USD 0 us-gaap/2024
0001641172-25-004643 20241231 Adjustments To Additional Paid In Capital Dividend In Excess Of Retained Earnings 1120979.0000 USD 4 0001641172-25-004643
0001641172-25-004643 20241231 Assets 0.0000 USD 0 us-gaap/2024 Consolidated Entities= Variable Interest Entities;
0001641172-25-004643 20231231 Cash 221511.0000 USD 0 us-gaap/2024
0001641172-25-004643 20221231 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations 763211.0000 USD 0 us-gaap/2024
0001641172-25-004643 20231231 Commitments And Contingencies USD 0 us-gaap/2024
0001641172-25-004643 20250331 Common Stock Shares Authorized 60000000.0000 shares 0 us-gaap/2024 Subsequent Event Type= Subsequent Event;
0001641172-25-004643 20231231 Common Stock Value 1149.0000 USD 0 us-gaap/2024
0001641172-25-004643 20231231 Discontinued Operation Gain Loss On Disposal Of Discontinued Operation Net Of Tax -1235885.0000 USD 4 us-gaap/2024
0001641172-25-004643 20231231 General And Administrative Expense 124249.0000 USD 4 us-gaap/2024 Consolidation Items= Operating Segments;
0001641172-25-004643 20231231 Gross Profit USD 4 us-gaap/2024
0001641172-25-004643 20231231 Income Loss From Continuing Operations Per Diluted Share -5.8200 USD 4 us-gaap/2024
0001641172-25-004643 20231231 Increase Decrease In Liability To Issue Common Stock 329855.0000 USD 4 0001641172-25-004643
0001641172-25-004643 20231231 Increase Decrease In Patient Deposits -241666.0000 USD 4 0001641172-25-004643
0001641172-25-004643 20231231 Increase Decrease In Prepaid Deferred Expense And Other Assets -265553.0000 USD 4 us-gaap/2024
0001641172-25-004643 20241231 Interest Expense Nonoperating 311997.0000 USD 4 us-gaap/2024 Consolidation Items= Operating Segments;
0001641172-25-004643 20231231 Investment Income Interest 27156.0000 USD 4 us-gaap/2024 Consolidation Items= Operating Segments;
0001641172-25-004643 20231231 Liabilities Of Disposal Group Including Discontinued Operation Current 1312711.0000 USD 0 us-gaap/2024
0001641172-25-004643 20231231 Net Cash Provided By Used In Operating Activities -2790151.0000 USD 4 us-gaap/2024
0001641172-25-004643 20241231 Net Income Loss USD 4 us-gaap/2024 Equity Components= Preferred Stock;
0001641172-25-004643 20241231 Net Income Losses -9045827.0000 USD 4 0001641172-25-004643
0001641172-25-004643 20231231 Operating Income Loss -6375508.0000 USD 4 us-gaap/2024
0001641172-25-004643 20241231 Operating Income Loss -5623267.0000 USD 4 us-gaap/2024 Consolidation Items= Operating Segments;
0001641172-25-004643 20241231 Payments To Acquire Property Plant And Equipment USD 4 us-gaap/2024
0001641172-25-004643 20241231 Preferred Stock Converstion 2.0000 USD 4 0001641172-25-004643
0001641172-25-004643 20230731 Preferred Stock Par Or Stated Value Per Share 1000.0000 USD 0 us-gaap/2024 Class Of Stock= Series A One Convertible Preferred Stock; Type Of Arrangement= Securities Purchase Agreement;
0001641172-25-004643 20241231 Preferred Stock Value 51.0000 USD 0 us-gaap/2024
0001641172-25-004643 20231231 Proceeds From Issuance Of Preferred Stock And Preference Stock 4045000.0000 USD 4 us-gaap/2024
0001641172-25-004643 20241231 Property Plant And Equipment Net 904680.0000 USD 0 us-gaap/2024
0001641172-25-004643 20221231 Shares Outstanding 1097843.0000 shares 0 us-gaap/2024 Equity Components= Common Stock;
0001641172-25-004643 20231231 Stock Issued During Period Preferred Stock Value USD 4 0001641172-25-004643 Equity Components= Common Stock;
0001641172-25-004643 20241231 Stock Issued During Period Shares Conversion Of Convertible Securities -2186.0000 shares 4 us-gaap/2024 Equity Components= Preferred Stock;
0001641172-25-004643 20241231 Stock Issued During Period Shares New Issues 48138.0000 shares 4 us-gaap/2024 Equity Components= Preferred Stock;
0001641172-25-004643 20231231 Stock Issued During Period Value New Issues 16647.0000 USD 4 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001641172-25-004643 20231231 Stock Issued During Period Value New Issues USD 4 us-gaap/2024 Equity Components= Retained Earnings;
0001641172-25-004643 20241231 Stock Issued During Period Value New Issues 48.0000 USD 4 us-gaap/2024 Equity Components= Preferred Stock;
0001641172-25-004643 20231231 Stock Issued During Period Value Reverse Stock Splits USD 4 0001641172-25-004643 Equity Components= Preferred Stock;
0001641172-25-004643 20231231 Stock Issued During Period Value Share Based Compensation Gross USD 4 us-gaap/2024 Equity Components= Preferred Stock;
0001641172-25-017193 20231231 Accounts And Other Receivables Net Current 731067.0000 USD 0 us-gaap/2024
0001641172-25-017193 20240630 Accounts Receivable Net Current 15750.0000 USD 0 us-gaap/2024 Restatement= Scenario Previously Reported;
0001641172-25-017193 20231231 Additional Paid In Capital 55184524.0000 USD 0 us-gaap/2024
0001641172-25-017193 20240630 Additional Paid In Capital 55958027.0000 USD 0 us-gaap/2024
0001641172-25-017193 20240630 Adjustments To Additional Paid In Capital Dividends In Excess Of Retained Earnings USD 1 us-gaap/2024 Equity Components= Retained Earnings;
0001641172-25-017193 20240630 Adjustments To Additional Paid In Capital Dividends In Excess Of Retained Earnings 727481.0000 USD 2 us-gaap/2024
0001641172-25-017193 20240630 Adjustments To Additional Paid In Capital Dividends In Excess Of Retained Earnings 727481.0000 USD 2 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001641172-25-017193 20240630 Adjustments To Additional Paid In Capital Dividends In Excess Of Retained Earnings USD 2 us-gaap/2024 Equity Components= Preferred Stock;
0001641172-25-017193 20240630 Adjustments To Additional Paid In Capital Other 525075.0000 USD 1 us-gaap/2024
0001641172-25-017193 20240630 Assets USD 0 us-gaap/2024 Restatement= Revision Of Prior Period Reclassification Adjustment;
0001641172-25-017193 20240630 Assets Of Disposal Group Including Discontinued Operation Current 95041.0000 USD 0 us-gaap/2024
0001641172-25-017193 20240630 Commitments And Contingencies USD 0 us-gaap/2024 Restatement= Revision Of Prior Period Reclassification Adjustment;
0001641172-25-017193 20231231 Common Stock Shares Issued 1148321.0000 shares 0 us-gaap/2024
0001641172-25-017193 20240630 Common Stock Value USD 0 us-gaap/2024 Restatement= Revision Of Prior Period Reclassification Adjustment;
0001641172-25-017193 20230630 Cost Of Revenue USD 1 us-gaap/2024
0001641172-25-017193 20240630 Cost Of Revenue 72002.0000 USD 2 us-gaap/2024
0001641172-25-017193 20230630 Gross Profit USD 1 us-gaap/2024
0001641172-25-017193 20240630 Gross Profit -56252.0000 USD 2 us-gaap/2024
0001641172-25-017193 20240630 Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest -1862005.0000 USD 2 us-gaap/2024 Restatement= Scenario Previously Reported;
0001641172-25-017193 20240630 Income Loss From Continuing Operations Per Diluted Share -2.2200 USD 2 us-gaap/2024
0001641172-25-017193 20230630 Income Loss From Discontinued Operations Net Of Tax -244409.0000 USD 1 us-gaap/2024
0001641172-25-017193 20240630 Income Loss From Discontinued Operations Net Of Tax Per Basic Share 0.0600 USD 2 us-gaap/2024
0001641172-25-017193 20230630 Income Loss From Discontinued Operations Net Of Tax Per Diluted Share -0.2200 USD 1 us-gaap/2024
0001641172-25-017193 20230630 Increase Decrease In Accounts Payable And Accrued Liabilities 738521.0000 USD 2 us-gaap/2024
0001641172-25-017193 20240630 Increase Decrease In Accounts Payable And Accrued Liabilities USD 2 us-gaap/2024 Restatement= Revision Of Prior Period Reclassification Adjustment;
0001641172-25-017193 20230630 Increase Decrease In Accounts Receivable -546496.0000 USD 2 us-gaap/2024
0001641172-25-017193 20240630 Increase Decrease In Accounts Receivable 15750.0000 USD 2 us-gaap/2024
0001641172-25-017193 20230630 Interest Expense Nonoperating 21217.0000 USD 1 us-gaap/2024
0001641172-25-017193 20240630 Investment Income Interest 995.0000 USD 2 us-gaap/2024
0001641172-25-017193 20240630 Liabilities And Stockholders Equity 2223483.0000 USD 0 us-gaap/2024 Restatement= Scenario Previously Reported;
0001641172-25-017193 20240630 Liabilities Of Disposal Group Including Discontinued Operation Current USD 0 us-gaap/2024 Restatement= Revision Of Prior Period Reclassification Adjustment;
0001641172-25-017193 20240630 Net Cash Provided By Used In Financing Activities 1974227.0000 USD 2 us-gaap/2024 Restatement= Scenario Previously Reported;
0001641172-25-017193 20230630 Net Cash Provided By Used In Operating Activities -1670284.0000 USD 2 us-gaap/2024
0001641172-25-017193 20230630 Net Income Loss USD 1 us-gaap/2024 Equity Components= Common Stock;
0001641172-25-017193 20230630 Net Income Loss -5101960.0000 USD 2 us-gaap/2024
0001641172-25-017193 20240630 Net Income Loss -1790623.0000 USD 2 us-gaap/2024
0001641172-25-017193 20240630 Net Income Loss USD 2 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001641172-25-017193 20230630 Net Income Loss Available To Common Stockholders Basic -5101960.0000 USD 2 us-gaap/2024
0001641172-25-017193 20240630 Preferred Dividends Accrued 88000.0000 USD 2 0001641172-25-017193 Restatement= Revision Of Prior Period Reclassification Adjustment;
0001641172-25-017193 20241031 Preferred Stock Par Or Stated Value Per Share 0.0010 USD 0 us-gaap/2024 Class Of Stock= Series G Preferred Stock; Subsequent Event Type= Subsequent Event;
0001641172-25-017193 20240630 Preferred Stock Shares Issued 450.0000 shares 0 us-gaap/2024 Class Of Stock= Series F Preferred Stock;
0001641172-25-017193 20240630 Preferred Stock Shares Outstanding 450.0000 shares 0 us-gaap/2024 Class Of Stock= Series F Preferred Stock; Restatement= Revision Of Prior Period Reclassification Adjustment;
0001641172-25-017193 20230630 Proceeds From Issuance Of Common Stock 64032.0000 USD 2 us-gaap/2024
0001641172-25-017193 20240630 Proceeds From Notes Payable USD 2 us-gaap/2024 Restatement= Revision Of Prior Period Reclassification Adjustment;
0001641172-25-017193 20240630 Property Plant And Equipment Net 1009066.0000 USD 0 us-gaap/2024 Restatement= Scenario Previously Reported;
0001641172-25-017193 20230630 Provision For Doubtful Accounts 6795.0000 USD 2 us-gaap/2024
0001641172-25-017193 20230331 Stockholders Equity USD 0 us-gaap/2024 Equity Components= Preferred Stock;
0001641172-25-017193 20231231 Stockholders Equity -752647.0000 USD 0 us-gaap/2024
0001641172-25-017193 20230630 Stock Issued During Period Value New Issues 47373.0000 USD 1 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001641172-25-017193 20240630 Stock Issued During Period Value Preferred Stock Net Of Issuance Costs 975909.0000 USD 1 0001641172-25-017193 Equity Components= Additional Paid In Capital;
0001641172-25-017193 20240630 Stock Issued During Period Value Preferred Stock Net Of Issuance Costs 43.0000 USD 1 0001641172-25-017193 Equity Components= Preferred Stock;
0001641172-25-017193 20240630 Stock Issued During Period Value Preferred Stock Net Of Issuance Costs USD 2 0001641172-25-017193 Equity Components= Retained Earnings;
0001641172-25-017193 20230630 Stock Issued During Period Value Share Based Compensation 47382.0000 USD 2 us-gaap/2024
0001641172-25-017196 20240930 Accounts Payable And Accrued Liabilities Current USD 0 us-gaap/2024 Restatement= Revision Of Prior Period Reclassification Adjustment;
0001641172-25-017196 20231231 Accounts Receivable Net Current USD 0 us-gaap/2024
0001641172-25-017196 20240930 Accounts Receivable Net Current USD 0 us-gaap/2024 Restatement= Revision Of Prior Period Reclassification Adjustment;
0001641172-25-017196 20240930 Adjustments To Additional Paid In Capital Dividends In Excess Of Retained Earnings USD 3 us-gaap/2024 Equity Components= Common Stock;
0001641172-25-017196 20240930 Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition 3562.0000 USD 1 us-gaap/2024
0001641172-25-017196 20240930 Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition 3562.0000 USD 1 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001641172-25-017196 20240930 Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition USD 1 us-gaap/2024 Equity Components= Retained Earnings;
0001641172-25-017196 20240930 Assets USD 0 us-gaap/2024 Restatement= Revision Of Prior Period Reclassification Adjustment;
0001641172-25-017196 20240930 Assets 1467611.0000 USD 0 us-gaap/2024 Restatement= Scenario Previously Reported;
0001641172-25-017196 20240930 Assets Current 510738.0000 USD 0 us-gaap/2024 Restatement= Scenario Previously Reported;
0001641172-25-017196 20231231 Cash 221511.0000 USD 0 us-gaap/2024
0001641172-25-017196 20240930 Cash USD 0 us-gaap/2024 Restatement= Revision Of Prior Period Reclassification Adjustment;
0001641172-25-017196 20221231 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations 763211.0000 USD 0 us-gaap/2024
0001641172-25-017196 20231231 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations USD 0 us-gaap/2024 Restatement= Revision Of Prior Period Reclassification Adjustment;
0001641172-25-017196 20240930 Cash Provided By Used In Operating Activities Discontinued Operations -31992.0000 USD 3 us-gaap/2024 Restatement= Scenario Previously Reported;
0001641172-25-017196 20231231 Commitments And Contingencies USD 0 us-gaap/2024
0001641172-25-017196 20240930 Commitments And Contingencies USD 0 us-gaap/2024
0001641172-25-017196 20240930 Common Stock Value USD 0 us-gaap/2024 Restatement= Revision Of Prior Period Reclassification Adjustment;
0001641172-25-017196 20240930 Converted Accrued C1 Dividends 29000.0000 USD 3 0001641172-25-017196
0001641172-25-017196 20240930 Converted Accrued C1 Dividends 29000.0000 USD 3 0001641172-25-017196 Restatement= Revision Of Prior Period Reclassification Adjustment;
0001641172-25-017196 20240930 Cost Of Revenue USD 1 us-gaap/2024 Restatement= Revision Of Prior Period Reclassification Adjustment;
0001641172-25-017196 20240930 Cost Of Revenue 194079.0000 USD 3 us-gaap/2024 Restatement= Scenario Previously Reported;
0001641172-25-017196 20240930 Dividends Payable Current 399520.0000 USD 0 us-gaap/2024
0001641172-25-017196 20230930 Earnings Per Share Basic -2.6300 USD 1 us-gaap/2024
0001641172-25-017196 20230930 Earnings Per Share Basic -7.2800 USD 3 us-gaap/2024
0001641172-25-017196 20240930 Earnings Per Share Diluted -0.5200 USD 3 us-gaap/2024 Restatement= Restatement Adjustment;
0001641172-25-017196 20240930 Gain Loss On Disposition Of Assets USD 1 us-gaap/2024
0001641172-25-017196 20230930 Gain Loss On Disposition Of Assets1 -3642799.0000 USD 3 us-gaap/2024
0001641172-25-017196 20240930 Gross Profit USD 1 us-gaap/2024 Restatement= Revision Of Prior Period Reclassification Adjustment;
0001641172-25-017196 20240930 Gross Profit -65777.0000 USD 1 us-gaap/2024 Restatement= Scenario Previously Reported;
0001641172-25-017196 20240930 Gross Profit -122029.0000 USD 3 us-gaap/2024
0001641172-25-017196 20240930 Income Loss From Continuing Operations Per Diluted Share -4.1400 USD 3 us-gaap/2024
0001641172-25-017196 20240930 Income Loss From Continuing Operations Per Diluted Share -0.5200 USD 3 us-gaap/2024 Restatement= Restatement Adjustment;
0001641172-25-017196 20240930 Income Loss From Discontinued Operations Net Of Tax -31992.0000 USD 3 us-gaap/2024
0001641172-25-017196 20240930 Income Loss From Discontinued Operations Net Of Tax Per Basic Share -0.0200 USD 3 us-gaap/2024
0001641172-25-017196 20230930 Income Loss From Discontinued Operations Net Of Tax Per Diluted Share 0.4100 USD 1 us-gaap/2024
0001641172-25-017196 20240930 Income Loss From Discontinued Operations Net Of Tax Per Diluted Share USD 1 us-gaap/2024 Restatement= Restatement Adjustment;
0001641172-25-017196 20240930 Income Loss From Discontinued Operations Net Of Tax Per Diluted Share -0.0200 USD 3 us-gaap/2024
0001641172-25-017196 20240930 Income Taxes Paid Net USD 3 us-gaap/2024 Restatement= Scenario Previously Reported;
0001641172-25-017196 20240930 Increase Decrease In Patient Deposits USD 3 0001641172-25-017196
0001641172-25-017196 20230930 Interest Expense Nonoperating 71050.0000 USD 1 us-gaap/2024
0001641172-25-017196 20240930 Interest Expense Nonoperating 106636.0000 USD 1 us-gaap/2024
0001641172-25-017196 20240930 Interest Expense Nonoperating 159062.0000 USD 3 us-gaap/2024
0001641172-25-017196 20240930 Investment Income Interest USD 3 us-gaap/2024 Restatement= Revision Of Prior Period Reclassification Adjustment;
0001641172-25-017196 20231231 Liabilities Of Disposal Group Including Discontinued Operation Current 1312711.0000 USD 0 us-gaap/2024
0001641172-25-017196 20230930 Net Cash Provided By Used In Operating Activities -2957156.0000 USD 3 us-gaap/2024
0001641172-25-017196 20240930 Net Cash Provided By Used In Operating Activities -2025227.0000 USD 3 us-gaap/2024 Restatement= Scenario Previously Reported;
0001641172-25-017196 20230930 Net Income Loss USD 1 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001641172-25-017196 20240930 Nonoperating Income Expense -156614.0000 USD 3 us-gaap/2024
0001641172-25-017196 20230930 Operating Expenses 3263444.0000 USD 1 us-gaap/2024
0001641172-25-017196 20240930 Operating Expenses 1930314.0000 USD 1 us-gaap/2024
0001641172-25-017196 20240930 Operating Expenses 3684636.0000 USD 3 us-gaap/2024
0001641172-25-017196 20240930 Operating Income Loss USD 1 us-gaap/2024 Restatement= Revision Of Prior Period Reclassification Adjustment;
0001641172-25-017196 20230930 Payments To Acquire Notes Receivable 3000000.0000 USD 3 us-gaap/2024
0001641172-25-017196 20240930 Payments To Acquire Notes Receivable 375000.0000 USD 3 us-gaap/2024
0001641172-25-017196 20240930 Preferred Dividends Accrued Converted Into C1 -218000.0000 USD 3 0001641172-25-017196
0001641172-25-017196 20230930 Preferred Stock Dividends Income Statement Impact 55000.0000 USD 3 us-gaap/2024
0001641172-25-017196 20240930 Preferred Stock Dividends Income Statement Impact 725347.0000 USD 3 us-gaap/2024 Restatement= Revision Of Prior Period Reclassification Adjustment;
0001641172-25-017196 20241031 Preferred Stock Par Or Stated Value Per Share 0.0010 USD 0 us-gaap/2024 Class Of Stock= Series G Preferred Stock; Subsequent Event Type= Subsequent Event;
0001641172-25-017196 20240930 Proceeds From Issuance Of Preferred Stock And Preference Stock 975951.0000 USD 3 us-gaap/2024
0001641172-25-017196 20240930 Proceeds From Notes Payable 1400000.0000 USD 3 us-gaap/2024
0001641172-25-017196 20240930 Provision For Doubtful Accounts USD 3 us-gaap/2024
0001641172-25-017196 20240930 Repayments Of Notes Payable USD 3 us-gaap/2024
0001641172-25-017196 20240930 Retained Earnings Accumulated Deficit -59933596.0000 USD 0 us-gaap/2024
0001641172-25-017196 20240930 Revenue From Contract With Customer Excluding Assessed Tax 72050.0000 USD 3 us-gaap/2024
0001641172-25-017196 20230930 Settlement Of Notes Receivable In Connection With Asset Purchase Agreement USD 3 0001641172-25-017196
0001641172-25-017196 20240930 Share Based Compensation 3562.0000 USD 3 us-gaap/2024
0001641172-25-017196 20221231 Shares Outstanding 1097843.0000 shares 0 us-gaap/2024 Equity Components= Common Stock;
0001641172-25-017196 20240930 Shares Outstanding 45826.0000 shares 0 us-gaap/2024 Equity Components= Preferred Stock;
0001641172-25-017196 20240930 Shares Outstanding 45826.0000 shares 0 us-gaap/2024 Equity Components= Preferred Stock; Restatement= Scenario Previously Reported;
0001641172-25-017196 20221231 Stockholders Equity -46519740.0000 USD 0 us-gaap/2024 Equity Components= Retained Earnings;
0001641172-25-017196 20230930 Stockholders Equity 4.0000 USD 0 us-gaap/2024 Equity Components= Preferred Stock;
0001641172-25-017196 20240930 Stockholders Equity -59933596.0000 USD 0 us-gaap/2024 Equity Components= Retained Earnings; Restatement= Scenario Previously Reported;
0001641172-25-017196 20240930 Stock Issued During Period Shares Conversion Of Series C1 Preferred Stock Into Common Shares 864846.0000 shares 3 0001641172-25-017196 Equity Components= Common Stock;
0001641172-25-017196 20230930 Stock Issued During Period Shares Preferred Stock Net Of Issuance Costs 4300.0000 shares 1 0001641172-25-017196 Equity Components= Preferred Stock;
0001641172-25-017196 20240930 Stock Issued During Period Value Conversion Of Series C1 Preferred Stock Into Common Shares -2.0000 USD 3 0001641172-25-017196 Equity Components= Preferred Stock;
0001641172-25-017196 20230930 Stock Issued During Period Value New Issues 12.0000 USD 3 us-gaap/2024 Equity Components= Common Stock;
0001641172-25-017196 20230930 Stock Issued During Period Value Preferred Stock Net Of Issuance Costs USD 1 0001641172-25-017196 Equity Components= Retained Earnings;
0001641172-25-017196 20230930 Stock Issued During Period Value Preferred Stock Net Of Issuance Costs USD 3 0001641172-25-017196 Equity Components= Common Stock;
0001641172-25-017196 20240930 Stock Issued During Period Value Preferred Stock Net Of Issuance Costs 975951.0000 USD 3 0001641172-25-017196
0001641172-25-017196 20240930 Weighted Average Number Of Diluted Shares Outstanding shares 1 us-gaap/2024 Restatement= Restatement Adjustment;
0001641172-25-017196 20240930 Weighted Average Number Of Diluted Shares Outstanding 1414912.0000 shares 3 us-gaap/2024
0001641172-25-017196 20230930 Weighted Average Number Of Shares Outstanding Basic 1102738.0000 shares 3 us-gaap/2024
0001641172-25-017196 20240930 Weighted Average Number Of Shares Outstanding Basic 1414912.0000 shares 3 us-gaap/2024
0001641172-25-017193 20240630 Common Stock Shares Outstanding 1494272.0000 shares 0 us-gaap/2024
0001641172-25-017216 20241231 Adjustments To Additional Paid In Capital Dividend In Excess Of Retained Earnings 3132653.0000 USD 4 0001641172-25-017216
0001641172-25-017216 20241231 Adjustments To Additional Paid In Capital Dividend In Excess Of Retained Earnings 3132653.0000 USD 4 0001641172-25-017216 Equity Components= Additional Paid In Capital;
0001641172-25-017216 20241231 Asset Impairment Charges 2300000.0000 USD 4 us-gaap/2024 Adjustments For New Accounting Pronouncements= Accounting Standards Update201613;
0001641172-25-017216 20231231 Assets 1144119.0000 USD 0 us-gaap/2024
0001641172-25-017216 20241231 Assets USD 0 us-gaap/2024 Restatement= Revision Of Prior Period Reclassification Adjustment;
0001641172-25-017216 20231231 Common Stock Par Or Stated Value Per Share 0.0010 USD 0 us-gaap/2024
0001641172-25-017216 20240930 Common Stock Par Or Stated Value Per Share 0.0010 USD 0 us-gaap/2024
0001641172-25-017216 20240930 Common Stock Shares Authorized 60000000.0000 shares 0 us-gaap/2024
0001641172-25-017216 20241231 Discontinued Operation Gain Loss On Disposal Of Discontinued Operation Net Of Tax -100041.0000 USD 4 us-gaap/2024
0001641172-25-017216 20241231 Gain Loss On Disposition Of Assets USD 4 us-gaap/2024
0001641172-25-017216 20241231 Gross Profit -233198.0000 USD 4 us-gaap/2024
0001641172-25-017216 20241231 Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest -6297778.0000 USD 4 us-gaap/2024
0001641172-25-017216 20241231 Income Loss From Continuing Operations Per Diluted Share -2.0000 USD 4 us-gaap/2024 Restatement= Revision Of Prior Period Reclassification Adjustment;
0001641172-25-017216 20231231 Income Loss From Discontinued Operations Net Of Tax -2943227.0000 USD 4 us-gaap/2024
0001641172-25-017216 20241231 Income Loss From Discontinued Operations Net Of Tax -2748049.0000 USD 4 us-gaap/2024 Restatement= Scenario Previously Reported;
0001641172-25-017216 20231231 Income Loss From Discontinued Operations Net Of Tax Per Basic Share -2.6500 USD 4 us-gaap/2024
0001641172-25-017216 20241231 Income Loss From Discontinued Operations Net Of Tax Per Diluted Share -1.7500 USD 4 us-gaap/2024 Restatement= Scenario Previously Reported;
0001641172-25-017216 20231231 Increase Decrease In Liability To Issue Common Stock 329855.0000 USD 4 0001641172-25-017216
0001641172-25-017216 20241231 Net Cash Provided By Used In Investing Activities -375000.0000 USD 4 us-gaap/2024
0001641172-25-017216 20241231 Net Cash Provided By Used In Operating Activities USD 4 us-gaap/2024 Restatement= Revision Of Prior Period Reclassification Adjustment;
0001641172-25-017216 20241231 Net Income Losses -9045827.0000 USD 4 0001641172-25-017216
0001641172-25-017216 20241231 Nonoperating Income Expense -674511.0000 USD 4 us-gaap/2024 Consolidation Items= Operating Segments;
0001641172-25-017216 20241231 Operating Expenses 5390069.0000 USD 4 us-gaap/2024
0001641172-25-017216 20241231 Operating Income Loss USD 4 us-gaap/2024 Restatement= Revision Of Prior Period Reclassification Adjustment;
0001641172-25-017216 20241231 Operating Income Loss -5623267.0000 USD 4 us-gaap/2024 Restatement= Scenario Previously Reported;
0001641172-25-017216 20241231 Preferred Dividends Accrued B1 88000.0000 USD 4 0001641172-25-017216
0001641172-25-017216 20241231 Preferred Stock Par Or Stated Value Per Share 1000.0000 USD 0 us-gaap/2024 Class Of Stock= Series C Two Preferred Stock;
0001641172-25-017216 20241231 Preferred Stock Par Or Stated Value Per Share 1038.0000 USD 0 us-gaap/2024 Class Of Stock= Series D Preferred Stock;
0001641172-25-017216 20241231 Preferred Stock Par Or Stated Value Per Share 1000.0000 USD 0 us-gaap/2024 Class Of Stock= Series G Preferred Stock;
0001641172-25-017216 20241231 Preferred Stock Value USD 0 us-gaap/2024 Restatement= Revision Of Prior Period Reclassification Adjustment;
0001641172-25-017216 20241231 Prepaid Expense And Other Assets Current 152122.0000 USD 0 us-gaap/2024
0001641172-25-017216 20231231 Retained Earnings Accumulated Deficit -55938325.0000 USD 0 us-gaap/2024
0001641172-25-017216 20241231 Revenue From Contract With Customer Excluding Assessed Tax USD 4 us-gaap/2024 Restatement= Revision Of Prior Period Reclassification Adjustment;
0001641172-25-017216 20231231 Share Based Compensation 83031.0000 USD 4 us-gaap/2024
0001641172-25-017216 20241231 Share Based Compensation 35415.0000 USD 4 us-gaap/2024 Restatement= Scenario Previously Reported;
0001641172-25-017216 20221231 Stockholders Equity USD 0 us-gaap/2024 Equity Components= Preferred Stock;
0001641172-25-017216 20241231 Stockholders Equity 1168.0000 USD 0 us-gaap/2024 Equity Components= Common Stock;
0001641172-25-017216 20241231 Stockholders Equity 1168.0000 USD 0 us-gaap/2024 Equity Components= Common Stock; Restatement= Scenario Previously Reported;
0001641172-25-017216 20241231 Stockholders Equity 51.0000 USD 0 us-gaap/2024 Equity Components= Preferred Stock; Restatement= Scenario Previously Reported;
0001641172-25-017216 20231231 Stock Issued During Period Preferred Stock Value 4045001.0000 USD 4 0001641172-25-017216
0001641172-25-017216 20231231 Stock Issued During Period Preferred Stock Value USD 4 0001641172-25-017216 Equity Components= Common Stock;
0001641172-25-017216 20241231 Stock Issued During Period Shares Share Based Compensation Gross 16665.0000 shares 4 us-gaap/2024 Equity Components= Common Stock;
0001641172-25-017216 20231231 Stock Issued During Period Value New Issues 16650.0000 USD 4 us-gaap/2024
0001641172-25-017216 20241231 Stock Issued During Period Value New Issues USD 4 us-gaap/2024 Equity Components= Retained Earnings;
0001641172-25-017216 20231231 Weighted Average Number Of Diluted Shares Outstanding 1111844.0000 shares 4 us-gaap/2024
0001641172-25-017216 20231231 Weighted Average Number Of Shares Outstanding Basic 1111844.0000 shares 4 us-gaap/2024
0001641172-25-017216 20241231 Weighted Average Number Of Shares Outstanding Basic 1569627.0000 shares 4 us-gaap/2024
0001641172-25-017193 20231231 Accounts Payable And Accrued Liabilities Current 454055.0000 USD 0 us-gaap/2024
0001641172-25-017193 20240630 Accrued Dividends -743000.0000 USD 2 0001641172-25-017193 Restatement= Revision Of Prior Period Reclassification Adjustment;
0001641172-25-017193 20240630 Adjustments To Additional Paid In Capital Dividends In Excess Of Retained Earnings 648116.0000 USD 1 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001641172-25-017193 20240630 Adjustments To Additional Paid In Capital Other USD 1 us-gaap/2024 Equity Components= Common Stock;
0001641172-25-017193 20240630 Adjustments To Additional Paid In Capital Other USD 2 us-gaap/2024 Equity Components= Retained Earnings;
0001641172-25-017193 20230630 Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition USD 2 us-gaap/2024 Equity Components= Common Stock;
0001641172-25-017193 20240630 Assets Current USD 0 us-gaap/2024 Restatement= Revision Of Prior Period Reclassification Adjustment;
0001641172-25-017193 20240630 Cash And Cash Equivalents At Carrying Value 890610.0000 USD 0 us-gaap/2024
0001641172-25-017193 20231231 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations 221511.0000 USD 0 us-gaap/2024 Restatement= Scenario Previously Reported;
0001641172-25-017193 20231231 Common Stock Par Or Stated Value Per Share 0.0010 USD 0 us-gaap/2024
0001641172-25-017193 20240630 Common Stock Par Or Stated Value Per Share 0.0010 USD 0 us-gaap/2024 Restatement= Revision Of Prior Period Reclassification Adjustment;
0001641172-25-017193 20240630 Common Stock Shares Authorized 60000000.0000 shares 0 us-gaap/2024
0001641172-25-017193 20240630 Gain Loss On Disposition Of Assets USD 2 us-gaap/2024
0001641172-25-017193 20240630 Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest USD 2 us-gaap/2024 Restatement= Revision Of Prior Period Reclassification Adjustment;
0001641172-25-017193 20230630 Income Loss From Continuing Operations Per Diluted Share -2.2300 USD 2 us-gaap/2024
0001641172-25-017193 20240630 Income Loss From Discontinued Operations Net Of Tax 71382.0000 USD 2 us-gaap/2024 Restatement= Scenario Previously Reported;
0001641172-25-017193 20240630 Increase Decrease In Prepaid Deferred Expense And Other Assets 55073.0000 USD 2 us-gaap/2024
0001641172-25-017193 20240630 Increase Decrease In Right Of Use Lease Liability USD 2 0001641172-25-017193
0001641172-25-017193 20240630 Interest Expense Nonoperating 11953.0000 USD 1 us-gaap/2024
0001641172-25-017193 20240630 Interest Paid Net USD 2 us-gaap/2024
0001641172-25-017193 20240630 Interest Paid Net USD 2 us-gaap/2024 Restatement= Revision Of Prior Period Reclassification Adjustment;
0001641172-25-017193 20240630 Liabilities Of Disposal Group Including Discontinued Operation Current 1318806.0000 USD 0 us-gaap/2024
0001641172-25-017193 20240630 Liabilities Of Disposal Group Including Discontinued Operation Current 1318806.0000 USD 0 us-gaap/2024 Restatement= Scenario Previously Reported;
0001641172-25-017193 20240630 Net Cash Provided By Used In Financing Activities USD 2 us-gaap/2024 Restatement= Revision Of Prior Period Reclassification Adjustment;
0001641172-25-017193 20240630 Net Cash Provided By Used In Investing Activities -375000.0000 USD 2 us-gaap/2024
0001641172-25-017193 20240630 Net Cash Provided By Used In Operating Activities USD 2 us-gaap/2024 Restatement= Revision Of Prior Period Reclassification Adjustment;
0001641172-25-017193 20240630 Net Cash Provided By Used In Operating Activities Continuing Operations USD 2 us-gaap/2024 Restatement= Revision Of Prior Period Reclassification Adjustment;
0001641172-25-017193 20230630 Net Income Loss -1403307.0000 USD 1 us-gaap/2024 Equity Components= Retained Earnings;
0001641172-25-017193 20240630 Net Income Loss USD 2 us-gaap/2024 Equity Components= Preferred Stock;
0001641172-25-017193 20230630 Nonoperating Income Expense -22060.0000 USD 2 us-gaap/2024
0001641172-25-017193 20240630 Operating Expenses 1345692.0000 USD 1 us-gaap/2024
0001641172-25-017193 20240630 Preferred Dividends Accrued Converted USD 2 0001641172-25-017193 Restatement= Scenario Previously Reported;
0001641172-25-017193 20231231 Preferred Stock Shares Authorized 5000000.0000 shares 0 us-gaap/2024 Restatement= Revision Of Prior Period Reclassification Adjustment;
0001641172-25-017193 20231231 Preferred Stock Shares Issued 1905.0000 shares 0 us-gaap/2024 Class Of Stock= Series B Two Preferred Stock;
0001641172-25-017193 20231231 Preferred Stock Shares Issued 1905.0000 shares 0 us-gaap/2024 Class Of Stock= Series B Two Preferred Stock; Restatement= Revision Of Prior Period Reclassification Adjustment;
0001641172-25-017193 20240630 Preferred Stock Shares Outstanding 3864.0000 shares 0 us-gaap/2024 Class Of Stock= Series C One Preferred Stock;
0001641172-25-017193 20240630 Preferred Stock Shares Outstanding 3864.0000 shares 0 us-gaap/2024 Class Of Stock= Series C One Preferred Stock; Restatement= Revision Of Prior Period Reclassification Adjustment;
0001641172-25-017193 20240630 Preferred Stock Shares Outstanding 1276.0000 shares 0 us-gaap/2024 Class Of Stock= Series C Two Preferred Stock; Restatement= Revision Of Prior Period Reclassification Adjustment;
0001641172-25-017193 20240630 Preferred Stock Value 47.0000 USD 0 us-gaap/2024 Restatement= Scenario Previously Reported;
0001641172-25-017193 20240630 Proceeds From Divestiture Of Businesses USD 2 us-gaap/2024
0001641172-25-017193 20230630 Proceeds From Issuance Of Preferred Stock And Preference Stock USD 2 us-gaap/2024
0001641172-25-017193 20240630 Proceeds From Notes Payable 1000000.0000 USD 2 us-gaap/2024 Restatement= Scenario Previously Reported;
0001641172-25-017193 20240630 Provision For Doubtful Accounts USD 2 us-gaap/2024
0001641172-25-017193 20240630 Repayments Of Notes Payable USD 2 us-gaap/2024
0001641172-25-017193 20221231 Shares Outstanding 1097843.0000 shares 0 us-gaap/2024 Equity Components= Common Stock;
0001641172-25-017193 20240331 Shares Outstanding 1148321.0000 shares 0 us-gaap/2024 Equity Components= Common Stock;
0001641172-25-017193 20240331 Shares Outstanding 4550.0000 shares 0 us-gaap/2024 Equity Components= Preferred Stock;
0001641172-25-017193 20221231 Stockholders Equity 4651256.0000 USD 0 us-gaap/2024
0001641172-25-017193 20221231 Stockholders Equity 51169898.0000 USD 0 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001641172-25-017193 20221231 Stockholders Equity -46519740.0000 USD 0 us-gaap/2024 Equity Components= Retained Earnings;
0001641172-25-017193 20230630 Stockholders Equity -51621700.0000 USD 0 us-gaap/2024 Equity Components= Retained Earnings;
0001641172-25-017193 20231231 Stockholders Equity -55938325.0000 USD 0 us-gaap/2024 Equity Components= Retained Earnings;
0001641172-25-017193 20240331 Stockholders Equity 55105159.0000 USD 0 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001641172-25-017193 20240630 Stockholders Equity -1769724.0000 USD 0 us-gaap/2024
0001641172-25-017193 20240630 Stockholders Equity 1150.0000 USD 0 us-gaap/2024 Equity Components= Common Stock; Restatement= Revision Of Prior Period Reclassification Adjustment;
0001641172-25-017193 20240630 Stockholders Equity -2294799.0000 USD 0 us-gaap/2024 Restatement= Scenario Previously Reported;
0001641172-25-017193 20240630 Stock Issued During Period Value Conversion Of Preferred Stock Into Common Shares USD 2 0001641172-25-017193
0001641172-25-017193 20241031 Stock Issued During Period Value New Issues 800.0000 USD 0 us-gaap/2024 Class Of Stock= Series G Preferred Stock; Subsequent Event Type= Subsequent Event;
0001641172-25-017193 20240630 Stock Issued During Period Value Preferred Stock Net Of Issuance Costs USD 2 0001641172-25-017193 Equity Components= Common Stock;
0001641172-25-017193 20240630 Stock Issued During Period Value Preferred Stock Net Of Issuance Costs 43.0000 USD 2 0001641172-25-017193 Equity Components= Preferred Stock;
0001641172-25-017193 20230630 Stock Issued During Period Value Share Based Compensation 9.0000 USD 2 us-gaap/2024 Equity Components= Common Stock;
0001641172-25-017193 20230630 Weighted Average Number Of Shares Outstanding Basic 1100504.0000 shares 2 us-gaap/2024
0001641172-25-017196 20240930 Accounts And Other Receivables Net Current USD 0 us-gaap/2024
0001641172-25-017196 20240930 Adjustments To Additional Paid In Capital Capitalized Dividends 1062777.0000 USD 1 0001641172-25-017196 Equity Components= Additional Paid In Capital;
0001641172-25-017196 20240930 Assets 1467611.0000 USD 0 us-gaap/2024
0001641172-25-017196 20240930 Capitalized Dividends D E F USD 3 0001641172-25-017196 Restatement= Scenario Previously Reported;
0001641172-25-017196 20231231 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations 221511.0000 USD 0 us-gaap/2024 Restatement= Scenario Previously Reported;
0001641172-25-017196 20240930 Liabilities And Stockholders Equity USD 0 us-gaap/2024 Restatement= Revision Of Prior Period Reclassification Adjustment;
0001641172-25-017196 20240930 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations 195511.0000 USD 0 us-gaap/2024
0001641172-25-017196 20240930 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect -26000.0000 USD 3 us-gaap/2024 Restatement= Scenario Previously Reported;
0001641172-25-017196 20231231 Common Stock Par Or Stated Value Per Share 0.0010 USD 0 us-gaap/2024
0001641172-25-017196 20231231 Common Stock Shares Issued 1148321.0000 shares 0 us-gaap/2024
0001641172-25-017196 20240930 Converted Accrued C1 Dividends USD 3 0001641172-25-017196 Restatement= Scenario Previously Reported;
0001641172-25-017196 20240930 Depreciation Depletion And Amortization 86988.0000 USD 3 us-gaap/2024 Restatement= Scenario Previously Reported;
0001641172-25-017196 20231231 Dividends Payable Current 130000.0000 USD 0 us-gaap/2024
0001641172-25-017196 20240930 Earnings Per Share Diluted -1.7600 USD 1 us-gaap/2024
0001641172-25-017196 20230930 Gain Loss On Disposition Of Assets -2266852.0000 USD 1 us-gaap/2024
0001641172-25-017196 20240930 Gain Loss On Disposition Of Assets USD 3 us-gaap/2024 Restatement= Scenario Previously Reported;
0001641172-25-017196 20240930 Gross Profit USD 3 us-gaap/2024 Restatement= Revision Of Prior Period Reclassification Adjustment;
0001641172-25-017196 20240930 Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest -2101274.0000 USD 1 us-gaap/2024
0001641172-25-017196 20240930 Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest -3963279.0000 USD 3 us-gaap/2024
0001641172-25-017196 20240930 Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest -3963279.0000 USD 3 us-gaap/2024
0001641172-25-017196 20240930 Income Loss From Continuing Operations Per Basic Share -1.7100 USD 1 us-gaap/2024
0001641172-25-017196 20240930 Income Loss From Continuing Operations Per Basic Share -1.3300 USD 1 us-gaap/2024 Restatement= Scenario Previously Reported;
0001641172-25-017196 20240930 Income Loss From Continuing Operations Per Basic Share -3.6200 USD 3 us-gaap/2024 Restatement= Scenario Previously Reported;
0001641172-25-017196 20240930 Income Loss From Continuing Operations Per Diluted Share -1.7100 USD 1 us-gaap/2024
0001641172-25-017196 20230930 Income Loss From Discontinued Operations Net Of Tax 449796.0000 USD 1 us-gaap/2024
0001641172-25-017196 20230930 Income Loss From Discontinued Operations Net Of Tax -2196405.0000 USD 3 us-gaap/2024
0001641172-25-017196 20240930 Increase Decrease In Accounts Payable And Accrued Liabilities 1915698.0000 USD 3 us-gaap/2024
0001641172-25-017196 20230930 Increase Decrease In Prepaid Deferred Expense And Other Assets 2772.0000 USD 3 us-gaap/2024
0001641172-25-017196 20230930 Interest Expense Debt USD 3 us-gaap/2024
0001641172-25-017196 20230930 Interest Expense Nonoperating 93113.0000 USD 3 us-gaap/2024
0001641172-25-017196 20240930 Interest Expense Nonoperating USD 1 us-gaap/2024 Restatement= Revision Of Prior Period Reclassification Adjustment;
0001641172-25-017196 20230930 Investment Income Interest 27030.0000 USD 3 us-gaap/2024
0001641172-25-017196 20240930 Investment Income Interest 1453.0000 USD 1 us-gaap/2024
0001641172-25-017196 20230930 Net Cash Provided By Used In Financing Activities 4288591.0000 USD 3 us-gaap/2024
0001641172-25-017196 20240930 Net Cash Provided By Used In Financing Activities 2374227.0000 USD 3 us-gaap/2024
0001641172-25-017196 20240930 Net Cash Provided By Used In Investing Activities -375000.0000 USD 3 us-gaap/2024 Restatement= Scenario Previously Reported;
0001641172-25-017196 20230930 Net Income Loss USD 1 us-gaap/2024 Equity Components= Common Stock;
0001641172-25-017196 20240930 Net Income Loss -2204648.0000 USD 1 us-gaap/2024
0001641172-25-017196 20240930 Net Income Loss USD 1 us-gaap/2024 Restatement= Revision Of Prior Period Reclassification Adjustment;
0001641172-25-017196 20230930 Net Income Loss Available To Common Stockholders Basic -8014631.0000 USD 3 us-gaap/2024
0001641172-25-017196 20240930 Net Income Loss Available To Common Stockholders Basic -725347.0000 USD 3 us-gaap/2024 Restatement= Revision Of Prior Period Reclassification Adjustment;
0001641172-25-017196 20240930 Notes Payable Current 1521081.0000 USD 0 us-gaap/2024
0001641172-25-017196 20230930 Operating Expenses 5697144.0000 USD 3 us-gaap/2024
0001641172-25-017196 20240930 Operating Expenses 1930314.0000 USD 1 us-gaap/2024 Restatement= Scenario Previously Reported;
0001641172-25-017196 20240930 Preferred Dividends Accrued B1 88000.0000 USD 3 0001641172-25-017196
0001641172-25-017196 20240930 Preferred Dividends Accrued C1 And C2 210000.0000 USD 3 0001641172-25-017196 Restatement= Revision Of Prior Period Reclassification Adjustment;
0001641172-25-017196 20230930 Preferred Stock Conversion USD 3 0001641172-25-017196
0001641172-25-017196 20240930 Preferred Stock Dividends Income Statement Impact 433430.0000 USD 1 us-gaap/2024 Restatement= Scenario Previously Reported;
0001641172-25-017196 20240930 Preferred Stock Shares Authorized 5000000.0000 shares 0 us-gaap/2024
0001641172-25-017196 20240930 Preferred Stock Shares Outstanding 45826.0000 shares 0 us-gaap/2024
0001641172-25-017196 20240930 Preferred Stock Shares Outstanding 17364.0000 shares 0 us-gaap/2024 Class Of Stock= Series D Preferred Stock;
0001641172-25-017196 20240930 Proceeds From Issuance Of Common Stock USD 3 us-gaap/2024
0001641172-25-017196 20240930 Proceeds From Sale Of Property Plant And Equipment USD 3 us-gaap/2024
0001641172-25-017196 20240930 Property Plant And Equipment Net USD 0 us-gaap/2024 Restatement= Revision Of Prior Period Reclassification Adjustment;
0001641172-25-017196 20230930 Provision For Doubtful Accounts 61599.0000 USD 3 us-gaap/2024
0001641172-25-017196 20230930 Repayments Of Notes Payable 60599.0000 USD 3 us-gaap/2024
0001641172-25-017196 20230930 Revenue From Contract With Customer Excluding Assessed Tax USD 1 us-gaap/2024
0001641172-25-017196 20240930 Revenue From Contract With Customer Excluding Assessed Tax 56300.0000 USD 1 us-gaap/2024
0001641172-25-017196 20240930 Settlement Of Notes Receivable In Connection With Asset Purchase Agreement 1083000.0000 USD 3 0001641172-25-017196
0001641172-25-017196 20230630 Shares Outstanding 1109335.0000 shares 0 us-gaap/2024 Equity Components= Common Stock;
0001641172-25-017196 20230630 Shares Outstanding shares 0 us-gaap/2024 Equity Components= Preferred Stock;
0001641172-25-017196 20221231 Stockholders Equity 4651256.0000 USD 0 us-gaap/2024
0001641172-25-017196 20221231 Stockholders Equity 51169898.0000 USD 0 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001641172-25-017196 20230630 Stockholders Equity -51621700.0000 USD 0 us-gaap/2024 Equity Components= Retained Earnings;
0001641172-25-017196 20230930 Stockholders Equity 55506616.0000 USD 0 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001641172-25-017196 20230930 Stockholders Equity 1110.0000 USD 0 us-gaap/2024 Equity Components= Common Stock;
0001641172-25-017196 20231231 Stockholders Equity 5.0000 USD 0 us-gaap/2024 Equity Components= Preferred Stock;
0001641172-25-017196 20240630 Stockholders Equity -1769724.0000 USD 0 us-gaap/2024
0001641172-25-017196 20240630 Stockholders Equity 47.0000 USD 0 us-gaap/2024 Equity Components= Preferred Stock;
0001641172-25-017196 20240930 Stockholders Equity -4799315.0000 USD 0 us-gaap/2024 Restatement= Scenario Previously Reported;
0001641172-25-017196 20240930 Stock Issued During Period Shares New Issues 17364.0000 shares 3 us-gaap/2024 Class Of Stock= Series D Preferred Stock;
0001641172-25-017196 20240930 Stock Issued During Period Value Conversion Of Series C1 Preferred Stock Into Common Shares 28886.0000 USD 3 0001641172-25-017196
0001641172-25-017196 20240930 Stock Issued During Period Value Conversion Of Series C1 Preferred Stock Into Common Shares 28886.0000 USD 3 0001641172-25-017196 Equity Components= Additional Paid In Capital;
0001641172-25-017196 20230930 Stock Issued During Period Value New Issues 64032.0000 USD 3 us-gaap/2024
0001641172-25-017196 20240930 Weighted Average Number Of Diluted Shares Outstanding 1909588.0000 shares 1 us-gaap/2024
0001641172-25-017196 20240930 Weighted Average Number Of Diluted Shares Outstanding shares 3 us-gaap/2024 Restatement= Restatement Adjustment;
0001641172-25-017196 20240930 Weighted Average Number Of Shares Outstanding Basic 1414912.0000 shares 3 us-gaap/2024 Restatement= Scenario Previously Reported;
0001641172-25-017216 20241231 Accounts And Other Receivables Net Current USD 0 us-gaap/2024 Restatement= Revision Of Prior Period Reclassification Adjustment;
0001641172-25-017216 20241231 Accounts Payable And Accrued Liabilities Current 3.0000 USD 0 us-gaap/2024 Restatement= Revision Of Prior Period Reclassification Adjustment;
0001641172-25-017216 20231231 Adjustments To Additional Paid In Capital Dividend In Excess Of Retained Earnings 130000.0000 USD 4 0001641172-25-017216
0001641172-25-017216 20231231 Asset Impairment Charges 3519322.0000 USD 4 us-gaap/2024
0001641172-25-017216 20231231 Assets Current 1144119.0000 USD 0 us-gaap/2024
0001641172-25-017216 20241231 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations 504189.0000 USD 0 us-gaap/2024
0001641172-25-017216 20231231 Commitments And Contingencies USD 0 us-gaap/2024
0001641172-25-017216 20231231 Common Stock Par Or Stated Value Per Share 4.2900 USD 0 us-gaap/2024 Title Of Individual= Board Of Directors Chairman;
0001641172-25-017216 20231231 Common Stock Shares Issued 10000.0000 shares 0 us-gaap/2024 Title Of Individual= Board Of Directors Chairman;
0001641172-25-017216 20240930 Common Stock Shares Outstanding 2013199.0000 shares 0 us-gaap/2024
0001641172-25-017216 20241231 Cost Of Revenue 305248.0000 USD 4 us-gaap/2024 Restatement= Scenario Previously Reported;
0001641172-25-017216 20241231 Discontinued Operation Income Loss From Discontinued Operation Before Income Tax -2648008.0000 USD 4 us-gaap/2024
0001641172-25-017216 20241231 Dividends Sharebased Compensation Paid In Kind USD 4 us-gaap/2024 Equity Components= Retained Earnings;
0001641172-25-017216 20231231 Earnings Per Share Basic -8.4700 USD 4 us-gaap/2024
0001641172-25-017216 20231231 Gain Loss On Disposition Of Assets 3433884.0000 USD 4 us-gaap/2024 Consolidation Items= Operating Segments;
0001641172-25-017216 20241231 Gain Loss On Disposition Of Assets USD 4 us-gaap/2024 Consolidation Items= Operating Segments;
0001641172-25-017216 20241231 Income Loss From Continuing Operations Per Basic Share -4.0100 USD 4 us-gaap/2024 Restatement= Scenario Previously Reported;
0001641172-25-017216 20231231 Income Loss From Continuing Operations Per Diluted Share -5.8200 USD 4 us-gaap/2024
0001641172-25-017216 20241231 Income Loss From Discontinued Operations Net Of Tax Per Basic Share USD 4 us-gaap/2024 Restatement= Revision Of Prior Period Reclassification Adjustment;
0001641172-25-017216 20241231 Income Loss From Discontinued Operations Net Of Tax Per Diluted Share USD 4 us-gaap/2024 Restatement= Revision Of Prior Period Reclassification Adjustment;
0001641172-25-017216 20241231 Income Taxes Paid Net USD 4 us-gaap/2024 Restatement= Scenario Previously Reported;
0001641172-25-017216 20241231 Income Tax Expense Benefit USD 4 us-gaap/2024 Restatement= Scenario Previously Reported;
0001641172-25-017216 20231231 Increase Decrease In Patient Deposits -241666.0000 USD 4 0001641172-25-017216
0001641172-25-017216 20241231 Increase Decrease In Patient Deposits USD 4 0001641172-25-017216
0001641172-25-017216 20241231 Increase Decrease In Right Of Use Lease Liability USD 4 0001641172-25-017216
0001641172-25-017216 20231231 Interest Expense Nonoperating 124966.0000 USD 4 us-gaap/2024
0001641172-25-017216 20241231 Interest Expense Nonoperating 311997.0000 USD 4 us-gaap/2024 Consolidation Items= Operating Segments;
0001641172-25-017216 20241231 Investment Income Interest 3470.0000 USD 4 us-gaap/2024
0001641172-25-017216 20241231 Investment Income Interest 3470.0000 USD 4 us-gaap/2024 Consolidation Items= Operating Segments;
0001641172-25-017216 20241231 Liabilities And Stockholders Equity 1589021.0000 USD 0 us-gaap/2024
0001641172-25-017216 20231231 Liabilities Of Disposal Group Including Discontinued Operation Current 1312711.0000 USD 0 us-gaap/2024
0001641172-25-017216 20241231 Net Cash Provided By Used In Investing Activities USD 4 us-gaap/2024 Restatement= Revision Of Prior Period Reclassification Adjustment;
0001641172-25-017216 20241231 Net Income Loss USD 4 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001641172-25-017216 20241231 Net Income Loss Available To Common Stockholders Basic -1881671.0000 USD 4 us-gaap/2024 Restatement= Revision Of Prior Period Reclassification Adjustment;
0001641172-25-017216 20241231 Nonoperating Income Expense USD 4 us-gaap/2024 Restatement= Revision Of Prior Period Reclassification Adjustment;
0001641172-25-017216 20241231 Operating Expenses 5390069.0000 USD 4 us-gaap/2024 Restatement= Scenario Previously Reported;
0001641172-25-017216 20241231 Other Nonoperating Income Expense USD 4 us-gaap/2024
0001641172-25-017216 20241231 Preferred Dividends Accrued Converted Into C1 -218000.0000 USD 4 0001641172-25-017216 Restatement= Revision Of Prior Period Reclassification Adjustment;
0001641172-25-017216 20240930 Preferred Stock Shares Outstanding 4550.0000 shares 0 us-gaap/2024
0001641172-25-017216 20231231 Prepaid Expense And Other Assets Current 94711.0000 USD 0 us-gaap/2024
0001641172-25-017216 20241231 Proceeds From Issuance Of Preferred Stock And Preference Stock 2221492.0000 USD 4 us-gaap/2024 Restatement= Scenario Previously Reported;
0001641172-25-017216 20241231 Proceeds From Notes Payable USD 4 us-gaap/2024 Restatement= Revision Of Prior Period Reclassification Adjustment;
0001641172-25-017216 20241231 Proceeds From Repayments Of Notes Payable USD 4 us-gaap/2024
0001641172-25-017216 20241231 Proceeds From Sale Of Practices USD 4 0001641172-25-017216
0001641172-25-017216 20241231 Provision For Doubtful Accounts USD 4 us-gaap/2024
0001641172-25-017216 20231231 Settlement Of Notes Receivable In Connection With Asset Purchase Agreement USD 4 0001641172-25-017216
0001641172-25-017216 20231231 Stock Issued During Period Preferred Stock Shares 4550.0000 shares 4 0001641172-25-017216 Equity Components= Preferred Stock;
0001641172-25-017216 20231231 Stock Issued During Period Preferred Stock Value USD 4 0001641172-25-017216 Equity Components= Retained Earnings;
0001641172-25-017216 20241231 Stock Issued During Period Shares New Issues 24172.0000 shares 4 us-gaap/2024 Class Of Stock= Series E Preferred Stock; Type Of Arrangement= Settlement And Release Agreement;
0001641172-25-017216 20241231 Stock Issued During Period Shares New Issues 48138.0000 shares 4 us-gaap/2024 Equity Components= Preferred Stock;
0001641172-25-017216 20231231 Stock Issued During Period Value New Issues 16647.0000 USD 4 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001641172-25-017216 20231231 Stock Issued During Period Value New Issues USD 4 us-gaap/2024 Equity Components= Retained Earnings;
0001641172-25-017216 20241231 Stock Issued During Period Value New Issues 4490058.0000 USD 4 us-gaap/2024
0001641172-25-017216 20231231 Stock Issued During Period Value Reverse Stock Splits USD 4 0001641172-25-017216
0001641172-25-017216 20241231 Stock Issued During Period Value Share Based Compensation Gross USD 4 us-gaap/2024 Equity Components= Retained Earnings;
0001641172-25-017216 20241231 Weighted Average Number Of Shares Outstanding Basic 1569627.0000 shares 4 us-gaap/2024 Restatement= Scenario Previously Reported;
0001641172-25-017216 20241231 Additional Paid In Capital 755455.0000 USD 0 us-gaap/2024 Restatement= Revision Of Prior Period Reclassification Adjustment;
0001641172-25-017193 20230630 Accrued Dividends USD 2 0001641172-25-017193
0001641172-25-017193 20240630 Adjustments To Additional Paid In Capital Other 525075.0000 USD 1 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001641172-25-017193 20240630 Adjustments To Additional Paid In Capital Other USD 1 us-gaap/2024 Equity Components= Preferred Stock;
0001641172-25-017193 20240630 Adjustments To Additional Paid In Capital Other USD 1 us-gaap/2024 Equity Components= Retained Earnings;
0001641172-25-017193 20240630 Adjustments To Additional Paid In Capital Other USD 2 us-gaap/2024 Equity Components= Common Stock;
0001641172-25-017193 20240630 Assets 2223483.0000 USD 0 us-gaap/2024 Restatement= Scenario Previously Reported;
0001641172-25-017193 20240630 Assets Current 1214417.0000 USD 0 us-gaap/2024 Restatement= Scenario Previously Reported;
0001641172-25-017193 20240630 Assets Of Disposal Group Including Discontinued Operation Current USD 0 us-gaap/2024 Restatement= Revision Of Prior Period Reclassification Adjustment;
0001641172-25-017193 20221231 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations 763211.0000 USD 0 us-gaap/2024
0001641172-25-017193 20240630 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect 669099.0000 USD 2 us-gaap/2024 Restatement= Scenario Previously Reported;
0001641172-25-017193 20231231 Commitments And Contingencies USD 0 us-gaap/2024
0001641172-25-017193 20240630 Commitments And Contingencies USD 0 us-gaap/2024 Restatement= Scenario Previously Reported;
0001641172-25-017193 20231231 Common Stock Shares Authorized 60000000.0000 shares 0 us-gaap/2024 Restatement= Revision Of Prior Period Reclassification Adjustment;
0001641172-25-017193 20240630 Depreciation Depletion And Amortization USD 2 us-gaap/2024 Restatement= Revision Of Prior Period Reclassification Adjustment;
0001641172-25-017193 20231231 Dividends Payable Current 130000.0000 USD 0 us-gaap/2024
0001641172-25-017193 20240630 Gain Loss On Disposition Of Assets USD 1 us-gaap/2024
0001641172-25-017193 20230630 Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest -2455760.0000 USD 2 us-gaap/2024
0001641172-25-017193 20240630 Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest -1862005.0000 USD 2 us-gaap/2024
0001641172-25-017193 20230630 Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest -1158898.0000 USD 1 us-gaap/2024
0001641172-25-017193 20240630 Income Loss From Continuing Operations Per Basic Share -1.7400 USD 1 us-gaap/2024
0001641172-25-017193 20240630 Income Loss From Continuing Operations Per Diluted Share -1.7400 USD 1 us-gaap/2024
0001641172-25-017193 20230630 Income Loss From Discontinued Operations Net Of Tax Per Diluted Share -2.4000 USD 2 us-gaap/2024
0001641172-25-017193 20240630 Income Loss From Discontinued Operations Net Of Tax Per Diluted Share 0.0300 USD 1 us-gaap/2024
0001641172-25-017193 20230630 Income Tax Expense Benefit USD 1 us-gaap/2024
0001641172-25-017193 20240630 Increase Decrease In Accounts Receivable USD 2 us-gaap/2024 Restatement= Revision Of Prior Period Reclassification Adjustment;
0001641172-25-017193 20240630 Increase Decrease In Patient Deposits USD 2 0001641172-25-017193
0001641172-25-017193 20240630 Increase Decrease In Prepaid Deferred Expense And Other Assets USD 2 us-gaap/2024 Restatement= Revision Of Prior Period Reclassification Adjustment;
0001641172-25-017193 20230630 Increase Decrease In Security Deposits 85304.0000 USD 2 us-gaap/2024
0001641172-25-017193 20240630 Interest Expense Debt USD 2 us-gaap/2024 Restatement= Revision Of Prior Period Reclassification Adjustment;
0001641172-25-017193 20230630 Interest Paid Net 24826.0000 USD 2 us-gaap/2024
0001641172-25-017193 20231231 Liabilities Of Disposal Group Including Discontinued Operation Current 1312711.0000 USD 0 us-gaap/2024
0001641172-25-017193 20230630 Net Cash Provided By Used In Investing Activities 1130000.0000 USD 2 us-gaap/2024
0001641172-25-017193 20240630 Net Cash Provided By Used In Investing Activities -375000.0000 USD 2 us-gaap/2024 Restatement= Scenario Previously Reported;
0001641172-25-017193 20240630 Net Income Loss USD 2 us-gaap/2024 Restatement= Revision Of Prior Period Reclassification Adjustment;
0001641172-25-017193 20240630 Net Income Loss Available To Common Stockholders Basic -2518104.0000 USD 2 us-gaap/2024
0001641172-25-017193 20240630 Preferred Dividends Accrued Converted -218000.0000 USD 2 0001641172-25-017193
0001641172-25-017193 20240630 Preferred Stock Dividends Income Statement Impact 727481.0000 USD 2 us-gaap/2024
0001641172-25-017193 20240630 Preferred Stock Shares Issued 3864.0000 shares 0 us-gaap/2024 Class Of Stock= Series C One Preferred Stock;
0001641172-25-017193 20240630 Preferred Stock Shares Issued 17364.0000 shares 0 us-gaap/2024 Class Of Stock= Series D Preferred Stock;
0001641172-25-017193 20240630 Preferred Stock Shares Issued 17364.0000 shares 0 us-gaap/2024 Class Of Stock= Series D Preferred Stock; Restatement= Revision Of Prior Period Reclassification Adjustment;
0001641172-25-017193 20231231 Preferred Stock Shares Outstanding 2645.0000 shares 0 us-gaap/2024 Class Of Stock= Series B One Preferred Stock;
0001641172-25-017193 20240630 Preferred Stock Value 47.0000 USD 0 us-gaap/2024
0001641172-25-017193 20231231 Prepaid Expense And Other Assets Current 94711.0000 USD 0 us-gaap/2024
0001641172-25-017193 20240630 Proceeds From Issuance Of Common Stock USD 2 us-gaap/2024
0001641172-25-017193 20230630 Repayments Of Debt And Capital Lease Obligations 9840.0000 USD 2 us-gaap/2024
0001641172-25-017193 20240630 Repayments Of Debt And Capital Lease Obligations 1724.0000 USD 2 us-gaap/2024 Restatement= Scenario Previously Reported;
0001641172-25-017193 20230630 Repayments Of Notes Payable 30117.0000 USD 2 us-gaap/2024
0001641172-25-017193 20230630 Revenue From Contract With Customer Excluding Assessed Tax USD 2 us-gaap/2024
0001641172-25-017193 20240630 Settlement Of Notes Receivable In Connection With Asset Purchase Agreement 1083000.0000 USD 2 0001641172-25-017193 Restatement= Scenario Previously Reported;
0001641172-25-017193 20230630 Stockholders Equity -358970.0000 USD 0 us-gaap/2024
0001641172-25-017193 20230630 Stockholders Equity 1110.0000 USD 0 us-gaap/2024 Equity Components= Common Stock;
0001641172-25-017193 20231231 Stockholders Equity 5.0000 USD 0 us-gaap/2024 Equity Components= Preferred Stock;
0001641172-25-017193 20240630 Stockholders Equity 55958027.0000 USD 0 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001641172-25-017193 20240630 Stockholders Equity 1150.0000 USD 0 us-gaap/2024 Equity Components= Common Stock;
0001641172-25-017193 20240630 Stockholders Equity 47.0000 USD 0 us-gaap/2024 Equity Components= Preferred Stock;
0001641172-25-017193 20240630 Stock Issued During Period Shares Preferred Stock Net Of Issuance Costs 43462.0000 shares 2 0001641172-25-017193 Equity Components= Preferred Stock;
0001641172-25-017196 20230930 Net Cash Provided By Used In Investing Activities -1870000.0000 USD 3 us-gaap/2024
0001641172-25-017193 20240630 Stock Issued During Period Value Conversion Of Preferred Stock Into Common Shares 1.0000 USD 1 0001641172-25-017193 Equity Components= Common Stock;
0001641172-25-017193 20240630 Stock Issued During Period Value Conversion Of Preferred Stock Into Common Shares -1.0000 USD 1 0001641172-25-017193 Equity Components= Preferred Stock;
0001641172-25-017193 20230630 Stock Issued During Period Value New Issues One 16647.0000 USD 2 0001641172-25-017193 Equity Components= Additional Paid In Capital;
0001641172-25-017193 20230630 Stock Issued During Period Value New Issues One USD 2 0001641172-25-017193 Equity Components= Retained Earnings;
0001641172-25-017193 20230630 Stock Issued During Period Value Share Based Compensation USD 2 us-gaap/2024 Equity Components= Retained Earnings;
0001641172-25-017193 20240630 Weighted Average Number Of Diluted Shares Outstanding 1181390.0000 shares 1 us-gaap/2024
0001641172-25-017196 20231231 Accounts And Other Receivables Net Current 731067.0000 USD 0 us-gaap/2024
0001641172-25-017196 20240930 Accounts And Other Receivables Net Current USD 0 us-gaap/2024 Restatement= Scenario Previously Reported;
0001641172-25-017196 20240930 Accounts Payable And Accrued Liabilities Current 2273070.0000 USD 0 us-gaap/2024
0001641172-25-017196 20240930 Additional Paid In Capital 55894475.0000 USD 0 us-gaap/2024
0001641172-25-017196 20240930 Additional Paid In Capital 761391.0000 USD 0 us-gaap/2024 Restatement= Revision Of Prior Period Reclassification Adjustment;
0001641172-25-017196 20230930 Adjustments To Additional Paid In Capital Dividends In Excess Of Retained Earnings 55000.0000 USD 3 us-gaap/2024
0001641172-25-017196 20230930 Adjustments To Additional Paid In Capital Dividends In Excess Of Retained Earnings USD 3 us-gaap/2024 Equity Components= Preferred Stock;
0001641172-25-017196 20240930 Adjustments To Additional Paid In Capital Dividends In Excess Of Retained Earnings USD 3 us-gaap/2024 Equity Components= Retained Earnings;
0001641172-25-017196 20230930 Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition 27702.0000 USD 3 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001641172-25-017196 20230930 Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition USD 3 us-gaap/2024 Equity Components= Common Stock;
0001641172-25-017196 20231231 Assets Current 1144119.0000 USD 0 us-gaap/2024
0001641172-25-017196 20240930 Assets Of Disposal Group Including Discontinued Operation Current USD 0 us-gaap/2024
0001641172-25-017196 20240930 Cash 195511.0000 USD 0 us-gaap/2024 Restatement= Scenario Previously Reported;
0001641172-25-017196 20240930 Cash Provided By Used In Operating Activities Discontinued Operations USD 3 us-gaap/2024 Restatement= Revision Of Prior Period Reclassification Adjustment;
0001641172-25-017196 20240930 Commitments And Contingencies USD 0 us-gaap/2024 Restatement= Revision Of Prior Period Reclassification Adjustment;
0001641172-25-017196 20240930 Commitments And Contingencies USD 0 us-gaap/2024 Restatement= Scenario Previously Reported;
0001641172-25-017196 20240930 Common Stock Shares Issued 2013199.0000 shares 0 us-gaap/2024
0001641172-25-017196 20230930 Cost Of Revenue USD 1 us-gaap/2024
0001641172-25-017196 20240930 Dividends Payable Current 1160911.0000 USD 0 us-gaap/2024 Restatement= Scenario Previously Reported;
0001641172-25-017196 20240930 Earnings Per Share Basic -0.3800 USD 1 us-gaap/2024 Restatement= Restatement Adjustment;
0001641172-25-017196 20240930 Earnings Per Share Basic -1.3800 USD 1 us-gaap/2024 Restatement= Scenario Previously Reported;
0001641172-25-017196 20240930 Gain Loss On Disposition Of Assets1 USD 3 us-gaap/2024
0001641172-25-017196 20240930 General And Administrative Expense USD 3 us-gaap/2024 Restatement= Revision Of Prior Period Reclassification Adjustment;
0001641172-25-017196 20240930 General And Administrative Expense 3684636.0000 USD 3 us-gaap/2024 Restatement= Scenario Previously Reported;
0001641172-25-017196 20230930 Gross Profit USD 1 us-gaap/2024
0001641172-25-017196 20230930 Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest -3307467.0000 USD 1 us-gaap/2024
0001641172-25-017196 20240930 Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest -3963279.0000 USD 3 us-gaap/2024 Restatement= Scenario Previously Reported;
0001641172-25-017196 20240930 Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interests -3963279.0000 USD 3 0001641172-25-017196
0001641172-25-017196 20240930 Income Loss From Discontinued Operations Net Of Tax -103374.0000 USD 1 us-gaap/2024 Restatement= Scenario Previously Reported;
0001641172-25-017196 20230930 Income Loss From Discontinued Operations Net Of Tax Per Basic Share -2.0000 USD 3 us-gaap/2024
0001641172-25-017196 20240930 Income Loss From Discontinued Operations Net Of Tax Per Basic Share -0.0500 USD 1 us-gaap/2024
0001641172-25-017196 20240930 Income Loss From Discontinued Operations Net Of Tax Per Basic Share USD 3 us-gaap/2024 Restatement= Restatement Adjustment;
0001641172-25-017196 20240930 Income Taxes Paid Net USD 3 us-gaap/2024 Restatement= Revision Of Prior Period Reclassification Adjustment;
0001641172-25-017196 20240930 Income Tax Expense Benefit USD 3 us-gaap/2024
0001641172-25-017196 20240930 Increase Decrease In Accounts Receivable 41700.0000 USD 3 us-gaap/2024
0001641172-25-017196 20230930 Increase Decrease In Patient Deposits -116452.0000 USD 3 0001641172-25-017196
0001641172-25-017196 20240930 Increase Decrease In Right Of Use Lease Liability USD 3 0001641172-25-017196
0001641172-25-017196 20240930 Interest Expense Debt 121080.0000 USD 3 us-gaap/2024
0001641172-25-017196 20230930 Interest Paid Net 96656.0000 USD 3 us-gaap/2024
0001641172-25-017196 20240930 Interest Paid Net USD 3 us-gaap/2024
0001641172-25-017196 20240930 Liabilities Current 6266926.0000 USD 0 us-gaap/2024 Restatement= Scenario Previously Reported;
0001641172-25-017196 20240930 Liabilities Of Disposal Group Including Discontinued Operation Current USD 0 us-gaap/2024 Restatement= Revision Of Prior Period Reclassification Adjustment;
0001641172-25-017196 20240930 Net Cash Provided By Used In Operating Activities USD 3 us-gaap/2024 Restatement= Revision Of Prior Period Reclassification Adjustment;
0001641172-25-017196 20230930 Net Income Loss USD 3 us-gaap/2024 Equity Components= Common Stock;
0001641172-25-017196 20230930 Net Income Loss USD 3 us-gaap/2024 Equity Components= Preferred Stock;
0001641172-25-017196 20240930 Nonoperating Income Expense USD 3 us-gaap/2024 Restatement= Revision Of Prior Period Reclassification Adjustment;
0001641172-25-017196 20240930 Operating Expenses USD 1 us-gaap/2024 Restatement= Revision Of Prior Period Reclassification Adjustment;
0001641172-25-017196 20230930 Operating Income Loss -3263444.0000 USD 1 us-gaap/2024
0001641172-25-017196 20240930 Operating Income Loss -1996091.0000 USD 1 us-gaap/2024 Restatement= Scenario Previously Reported;
0001641172-25-017196 20230930 Preferred Dividends Accrued C1 And C2 USD 3 0001641172-25-017196
0001641172-25-017196 20240930 Preferred Dividends Accrued C1 And C2 210000.0000 USD 3 0001641172-25-017196
0001641172-25-017196 20240930 Preferred Stock Dividends Income Statement Impact 1160911.0000 USD 3 us-gaap/2024 Restatement= Scenario Previously Reported;
0001641172-25-017196 20231231 Preferred Stock Shares Issued 4550.0000 shares 0 us-gaap/2024
0001641172-25-017196 20231231 Preferred Stock Shares Outstanding 4550.0000 shares 0 us-gaap/2024
0001641172-25-017196 20240930 Prepaid Expense And Other Assets Current 273527.0000 USD 0 us-gaap/2024
0001641172-25-017196 20240930 Proceeds From Divestiture Of Businesses USD 3 us-gaap/2024
0001641172-25-017196 20230930 Proceeds From Notes Payable USD 3 us-gaap/2024
0001641172-25-017196 20240930 Property Plant And Equipment Net 956873.0000 USD 0 us-gaap/2024 Restatement= Scenario Previously Reported;
0001641172-25-017196 20230930 Repayments Of Debt And Capital Lease Obligations 14842.0000 USD 3 us-gaap/2024
0001641172-25-017196 20240930 Repayments Of Debt And Capital Lease Obligations USD 3 us-gaap/2024 Restatement= Revision Of Prior Period Reclassification Adjustment;
0001641172-25-017196 20240930 Share Based Compensation USD 3 us-gaap/2024 Restatement= Revision Of Prior Period Reclassification Adjustment;
0001641172-25-017196 20230930 Shares Outstanding 4300.0000 shares 0 us-gaap/2024 Equity Components= Preferred Stock;
0001641172-25-017196 20231231 Shares Outstanding 1148321.0000 shares 0 us-gaap/2024 Equity Components= Common Stock;
0001641172-25-017196 20231231 Shares Outstanding 4550.0000 shares 0 us-gaap/2024 Equity Components= Preferred Stock;
0001641172-25-017196 20221231 Stockholders Equity 1098.0000 USD 0 us-gaap/2024 Equity Components= Common Stock;
0001641172-25-017196 20230630 Stockholders Equity -358970.0000 USD 0 us-gaap/2024
0001641172-25-017196 20230630 Stockholders Equity 1110.0000 USD 0 us-gaap/2024 Equity Components= Common Stock;
0001641172-25-017196 20230930 Stockholders Equity -54479371.0000 USD 0 us-gaap/2024 Equity Components= Retained Earnings;
0001641172-25-017196 20240630 Stockholders Equity 55958027.0000 USD 0 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001641172-25-017196 20240630 Stockholders Equity 1150.0000 USD 0 us-gaap/2024 Equity Components= Common Stock;
0001641172-25-017196 20240930 Stockholders Equity -4037924.0000 USD 0 us-gaap/2024
0001641172-25-017196 20241031 Stock Issued During Period Value New Issues 800.0000 USD 0 us-gaap/2024 Class Of Stock= Series G Preferred Stock; Subsequent Event Type= Subsequent Event;
0001641172-25-017196 20240930 Stock Issued During Period Value Preferred Stock Net Of Issuance Costs USD 3 0001641172-25-017196 Equity Components= Retained Earnings;
0001641172-25-017216 20231231 Adjustments To Additional Paid In Capital Dividend In Excess Of Retained Earnings USD 4 0001641172-25-017216 Equity Components= Retained Earnings;
0001641172-25-017216 20241231 Adjustments To Additional Paid In Capital Dividend In Excess Of Retained Earnings USD 4 0001641172-25-017216 Equity Components= Retained Earnings;

Description
Field Name Field Description
adsh Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission.
tag The unique identifier (name) for a tag in a specific taxonomy release.
version For a standard tag, an identifier for the taxonomy; otherwise the accession number where the tag was defined.
ddate The end date for the data value, rounded to the nearest month end.
qtrs The count of the number of quarters represented by the data value, rounded to the nearest whole number. “0” indicates it is a point-in-time value.
uom The unit of measure for the value.
segments Tags used to represent axis and member reporting.
coreg If specified, indicates a specific co-registrant, the parent company, or other entity (e.g., guarantor). NULL indicates the consolidated entity.
value The value. This is not scaled, it is as found in the Interactive Data file, but is limited to four digits to the right of the decimal point.
footnote The text of any superscripted footnotes on the value, as shown on the statement page, truncated to 512 characters, or if there is no footnote, then this field will be blank.

Tags

tag version custom abstract datatype iord crdr tlabel doc
Increase Decrease In Accounts Receivable us-gaap/2024 0 0 monetary D C Increase (Decrease) in Accounts Receivable The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.
Assets Current us-gaap/2024 0 0 monetary I D Assets, Current Amount of asset recognized for present right to economic benefit, classified as current.
Revenue From Contract With Customer Excluding Assessed Tax us-gaap/2024 0 0 monetary D C Revenue from Contract with Customer, Excluding Assessed Tax Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.
Stock Issued During Period Value Reverse Stock Splits 0001641172-25-017216 1 0 monetary D C Issuance of fractional shares with reverse stock split Stock issued during period value reverse stock splits.
Payments To Acquire Property Plant And Equipment us-gaap/2024 0 0 monetary D C Payments to Acquire Property, Plant, and Equipment The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.
Accounts Payable And Accrued Liabilities Current us-gaap/2024 0 0 monetary I C Accounts Payable and Accrued Liabilities, Current Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.
Increase Decrease In Liability To Issue Common Stock 0001641172-25-017216 1 0 monetary D C IncreaseDecreaseInLiabilityToIssueCommonStock Liability to issue common stock.
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest us-gaap/2024 0 0 monetary D C Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.
Increase Decrease In Deferred Compensation us-gaap/2024 0 0 monetary D D Increase (Decrease) in Deferred Compensation The increase (decrease) during the reporting period in the obligation created by employee agreements whereby earned compensation will be paid in the future.
Liabilities us-gaap/2024 0 0 monetary I C Liabilities Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others.
Liabilities And Stockholders Equity us-gaap/2024 0 0 monetary I C Liabilities and Equity Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.
Liabilities Of Disposal Group Including Discontinued Operation Current us-gaap/2024 0 0 monetary I C Disposal Group, Including Discontinued Operation, Liabilities, Current Amount classified as liabilities attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.
Retained Earnings Accumulated Deficit us-gaap/2024 0 0 monetary I C Retained Earnings (Accumulated Deficit) Amount of accumulated undistributed earnings (deficit).
Stock Issued During Period Value Share Based Compensation Gross us-gaap/2024 0 0 monetary D C Shares Issued, Value, Share-Based Payment Arrangement, before Forfeiture Value, before forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).
Increase Decrease In Right Of Use Lease Liability 0001641172-25-004643 1 0 monetary D C IncreaseDecreaseInRightOfUseLeaseLiability Increase decrease in right of use lease liability.
Preferred Dividends Accrued B1 0001641172-25-017216 1 0 monetary D D Preferred dividends accrued B-1 Preferred dividends accrued B-1.
Stock Issued During Period Preferred Stock Shares 0001641172-25-017216 1 0 shares D Issuance of preferred stock net of issuance costs, shares Stock issued during period preferred stock shares.
Stock Issued During Period Shares Preferred Stock Net Of Issuance Costs 0001641172-25-017196 1 0 shares D Issuance of preferred stock net of issuance costs, shares Stock issued during period shares preferred stock net of issuance costs.
Settlement Of Notes Receivable In Connection With Asset Purchase Agreement 0001641172-25-017193 1 0 monetary D D Settlement of notes receivable in connection with asset purchase agreement Settlement of notes receivable in connection with asset purchase agreement.
Accounts Receivable Net Current us-gaap/2024 0 0 monetary I D Accounts Receivable, after Allowance for Credit Loss, Current Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.
Additional Paid In Capital us-gaap/2024 0 0 monetary I C Additional Paid in Capital Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.
Asset Impairment Charges us-gaap/2024 0 0 monetary D D Asset Impairment Charges Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.
Common Stock Par Or Stated Value Per Share us-gaap/2024 0 0 perShare I Common Stock, Par or Stated Value Per Share Face amount or stated value per share of common stock.
Common Stock Shares Outstanding us-gaap/2024 0 0 shares I Common Stock, Shares, Outstanding Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Discontinued Operation Gain Loss On Disposal Of Discontinued Operation Net Of Tax us-gaap/2024 0 0 monetary D C Discontinued Operation, Gain (Loss) on Disposal of Discontinued Operation, Net of Tax Amount after tax of gain (loss) not previously recognized resulting from the disposal of a discontinued operation.
Gain Loss On Disposition Of Assets1 us-gaap/2024 0 0 monetary D C Gain (Loss) on Disposition of Assets Amount of gain (loss) on sale or disposal of assets, including but not limited to property plant and equipment, intangible assets and equity in securities of subsidiaries or equity method investee.
Income Tax Expense Benefit us-gaap/2024 0 0 monetary D D Income Tax Expense (Benefit) Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Increase Decrease In Patient Deposits 0001641172-25-004643 1 0 monetary D D Patient deposits Increase decrease in patient deposits.
Net Income Loss us-gaap/2024 0 0 monetary D C Net Income (Loss) Attributable to Parent The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Stockholders Equity us-gaap/2024 0 0 monetary I C Equity, Attributable to Parent Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.
Stock Issued During Period Value Conversion Of Convertible Securities us-gaap/2024 0 0 monetary D C Stock Issued During Period, Value, Conversion of Convertible Securities The gross value of stock issued during the period upon the conversion of convertible securities.
Stock Issued During Period Value Share Based Compensation us-gaap/2024 0 0 monetary D C Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).
Weighted Average Number Of Diluted Shares Outstanding us-gaap/2024 0 0 shares D Weighted Average Number of Shares Outstanding, Diluted The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Preferred Stock Converstion 0001641172-25-004643 1 0 monetary D D Preferred stock conversion Preferred stock converstion
Adjustments To Additional Paid In Capital Issuance Of Employee Stock Option 0001641172-25-017216 1 0 monetary D C Issuance of employee stock options Adjustments to additional paid in capital issuance of employee stock option.
Preferred Dividends Accrued Converted Into C1 0001641172-25-017216 1 0 monetary D C Preferred dividends accrued converted into C-1 Preferred dividends accrued converted into C-1.
Net Income Losses 0001641172-25-017196 1 0 monetary D C Net income losses Net income losses.
Stock Issued During Period Value New Issues One 0001641172-25-017193 1 0 monetary D C Issuance of common stock from ATM Stock issued during period value new issues one.
Adjustments To Additional Paid In Capital Other us-gaap/2024 0 0 monetary D C Adjustments to Additional Paid in Capital, Other Amount of other increase (decrease) in additional paid in capital (APIC).
Assets us-gaap/2024 0 0 monetary I D Assets Amount of asset recognized for present right to economic benefit.
Cash us-gaap/2024 0 0 monetary I D Cash Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.
Common Stock Shares Issued us-gaap/2024 0 0 shares I Common Stock, Shares, Issued Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Earnings Per Share Diluted us-gaap/2024 0 0 perShare D Earnings Per Share, Diluted The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.
Gross Profit us-gaap/2024 0 0 monetary D C Gross Profit Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.
Net Cash Provided By Used In Operating Activities Continuing Operations us-gaap/2024 0 0 monetary D Net Cash Provided by (Used in) Operating Activities, Continuing Operations Amount of cash inflow (outflow) from operating activities, excluding discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
Proceeds From Issuance Of Preferred Stock And Preference Stock us-gaap/2024 0 0 monetary D D Proceeds from Issuance of Preferred Stock and Preference Stock Proceeds from issuance of capital stock which provides for a specific dividend that is paid to the shareholders before any dividends to common stockholders and which takes precedence over common stockholders in the event of liquidation.
Proceeds From Notes Payable us-gaap/2024 0 0 monetary D D Proceeds from Notes Payable The cash inflow from a borrowing supported by a written promise to pay an obligation.
Stock Issued During Period Shares Conversion Of Convertible Securities us-gaap/2024 0 0 shares D Stock Issued During Period, Shares, Conversion of Convertible Securities Number of shares issued during the period as a result of the conversion of convertible securities.
Stock Issued During Period Preferred Stock Value 0001641172-25-017216 1 0 monetary D C Issuance of preferred stock net of issuance costs Stock issued during period preferred stock value.
Stock Issued During Period Shares Reverse Stock Splits us-gaap/2024 0 0 shares D Stock Issued During Period, Shares, Reverse Stock Splits Reduction in the number of shares during the period as a result of a reverse stock split.
Adjustments To Additional Paid In Capital Dividend In Excess Of Retained Earnings 0001641172-25-004643 1 0 monetary D D AdjustmentsToAdditionalPaidInCapitalDividendInExcessOfRetainedEarnings Adjustments to additional paid in capital dividend in excess of retained earnings.
Settlement Of Notes Receivable In Connection With Asset Purchase Agreement 0001641172-25-017196 1 0 monetary D C Settlement of notes receivable in connection with asset purchase agreement Settlement of notes receivable in connection with asset purchase agreement..
Preferred Dividends Accrued Converted 0001641172-25-017193 1 0 monetary D D Preferred dividends accrued converted into C-1 Preferred dividends accrued converted.
Stock Issued During Period Shares Preferred Stock Net Of Issuance Costs 0001641172-25-017193 1 0 shares D Issuance of preferred stock net of issuance costs, shares Stock issued during period shares preferred stock net of issuance costs.
Cash Provided By Used In Operating Activities Discontinued Operations us-gaap/2024 0 0 monetary D D Cash Provided by (Used in) Operating Activities, Discontinued Operations Amount of cash inflow (outflow) of operating activities of discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
Cost Of Revenue us-gaap/2024 0 0 monetary D D Cost of Revenue The aggregate cost of goods produced and sold and services rendered during the reporting period.
Increase Decrease In Liability To Issue Common Stock 0001641172-25-004643 1 0 monetary D C IncreaseDecreaseInLiabilityToIssueCommonStock Liability to issue common stock.
Depreciation Depletion And Amortization us-gaap/2024 0 0 monetary D D Depreciation, Depletion and Amortization The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.
Discontinued Operation Income Loss From Discontinued Operation Before Income Tax us-gaap/2024 0 0 monetary D C Discontinued Operation, Income (Loss) from Discontinued Operation, before Income Tax Amount before tax of income (loss) from a discontinued operation. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.
Income Loss From Continuing Operations Per Diluted Share us-gaap/2024 0 0 perShare D Income (Loss) from Continuing Operations, Per Diluted Share The amount of net income (loss) derived from continuing operations during the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.
Income Loss From Discontinued Operations Net Of Tax us-gaap/2024 0 0 monetary D C Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest Amount after tax of income (loss) from a discontinued operation including the portion attributable to the noncontrolling interest. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.
Income Loss From Discontinued Operations Net Of Tax Per Diluted Share us-gaap/2024 0 0 perShare D Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Diluted Share Per diluted share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation and gain (loss) from the disposal of the discontinued operation.
Increase Decrease In Security Deposits us-gaap/2024 0 0 monetary D D Increase (Decrease) in Security Deposits The increase (decrease) during the reporting period in security deposits.
Interest Expense Nonoperating us-gaap/2024 0 0 monetary D D Interest Expense, Nonoperating Amount of interest expense classified as nonoperating.
Liabilities Current us-gaap/2024 0 0 monetary I C Liabilities, Current Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.
Preferred Stock Shares Issued us-gaap/2024 0 0 shares I Preferred Stock, Shares Issued Number of shares issued for nonredeemable preferred shares and preferred shares redeemable solely at option of issuer. Includes, but is not limited to, preferred shares issued, repurchased, and held as treasury shares. Excludes preferred shares classified as debt.
Share Based Compensation us-gaap/2024 0 0 monetary D D Share-Based Payment Arrangement, Noncash Expense Amount of noncash expense for share-based payment arrangement.
Proceeds From Sale Of Practices 0001641172-25-004643 1 0 monetary D D Proceeds from sale of practices Proceeds from sale of practices.
Settlement Of Notes Receivable In Connection With Asset Purchase Agreement 0001641172-25-004643 1 0 monetary D C Settlement of notes receivable in connection with asset purchase agreement Settlement of notes receivable in connection with asset purchase agreement.
Stock Issued During Period Value Reverse Stock Splits 0001641172-25-004643 1 0 monetary D C Issuance of fractional shares with reverse stock split Stock issued during period value reverse stock splits.
Adjustments To Additional Paid In Capital Dividend In Excess Of Retained Earnings 0001641172-25-017216 1 0 monetary D D AdjustmentsToAdditionalPaidInCapitalDividendInExcessOfRetainedEarnings Adjustments to additional paid in capital dividend in excess of retained earnings.
Preferred Stock Conversion 0001641172-25-017196 1 0 monetary D C Preferred stock conversion Preferred stock conversion.
Stock Issued During Period Value Conversion Of Series C1 Preferred Stock Into Common Shares 0001641172-25-017196 1 0 monetary D C Conversion of Series C-1 preferred stock into common shares Stock issued during period value conversion of series C1 preferred stock into common shares.
Increase Decrease In Patient Deposits 0001641172-25-017193 1 0 monetary D D Patient deposits Increase decrease in patient deposits.
Increase Decrease In Right Of Use Lease Liability 0001641172-25-017193 1 0 monetary D C IncreaseDecreaseInRightOfUseLeaseLiability Increase decrease in right of use lease liability.
Accounts And Other Receivables Net Current us-gaap/2024 0 0 monetary I D Accounts and Other Receivables, Net, Current Amount, after allowance, receivable from customers, clients, or other third-parties, and receivables classified as other due within one year or the normal operating cycle, if longer.
Adjustments To Additional Paid In Capital Dividends In Excess Of Retained Earnings us-gaap/2024 0 0 monetary D D Adjustments to Additional Paid in Capital, Dividends in Excess of Retained Earnings Amount of decrease in additional paid in capital (APIC) resulting from dividends legally declared (or paid) in excess of retained earnings balance.
Interest Expense Debt us-gaap/2024 0 0 monetary D D Interest Expense, Debt Amount of the cost of borrowed funds accounted for as interest expense for debt.
Cash And Cash Equivalents At Carrying Value us-gaap/2024 0 0 monetary I D Cash and Cash Equivalents, at Carrying Value Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.
Dividends Payable Current us-gaap/2024 0 0 monetary I C Dividends Payable, Current Carrying value as of the balance sheet date of dividends declared but unpaid on equity securities issued by the entity and outstanding. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
Dividends Sharebased Compensation Paid In Kind us-gaap/2024 0 0 monetary D D Dividend, Share-Based Payment Arrangement, Paid-in-Kind Amount of paid and unpaid paid-in-kind dividends declared for award under share-based payment arrangement.
Income Taxes Paid Net us-gaap/2024 0 0 monetary D C Income Taxes Paid, Net Amount, after refund, of cash paid to foreign, federal, state, and local jurisdictions as income tax.
Increase Decrease In Prepaid Deferred Expense And Other Assets us-gaap/2024 0 0 monetary D C Increase (Decrease) in Prepaid Expense and Other Assets Amount of increase (decrease) in prepaid expenses, and assets classified as other.
Nonoperating Income Expense us-gaap/2024 0 0 monetary D C Nonoperating Income (Expense) The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Preferred Stock Value us-gaap/2024 0 0 monetary I C Preferred Stock, Value, Issued Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.
Proceeds From Repayments Of Notes Payable us-gaap/2024 0 0 monetary D D Proceeds from (Repayments of) Notes Payable Amount of cash inflow (outflow) from long-term debt supported by a written promise to pay an obligation.
Proceeds From Sale Of Property Plant And Equipment us-gaap/2024 0 0 monetary D D Proceeds from Sale of Property, Plant, and Equipment The cash inflow from the sale of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale.
Stock Issued During Period Shares Share Based Compensation Gross us-gaap/2024 0 0 shares D Shares Issued, Shares, Share-Based Payment Arrangement, before Forfeiture Number, before forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).
Net Income Losses 0001641172-25-017216 1 0 monetary D C Net income losses Net income losses
Net Income Losses 0001641172-25-004643 1 0 monetary D C Net income losses Net income losses
Capitalized Dividends D E F 0001641172-25-017196 1 0 monetary D C CapitalizedDividendsDEF Capitalized dividends DEF.
Preferred Dividends Accrued C1 And C2 0001641172-25-017196 1 0 monetary D C Preferred dividends accrued C-1 & C-2 Preferred dividends accrued C-1 & C-2.
Stock Issued During Period Shares Conversion Of Series C1 Preferred Stock Into Common Shares 0001641172-25-017196 1 0 shares D Conversion of Series C-1 preferred stock into common shares, shares Stock issued during period shares conversion of series C1 preferred stock into common shares.
Accrued Dividends 0001641172-25-017193 1 0 monetary D D Preferred dividends accrued C-1 & C-2 Accrued dividends.
Preferred Dividends Accrued 0001641172-25-017193 1 0 monetary D D Preferred dividends accrued B-1 Preferred dividends accrued.
Assets Of Disposal Group Including Discontinued Operation Current us-gaap/2024 0 0 monetary I D Disposal Group, Including Discontinued Operation, Assets, Current Amount classified as assets attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.
Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition us-gaap/2024 0 0 monetary D C APIC, Share-Based Payment Arrangement, Option, Increase for Cost Recognition Amount of increase to additional paid-in capital (APIC) for recognition of cost for option under share-based payment arrangement.
Notes Payable Current us-gaap/2024 0 0 monetary I C Notes Payable, Current Sum of the carrying values as of the balance sheet date of the portions of long-term notes payable due within one year or the operating cycle if longer.
Net Cash Provided By Used In Operating Activities us-gaap/2024 0 0 monetary D Net Cash Provided by (Used in) Operating Activities Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
Operating Expenses us-gaap/2024 0 0 monetary D D Operating Expenses Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.
Operating Income Loss us-gaap/2024 0 0 monetary D C Operating Income (Loss) The net result for the period of deducting operating expenses from operating revenues.
Prepaid Expense And Other Assets Current us-gaap/2024 0 0 monetary I D Prepaid Expense and Other Assets, Current Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.
Repayments Of Notes Payable us-gaap/2024 0 0 monetary D C Repayments of Notes Payable The cash outflow for a borrowing supported by a written promise to pay an obligation.
Preferred Stock Converstion 0001641172-25-017216 1 0 monetary D D Preferred stock conversion Preferred stock converstion
Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interests 0001641172-25-004643 1 0 monetary D C IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterests Income loss from continuing operations including portion attributable to noncontrolling interests
Increase Decrease In Right Of Use Lease Liability 0001641172-25-017196 1 0 monetary D C IncreaseDecreaseInRightOfUseLeaseLiability Increase decrease in right of use lease liability.
Capitalized Dividends 0001641172-25-017193 1 0 monetary D D CapitalizedDividends Capitalized dividends.
Stock Issued During Period Shares Conversion Of Preferred Stock Into Common Shares 0001641172-25-017193 1 0 shares D Conversion of preferred stock into common shares, shares Stock issued during period shares conversion of preferred stock into common shares.
General And Administrative Expense us-gaap/2024 0 0 monetary D D General and Administrative Expense The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.
Common Stock Value us-gaap/2024 0 0 monetary I C Common Stock, Value, Issued Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.
Income Loss From Continuing Operations Per Basic Share us-gaap/2024 0 0 perShare D Income (Loss) from Continuing Operations, Per Basic Share The amount of net income (loss) from continuing operations per each share of common stock or unit outstanding during the reporting period.
Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interests 0001641172-25-017216 1 0 monetary D C IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterests Income loss from continuing operations including portion attributable to noncontrolling interests
Proceeds From Divestiture Of Businesses us-gaap/2024 0 0 monetary D D Proceeds from Divestiture of Businesses The cash inflow associated with the amount received from the sale of a portion of the company's business, for example a segment, division, branch or other business, during the period.
Stock Issued During Period Shares New Issues us-gaap/2024 0 0 shares D Stock Issued During Period, Shares, New Issues Number of new stock issued during the period.
Adjustments To Additional Paid In Capital Issuance Of Employee Stock Option 0001641172-25-004643 1 0 monetary D C Issuance of employee stock options Adjustments to additional paid in capital issuance of employee stock option.
Stock Issued During Period Preferred Stock Shares 0001641172-25-004643 1 0 shares D Issuance of preferred stock net of issuance costs, shares Stock issued during period preferred stock shares.
Adjustments To Additional Paid In Capital Capitalized Dividends 0001641172-25-017196 1 0 monetary D C Capitalized dividends D, E & F Adjustments to additional paid in capital capitalized dividends.
Stock Issued During Period Value Preferred Stock Net Of Issuance Costs 0001641172-25-017196 1 0 monetary D C Issuance of preferred stock net of issuance costs Stock issued during period value preferred stock net of issuance costs.
Increase Decrease In Patient Deposits 0001641172-25-017216 1 0 monetary D D Patient deposits Increase decrease in patient deposits.
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect us-gaap/2024 0 0 monetary D D Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.
Commitments And Contingencies us-gaap/2024 0 0 monetary I C Commitments and Contingencies Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.
Common Stock Shares Authorized us-gaap/2024 0 0 shares I Common Stock, Shares Authorized The maximum number of common shares permitted to be issued by an entity's charter and bylaws.
Gains Losses On Extinguishment Of Debt us-gaap/2024 0 0 monetary D C Gain (Loss) on Extinguishment of Debt Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.
Gain Loss On Disposition Of Assets us-gaap/2024 0 0 monetary D C Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property Amount of gain (loss) on sale or disposal of property, plant and equipment assets, excluding oil and gas property and timber property.
Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest us-gaap/2024 0 0 monetary D C Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest Amount after tax of income (loss) from continuing operations including portion attributable to the noncontrolling interest.
Income Loss From Discontinued Operations Net Of Tax Per Basic Share us-gaap/2024 0 0 perShare D Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share Per basic share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation and gain (loss) from the disposal of the discontinued operation.
Interest Paid Net us-gaap/2024 0 0 monetary D C Interest Paid, Excluding Capitalized Interest, Operating Activities Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.
Net Cash Provided By Used In Financing Activities us-gaap/2024 0 0 monetary D D Net Cash Provided by (Used in) Financing Activities Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Net Income Loss Available To Common Stockholders Basic us-gaap/2024 0 0 monetary D C Net Income (Loss) Available to Common Stockholders, Basic Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.
Payments To Acquire Notes Receivable us-gaap/2024 0 0 monetary D C Payments to Acquire Notes Receivable The cash outflow to acquire an agreement for an unconditional promise by the maker to pay the entity (holder) a definite sum of money at a future date. Such amount may include accrued interest receivable in accordance with the terms of the note. The note also may contain provisions including a discount or premium, payable on demand, secured, or unsecured, interest bearing or noninterest bearing, among myriad other features and characteristics.
Preferred Stock Par Or Stated Value Per Share us-gaap/2024 0 0 perShare I Preferred Stock, Par or Stated Value Per Share Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.
Shares Outstanding us-gaap/2024 0 0 shares I Shares, Outstanding Number of shares issued which are neither cancelled nor held in the treasury.
Preferred Dividends Accrued C1 And C2 0001641172-25-017216 1 0 monetary D C Preferred dividends accrued C-1 & C-2 Preferred dividends accrued C-1 & C-2.
Increase Decrease In Patient Deposits 0001641172-25-017196 1 0 monetary D D Patient deposits Increase decrease in patient deposits.
Preferred Dividends Accrued B1 0001641172-25-017196 1 0 monetary D C Preferred dividends accrued B-1 Preferred dividends accrued B-1.
Stock Issued During Period Value Conversion Of Preferred Stock Into Common Shares 0001641172-25-017193 1 0 monetary D C Conversion of preferred stock into common shares Stock issued during period value conversion of preferred stock into common shares.
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations us-gaap/2024 0 0 monetary I D Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.
Earnings Per Share Basic us-gaap/2024 0 0 perShare D Earnings Per Share, Basic The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
Increase Decrease In Accounts Payable And Accrued Liabilities us-gaap/2024 0 0 monetary D D Increase (Decrease) in Accounts Payable and Accrued Liabilities The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.
Investment Income Interest us-gaap/2024 0 0 monetary D C Investment Income, Interest Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.
Preferred Stock Dividends Income Statement Impact us-gaap/2024 0 0 monetary D D Preferred Stock Dividends, Income Statement Impact The amount of preferred stock dividends that is an adjustment to net income apportioned to common stockholders.
Net Cash Provided By Used In Investing Activities us-gaap/2024 0 0 monetary D D Net Cash Provided by (Used in) Investing Activities Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.
Other Nonoperating Income Expense us-gaap/2024 0 0 monetary D C Other Nonoperating Income (Expense) Amount of income (expense) related to nonoperating activities, classified as other.
Preferred Stock Shares Authorized us-gaap/2024 0 0 shares I Preferred Stock, Shares Authorized The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.
Preferred Stock Shares Outstanding us-gaap/2024 0 0 shares I Preferred Stock, Shares Outstanding Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.
Proceeds From Issuance Of Common Stock us-gaap/2024 0 0 monetary D D Proceeds from Issuance of Common Stock The cash inflow from the additional capital contribution to the entity.
Stock Issued During Period Value New Issues us-gaap/2024 0 0 monetary D C Stock Issued During Period, Value, New Issues Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.
Stock Issued During Period Preferred Stock Value 0001641172-25-004643 1 0 monetary D C Issuance of preferred stock net of issuance costs Stock issued during period preferred stock value.
Converted Accrued C1 Dividends 0001641172-25-017196 1 0 monetary D C Converted accrued C-1 dividends Converted accrued C1 dividends.
Preferred Dividends Accrued Converted Into C1 0001641172-25-017196 1 0 monetary D C Preferred dividends accrued converted into C-1 Preferred dividends accrued converted into C-1.
Stock Issued During Period Value Preferred Stock Net Of Issuance Costs 0001641172-25-017193 1 0 monetary D C Issuance of preferred stock net of issuance costs Stock issued during period value preferred stock net of issuance costs.
Property Plant And Equipment Net us-gaap/2024 0 0 monetary I D Property, Plant and Equipment, Net Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.
Provision For Doubtful Accounts us-gaap/2024 0 0 monetary D D Accounts Receivable, Credit Loss Expense (Reversal) Amount of expense (reversal of expense) for expected credit loss on accounts receivable.
Repayments Of Debt And Capital Lease Obligations us-gaap/2024 0 0 monetary D C Repayments of Debt and Lease Obligation Amount of cash outflow for short-term and long-term debt and lease obligation.
Weighted Average Number Of Shares Outstanding Basic us-gaap/2024 0 0 shares D Weighted Average Number of Shares Outstanding, Basic Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Accrued Dividends 0001641172-25-004643 1 0 monetary D D Accrued dividends Accrued dividends.
Increase Decrease In Right Of Use Lease Liability 0001641172-25-017216 1 0 monetary D C IncreaseDecreaseInRightOfUseLeaseLiability Increase decrease in right of use lease liability.
Proceeds From Sale Of Practices 0001641172-25-017216 1 0 monetary D D Proceeds from sale of practices Proceeds from sale of practices.
Settlement Of Notes Receivable In Connection With Asset Purchase Agreement 0001641172-25-017216 1 0 monetary D C Settlement of notes receivable in connection with asset purchase agreement Settlement of notes receivable in connection with asset purchase agreement.
Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interests 0001641172-25-017196 1 0 monetary D C IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterests Income loss from continuing operations including portion attributable to noncontrolling interests.

Description
Field Name Field Description
tag The unique identifier (name) for a tag in a specific taxonomy release.
version For a standard tag, an identifier for the taxonomy; otherwise the accession number where the tag was defined.
custom 1 if tag is custom (version=adsh), 0 if it is standard. Note: This flag is technically redundant with the version and adsh columns.
abstract 1 if the tag is not used to represent a numeric fact.
datatype If abstract=1, then NULL, otherwise the data type (e.g., monetary) for the tag.
iord If abstract=1, then NULL; otherwise, “I” if the value is a point-in time, or “D” if the value is a duration.
crdr If datatype = monetary, then the tag’s natural accounting balance (debit or credit); if not defined, then NULL.
tlabel If a standard tag, then the label text provided by the taxonomy, otherwise the text provided by the filer. A tag which had neither would have a NULL value here.
doc The detailed definition for the tag. If a standard tag, then the text provided by the taxonomy, otherwise the text assigned by the filer. Some tags have neither, and this field is NULL.

Presentation of Statements

adsh report line stmt inpth rfile tag version plabel negating
0001641172-25-017193 6 27 CF 0 H Proceeds From Issuance Of Common Stock us-gaap/2024 Proceeds from issuance of common stock 0
0001641172-25-017193 2 3 BS 0 H Cash And Cash Equivalents At Carrying Value us-gaap/2024 Cash 0
0001641172-25-017193 2 4 BS 0 H Accounts Receivable Net Current us-gaap/2024 Accounts receivable, net 0
0001641172-25-017193 2 5 BS 0 H Prepaid Expense And Other Assets Current us-gaap/2024 Prepaid expenses and other current assets 0
0001641172-25-017193 2 6 BS 0 H Accounts And Other Receivables Net Current us-gaap/2024 Note receivable, net 0
0001641172-25-017193 2 7 BS 0 H Assets Of Disposal Group Including Discontinued Operation Current us-gaap/2024 Assets of discontinued operations 0
0001641172-25-017193 2 8 BS 0 H Assets Current us-gaap/2024 Total current assets 0
0001641172-25-017193 2 9 BS 0 H Property Plant And Equipment Net us-gaap/2024 Property and equipment, net 0
0001641172-25-017193 2 10 BS 0 H Assets us-gaap/2024 Total assets 0
0001641172-25-017193 2 13 BS 0 H Accounts Payable And Accrued Liabilities Current us-gaap/2024 Accounts payable and accrued expenses 0
0001641172-25-017193 2 14 BS 0 H Dividends Payable Current us-gaap/2024 Dividends payable C-1 & C-2 0
0001641172-25-017193 2 15 BS 0 H Notes Payable Current us-gaap/2024 Note payable, net 0
0001641172-25-017193 2 16 BS 0 H Liabilities Of Disposal Group Including Discontinued Operation Current us-gaap/2024 Liabilities of discontinued operations 0
0001641172-25-017193 2 17 BS 0 H Liabilities Current us-gaap/2024 Total current liabilities 0
0001641172-25-017193 2 18 BS 0 H Commitments And Contingencies us-gaap/2024 Commitment and Contingencies Note 12 0
0001641172-25-017193 2 20 BS 0 H Preferred Stock Value us-gaap/2024 Preferred stock - $0.001 par value, 5,000,000 authorized, 3,864 Series C-1, 1,276 Series C-2, 17,364 Series D, 24,172 Series E and 450 Series F issued and outstanding at June 30, 2024 and 5,000,000 authorized, 2,645 Series B-1 and 1,905 Series B-2 issued and outstanding at December 31, 2023. 0
0001641172-25-017193 2 21 BS 0 H Common Stock Value us-gaap/2024 Common stock - $0.001 par value, 60,000,000 authorized; 1,494,272 issued and outstanding at June 30, 2024 and 1,148,321 issued and outstanding at December 31, 2023. 0
0001641172-25-017193 2 22 BS 0 H Additional Paid In Capital us-gaap/2024 Additional paid-in capital 0
0001641172-25-017193 2 23 BS 0 H Retained Earnings Accumulated Deficit us-gaap/2024 Accumulated deficit 0
0001641172-25-017193 2 24 BS 0 H Stockholders Equity us-gaap/2024 Total stockholders deficit 0
0001641172-25-017193 2 25 BS 0 H Liabilities And Stockholders Equity us-gaap/2024 Total liabilities and stockholders deficit 0
0001641172-25-017193 3 12 BS 1 H Preferred Stock Par Or Stated Value Per Share us-gaap/2024 Preferred stock, par value 0
0001641172-25-017193 3 13 BS 1 H Preferred Stock Shares Authorized us-gaap/2024 Preferred stock, shares authorized 0
0001641172-25-017193 3 14 BS 1 H Preferred Stock Shares Issued us-gaap/2024 Preferred stock, shares issued 0
0001641172-25-017193 3 15 BS 1 H Preferred Stock Shares Outstanding us-gaap/2024 Preferred stock, shares outstanding 0
0001641172-25-017193 3 16 BS 1 H Common Stock Par Or Stated Value Per Share us-gaap/2024 Common stock, par value 0
0001641172-25-017193 3 17 BS 1 H Common Stock Shares Authorized us-gaap/2024 Common stock, shares authorized 0
0001641172-25-017193 3 18 BS 1 H Common Stock Shares Issued us-gaap/2024 Common stock, shares issued 0
0001641172-25-017193 3 19 BS 1 H Common Stock Shares Outstanding us-gaap/2024 Common stock, shares outstanding 0
0001641172-25-017193 4 1 IS 0 H Revenue From Contract With Customer Excluding Assessed Tax us-gaap/2024 Revenues, net 0
0001641172-25-017193 4 2 IS 0 H Cost Of Revenue us-gaap/2024 Cost of revenues 0
0001641172-25-017193 4 3 IS 0 H Gross Profit us-gaap/2024 Gross profit 0
0001641172-25-017193 4 5 IS 0 H General And Administrative Expense us-gaap/2024 General and administrative 0
0001641172-25-017193 4 6 IS 0 H Gain Loss On Disposition Of Assets us-gaap/2024 Loss on disposal or impairment of assets 1
0001641172-25-017193 4 7 IS 0 H Operating Expenses us-gaap/2024 Total operating expenses 0
0001641172-25-017193 4 8 IS 0 H Operating Income Loss us-gaap/2024 Operating loss 0
0001641172-25-017193 4 10 IS 0 H Investment Income Interest us-gaap/2024 Interest income 0
0001641172-25-017193 4 11 IS 0 H Interest Expense Nonoperating us-gaap/2024 Interest expense 1
0001641172-25-017193 4 12 IS 0 H Nonoperating Income Expense us-gaap/2024 Total other income (expenses) 0
0001641172-25-017193 4 13 IS 0 H Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest us-gaap/2024 Net loss before income taxes 0
0001641172-25-017193 4 14 IS 0 H Income Tax Expense Benefit us-gaap/2024 Income taxes 0
0001641172-25-017193 4 15 IS 0 H Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest us-gaap/2024 Net loss from continuing operations 0
0001641172-25-017193 4 16 IS 0 H Income Loss From Discontinued Operations Net Of Tax us-gaap/2024 Net income (loss) from discontinued operations 0
0001641172-25-017193 4 17 IS 0 H Net Income Loss us-gaap/2024 Net loss 0
0001641172-25-017193 4 18 IS 0 H Preferred Stock Dividends Income Statement Impact us-gaap/2024 Preferred dividends 1
0001641172-25-017193 4 19 IS 0 H Net Income Loss Available To Common Stockholders Basic us-gaap/2024 Net loss available to common stockholders 0
0001641172-25-017193 4 20 IS 0 H Income Loss From Continuing Operations Per Basic Share us-gaap/2024 Net loss per share from continuing operations basic 0
0001641172-25-017193 4 21 IS 0 H Income Loss From Continuing Operations Per Diluted Share us-gaap/2024 Net loss per share from continuing operations diluted 0
0001641172-25-017193 4 22 IS 0 H Income Loss From Discontinued Operations Net Of Tax Per Basic Share us-gaap/2024 Income (Loss) per share from discontinued operations basic 0
0001641172-25-017193 4 23 IS 0 H Income Loss From Discontinued Operations Net Of Tax Per Diluted Share us-gaap/2024 Income (Loss) per share from discontinued operations diluted 0
0001641172-25-017193 4 24 IS 0 H Earnings Per Share Basic us-gaap/2024 Net loss per share basic 0
0001641172-25-017193 4 25 IS 0 H Earnings Per Share Diluted us-gaap/2024 Net loss per share diluted 0
0001641172-25-017193 4 26 IS 0 H Weighted Average Number Of Shares Outstanding Basic us-gaap/2024 Weighted average common shares outstanding, basic 0
0001641172-25-017193 4 27 IS 0 H Weighted Average Number Of Diluted Shares Outstanding us-gaap/2024 Weighted average common shares outstanding, diluted 0
0001641172-25-017193 5 9 EQ 0 H Stockholders Equity us-gaap/2024 Balance 0
0001641172-25-017193 5 10 EQ 0 H Shares Outstanding us-gaap/2024 Balance, shares 0
0001641172-25-017193 5 11 EQ 0 H Stock Issued During Period Value Preferred Stock Net Of Issuance Costs 0001641172-25-017193 Issuance of preferred stock net of issuance costs 0
0001641172-25-017193 5 12 EQ 0 H Stock Issued During Period Shares Preferred Stock Net Of Issuance Costs 0001641172-25-017193 Issuance of preferred stock net of issuance costs, shares 0
0001641172-25-017193 5 13 EQ 0 H Adjustments To Additional Paid In Capital Dividends In Excess Of Retained Earnings us-gaap/2024 Dividends declared 1
0001641172-25-017193 5 14 EQ 0 H Adjustments To Additional Paid In Capital Other us-gaap/2024 Capitalized dividends D, E & F 0
0001641172-25-017193 5 15 EQ 0 H Stock Issued During Period Value Conversion Of Preferred Stock Into Common Shares 0001641172-25-017193 Conversion of preferred stock into common shares 0
0001641172-25-017193 5 16 EQ 0 H Stock Issued During Period Shares Conversion Of Preferred Stock Into Common Shares 0001641172-25-017193 Conversion of preferred stock into common shares, shares 0
0001641172-25-017193 5 17 EQ 0 H Net Income Loss us-gaap/2024 Net loss 0
0001641172-25-017193 5 18 EQ 0 H Stock Issued During Period Value New Issues us-gaap/2024 Issuance of common stock 0
0001641172-25-017193 5 19 EQ 0 H Stock Issued During Period Shares New Issues us-gaap/2024 Issuance of common stock, shares 0
0001641172-25-017193 5 20 EQ 0 H Stock Issued During Period Value New Issues One 0001641172-25-017193 Issuance of common stock from ATM 0
0001641172-25-017193 5 21 EQ 0 H Stock Issued During Period Shares New Issues One 0001641172-25-017193 Issuance of common stock from ATM, shares 0
0001641172-25-017193 5 22 EQ 0 H Stock Issued During Period Value Share Based Compensation us-gaap/2024 Issuance of common stock - compensation 0
0001641172-25-017193 5 23 EQ 0 H Stock Issued During Period Shares Share Based Compensation us-gaap/2024 Issuance of common stock - compensation, shares 0
0001641172-25-017193 5 24 EQ 0 H Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition us-gaap/2024 Share based compensation, net 0
0001641172-25-017193 5 25 EQ 0 H Stockholders Equity us-gaap/2024 Balance 0
0001641172-25-017193 5 26 EQ 0 H Shares Outstanding us-gaap/2024 Balance, shares 0
0001641172-25-017193 6 2 CF 0 H Net Income Loss us-gaap/2024 Net loss 0
0001641172-25-017193 6 3 CF 0 H Income Loss From Discontinued Operations Net Of Tax us-gaap/2024 Net income (loss) from discontinued operations 0
0001641172-25-017193 6 4 CF 0 H Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest us-gaap/2024 Net loss from continuing operations 0
0001641172-25-017193 6 6 CF 0 H Depreciation Depletion And Amortization us-gaap/2024 Depreciation and amortization 0
0001641172-25-017193 6 7 CF 0 H Interest Expense Debt us-gaap/2024 Interest expense - OID 0
0001641172-25-017193 6 8 CF 0 H Share Based Compensation us-gaap/2024 Share based compensation, net 0
0001641172-25-017193 6 9 CF 0 H Gain Loss On Disposition Of Assets1 us-gaap/2024 Loss on disposition or impairment of assets 1
0001641172-25-017193 6 10 CF 0 H Provision For Doubtful Accounts us-gaap/2024 Bad debt expense (recovery) 0
0001641172-25-017193 6 12 CF 0 H Increase Decrease In Accounts Receivable us-gaap/2024 Accounts receivable 1
0001641172-25-017193 6 13 CF 0 H Increase Decrease In Prepaid Deferred Expense And Other Assets us-gaap/2024 Prepaid expenses and other current assets 1
0001641172-25-017193 6 14 CF 0 H Increase Decrease In Security Deposits us-gaap/2024 Security deposits 0
0001641172-25-017193 6 15 CF 0 H Increase Decrease In Right Of Use Lease Liability 0001641172-25-017193 Right of use lease liability 1
0001641172-25-017193 6 16 CF 0 H Increase Decrease In Accounts Payable And Accrued Liabilities us-gaap/2024 Accounts payable and accrued expenses 0
0001641172-25-017193 6 17 CF 0 H Increase Decrease In Patient Deposits 0001641172-25-017193 Patient deposits 0
0001641172-25-017193 6 18 CF 0 H Net Cash Provided By Used In Operating Activities Continuing Operations us-gaap/2024 Net cash provided (used) in operating activities from continuing operations 0
0001641172-25-017193 6 19 CF 0 H Cash Provided By Used In Operating Activities Discontinued Operations us-gaap/2024 Net cash provided (used) in operating activities from discontinued operations 0
0001641172-25-017193 6 20 CF 0 H Net Cash Provided By Used In Operating Activities us-gaap/2024 Net cash used in operating activities 0
0001641172-25-017193 6 22 CF 0 H Proceeds From Divestiture Of Businesses us-gaap/2024 Proceeds from sale of Chicago 0
0001641172-25-017193 6 23 CF 0 H Proceeds From Sale Of Property Plant And Equipment us-gaap/2024 Proceeds from sale of fixed assets 0
0001641172-25-017193 6 24 CF 0 H Payments To Acquire Notes Receivable us-gaap/2024 Note receivable 1
0001641172-25-017193 6 25 CF 0 H Net Cash Provided By Used In Investing Activities us-gaap/2024 Net cash used in investing activities 0
0001641172-25-017193 6 28 CF 0 H Proceeds From Issuance Of Preferred Stock And Preference Stock us-gaap/2024 Proceeds from issuance of preferred stock, net of offering costs 0
0001641172-25-017193 6 29 CF 0 H Repayments Of Notes Payable us-gaap/2024 Payments on notes payable 1
0001641172-25-017193 6 30 CF 0 H Proceeds From Notes Payable us-gaap/2024 Proceeds from notes payable 0
0001641172-25-017193 6 31 CF 0 H Repayments Of Debt And Capital Lease Obligations us-gaap/2024 Payments on finance lease obligation 1
0001641172-25-017193 6 32 CF 0 H Net Cash Provided By Used In Financing Activities us-gaap/2024 Net cash provided in financing activities 0
0001641172-25-017193 6 33 CF 0 H Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect us-gaap/2024 Net increase (decrease) in cash 0
0001641172-25-017193 6 34 CF 0 H Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations us-gaap/2024 Cash, beginning of period 0
0001641172-25-017193 6 35 CF 0 H Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations us-gaap/2024 Cash, end of period 0
0001641172-25-017193 6 37 CF 0 H Interest Paid Net us-gaap/2024 Interest paid 0
0001641172-25-017193 6 38 CF 0 H Income Taxes Paid Net us-gaap/2024 Income tax 0
0001641172-25-017193 6 39 CF 0 H Accrued Dividends 0001641172-25-017193 Preferred dividends accrued C-1 & C-2 0
0001641172-25-017193 6 40 CF 0 H Preferred Dividends Accrued 0001641172-25-017193 Preferred dividends accrued B-1 0
0001641172-25-017193 6 41 CF 0 H Preferred Dividends Accrued Converted 0001641172-25-017193 Preferred dividends accrued converted into C-1 0
0001641172-25-017193 6 42 CF 0 H Capitalized Dividends 0001641172-25-017193 Capitalized dividends D, E & F 0
0001641172-25-017193 6 43 CF 0 H Settlement Of Notes Receivable In Connection With Asset Purchase Agreement 0001641172-25-017193 Settlement of notes receivable in connection with asset purchase agreement 0
0001641172-25-017196 2 3 BS 0 H Cash us-gaap/2024 Cash 0
0001641172-25-017196 2 4 BS 0 H Accounts Receivable Net Current us-gaap/2024 Accounts receivable, net 0
0001641172-25-017196 2 5 BS 0 H Prepaid Expense And Other Assets Current us-gaap/2024 Prepaid expenses and other current assets 0
0001641172-25-017196 2 6 BS 0 H Accounts And Other Receivables Net Current us-gaap/2024 Note receivable, net 0
0001641172-25-017196 2 7 BS 0 H Assets Of Disposal Group Including Discontinued Operation Current us-gaap/2024 Assets of discontinued operations 0
0001641172-25-017196 2 8 BS 0 H Assets Current us-gaap/2024 Total current assets 0
0001641172-25-017196 2 9 BS 0 H Property Plant And Equipment Net us-gaap/2024 Property and equipment, net 0
0001641172-25-017196 2 10 BS 0 H Assets us-gaap/2024 Total assets 0
0001641172-25-017196 2 13 BS 0 H Accounts Payable And Accrued Liabilities Current us-gaap/2024 Accounts payable and accrued expenses 0
0001641172-25-017196 2 14 BS 0 H Dividends Payable Current us-gaap/2024 Dividends payable C-1 & C-2 0
0001641172-25-017196 2 15 BS 0 H Notes Payable Current us-gaap/2024 Note payable, net 0
0001641172-25-017196 2 16 BS 0 H Liabilities Of Disposal Group Including Discontinued Operation Current us-gaap/2024 Liabilities of discontinued operations 0
0001641172-25-017196 2 17 BS 0 H Liabilities Current us-gaap/2024 Total current liabilities 0
0001641172-25-017196 2 18 BS 0 H Commitments And Contingencies us-gaap/2024 Commitments and Contingencies Note 12 0
0001641172-25-017196 2 20 BS 0 H Preferred Stock Value us-gaap/2024 Preferred stock - $0.001 par value, 5,000,000 authorized,45,826 Preferred stock at September 30, 2024 and 4,550 at December 31, 2023 issued and outstanding 0
0001641172-25-017196 2 21 BS 0 H Common Stock Value us-gaap/2024 Common stock - $0.001 par value, 60,000,000 authorized; 2,013,199 at September 30, 2024 and 1,148,321 at December 31, 2023 issued and outstanding 0
0001641172-25-017196 2 22 BS 0 H Additional Paid In Capital us-gaap/2024 Additional paid-in capital 0
0001641172-25-017196 2 23 BS 0 H Retained Earnings Accumulated Deficit us-gaap/2024 Accumulated deficit 0
0001641172-25-017196 2 24 BS 0 H Stockholders Equity us-gaap/2024 Total stockholders deficit 0
0001641172-25-017196 2 25 BS 0 H Liabilities And Stockholders Equity us-gaap/2024 Total liabilities and stockholders deficit 0
0001641172-25-017196 3 1 BS 1 H Preferred Stock Par Or Stated Value Per Share us-gaap/2024 Preferred Stock, Par or Stated Value Per Share 0
0001641172-25-017196 3 2 BS 1 H Preferred Stock Shares Authorized us-gaap/2024 Preferred stock, shares authorized 0
0001641172-25-017196 3 3 BS 1 H Preferred Stock Shares Issued us-gaap/2024 Preferred stock, shares issued 0
0001641172-25-017196 3 4 BS 1 H Preferred Stock Shares Outstanding us-gaap/2024 Preferred stock, shares outstanding 0
0001641172-25-017196 3 5 BS 1 H Common Stock Par Or Stated Value Per Share us-gaap/2024 Common stock, par value 0
0001641172-25-017196 3 6 BS 1 H Common Stock Shares Authorized us-gaap/2024 Common stock, shares authorized 0
0001641172-25-017196 3 7 BS 1 H Common Stock Shares Issued us-gaap/2024 Common stock, shares issued 0
0001641172-25-017196 3 8 BS 1 H Common Stock Shares Outstanding us-gaap/2024 Common stock, shares outstanding 0
0001641172-25-017196 4 6 IS 0 H Revenue From Contract With Customer Excluding Assessed Tax us-gaap/2024 Revenues, net 0
0001641172-25-017196 4 7 IS 0 H Cost Of Revenue us-gaap/2024 Cost of revenues 0
0001641172-25-017196 4 8 IS 0 H Gross Profit us-gaap/2024 Gross profit 0
0001641172-25-017196 4 10 IS 0 H General And Administrative Expense us-gaap/2024 General and administrative 0
0001641172-25-017196 4 11 IS 0 H Gain Loss On Disposition Of Assets us-gaap/2024 Loss on disposal or impairment of assets 1
0001641172-25-017196 4 12 IS 0 H Operating Expenses us-gaap/2024 Total operating expenses 0
0001641172-25-017196 4 13 IS 0 H Operating Income Loss us-gaap/2024 Operating loss 0
0001641172-25-017196 4 15 IS 0 H Investment Income Interest us-gaap/2024 Interest income 0
0001641172-25-017196 4 16 IS 0 H Interest Expense Nonoperating us-gaap/2024 Interest expense 1
0001641172-25-017196 4 17 IS 0 H Nonoperating Income Expense us-gaap/2024 Total other income (expenses) 0
0001641172-25-017196 4 18 IS 0 H Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest us-gaap/2024 Net loss before income taxes 0
0001641172-25-017196 4 19 IS 0 H Income Tax Expense Benefit us-gaap/2024 Income taxes 0
0001641172-25-017196 4 20 IS 0 H Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interests 0001641172-25-017196 Net loss from continuing operations 0
0001641172-25-017196 4 21 IS 0 H Income Loss From Discontinued Operations Net Of Tax us-gaap/2024 Net income (loss) from discontinued operations 0
0001641172-25-017196 4 22 IS 0 H Net Income Loss us-gaap/2024 Net loss 0
0001641172-25-017196 4 23 IS 0 H Preferred Stock Dividends Income Statement Impact us-gaap/2024 Preferred dividends 1
0001641172-25-017196 4 24 IS 0 H Net Income Loss Available To Common Stockholders Basic us-gaap/2024 Net loss available to common stockholders 0
0001641172-25-017196 4 25 IS 0 H Income Loss From Continuing Operations Per Basic Share us-gaap/2024 Net loss per share from continuing operations - Basic 0
0001641172-25-017196 4 26 IS 0 H Income Loss From Continuing Operations Per Diluted Share us-gaap/2024 Net loss per share from continuing operations - Diluted 0
0001641172-25-017196 4 27 IS 0 H Income Loss From Discontinued Operations Net Of Tax Per Basic Share us-gaap/2024 Income (Loss) per share from discontinued operations basic 0
0001641172-25-017196 4 28 IS 0 H Income Loss From Discontinued Operations Net Of Tax Per Diluted Share us-gaap/2024 Income (Loss) per share from discontinued operations diluted 0
0001641172-25-017196 4 29 IS 0 H Earnings Per Share Basic us-gaap/2024 Net loss per share - Basic 0
0001641172-25-017196 4 30 IS 0 H Earnings Per Share Diluted us-gaap/2024 Net loss per share - Diluted 0
0001641172-25-017196 4 31 IS 0 H Weighted Average Number Of Shares Outstanding Basic us-gaap/2024 Basic 0
0001641172-25-017196 4 32 IS 0 H Weighted Average Number Of Diluted Shares Outstanding us-gaap/2024 Diluted 0
0001641172-25-017196 5 9 EQ 0 H Stockholders Equity us-gaap/2024 Balance 0
0001641172-25-017196 5 10 EQ 0 H Shares Outstanding us-gaap/2024 Balance, shares 0
0001641172-25-017196 5 11 EQ 0 H Adjustments To Additional Paid In Capital Dividends In Excess Of Retained Earnings us-gaap/2024 Dividends declared 1
0001641172-25-017196 5 12 EQ 0 H Adjustments To Additional Paid In Capital Capitalized Dividends 0001641172-25-017196 Capitalized dividends D, E & F 0
0001641172-25-017196 5 13 EQ 0 H Stock Issued During Period Value Conversion Of Series C1 Preferred Stock Into Common Shares 0001641172-25-017196 Conversion of Series C-1 preferred stock into common shares 0
0001641172-25-017196 5 14 EQ 0 H Stock Issued During Period Shares Conversion Of Series C1 Preferred Stock Into Common Shares 0001641172-25-017196 Conversion of Series C-1 preferred stock into common shares, shares 0
0001641172-25-017196 5 15 EQ 0 H Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition us-gaap/2024 Share based compensation expense 0
0001641172-25-017196 5 16 EQ 0 H Net Income Loss us-gaap/2024 Net loss 0
0001641172-25-017196 5 17 EQ 0 H Stock Issued During Period Value Preferred Stock Net Of Issuance Costs 0001641172-25-017196 Issuance of preferred stock net of issuance costs 0
0001641172-25-017196 5 18 EQ 0 H Stock Issued During Period Shares Preferred Stock Net Of Issuance Costs 0001641172-25-017196 Issuance of preferred stock net of issuance costs, shares 0
0001641172-25-017196 5 19 EQ 0 H Stock Issued During Period Value New Issues us-gaap/2024 Issuance of common stock 0
0001641172-25-017196 5 20 EQ 0 H Stock Issued During Period Shares New Issues us-gaap/2024 Issuance of common stock, shares 0
0001641172-25-017196 5 21 EQ 0 H Stockholders Equity us-gaap/2024 Balance 0
0001641172-25-017196 5 22 EQ 0 H Shares Outstanding us-gaap/2024 Balance, shares 0
0001641172-25-017196 6 2 CF 0 H Net Income Losses 0001641172-25-017196 Net loss 0
0001641172-25-017196 6 3 CF 0 H Income Loss From Discontinued Operations Net Of Tax us-gaap/2024 Net income (loss) from discontinued operations 0
0001641172-25-017196 6 4 CF 0 H Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest us-gaap/2024 Net loss from continuing operations 0
0001641172-25-017196 6 6 CF 0 H Depreciation Depletion And Amortization us-gaap/2024 Depreciation and amortization 0
0001641172-25-017196 6 7 CF 0 H Interest Expense Debt us-gaap/2024 Interest expense - OID 0
0001641172-25-017196 6 8 CF 0 H Share Based Compensation us-gaap/2024 Share based compensation, net 0
0001641172-25-017196 6 9 CF 0 H Gain Loss On Disposition Of Assets1 us-gaap/2024 Loss on disposition or impairment of assets 1
0001641172-25-017196 6 10 CF 0 H Provision For Doubtful Accounts us-gaap/2024 Bad debt expense (recovery) 0
0001641172-25-017196 6 12 CF 0 H Increase Decrease In Accounts Receivable us-gaap/2024 Accounts receivable 1
0001641172-25-017196 6 13 CF 0 H Increase Decrease In Prepaid Deferred Expense And Other Assets us-gaap/2024 Prepaid expenses and other current assets 1
0001641172-25-017196 6 14 CF 0 H Increase Decrease In Security Deposits us-gaap/2024 Security deposits 0
0001641172-25-017196 6 15 CF 0 H Increase Decrease In Right Of Use Lease Liability 0001641172-25-017196 Right of use lease liability 1
0001641172-25-017196 6 16 CF 0 H Increase Decrease In Accounts Payable And Accrued Liabilities us-gaap/2024 Accounts payable and accrued expenses 0
0001641172-25-017196 6 17 CF 0 H Increase Decrease In Patient Deposits 0001641172-25-017196 Patient deposits 0
0001641172-25-017196 6 18 CF 0 H Net Cash Provided By Used In Operating Activities Continuing Operations us-gaap/2024 Net cash provided (used) in operating activities from continuing operations 0
0001641172-25-017196 6 19 CF 0 H Cash Provided By Used In Operating Activities Discontinued Operations us-gaap/2024 Net cash provided (used) in operating activities from discontinued operations 0
0001641172-25-017196 6 20 CF 0 H Net Cash Provided By Used In Operating Activities us-gaap/2024 Net cash used in operating activities 0
0001641172-25-017196 6 22 CF 0 H Proceeds From Divestiture Of Businesses us-gaap/2024 Proceeds from sale of Chicago 0
0001641172-25-017196 6 23 CF 0 H Proceeds From Sale Of Property Plant And Equipment us-gaap/2024 Proceeds from sale of fixed assets 0
0001641172-25-017196 6 24 CF 0 H Payments To Acquire Notes Receivable us-gaap/2024 Note receivable 1
0001641172-25-017196 6 25 CF 0 H Net Cash Provided By Used In Investing Activities us-gaap/2024 Net cash used in investing activities 0
0001641172-25-017196 6 27 CF 0 H Proceeds From Issuance Of Common Stock us-gaap/2024 Proceeds from issuance of common stock 0
0001641172-25-017196 6 28 CF 0 H Proceeds From Issuance Of Preferred Stock And Preference Stock us-gaap/2024 Proceeds from issuance of preferred stock, net of offering costs 0
0001641172-25-017196 6 29 CF 0 H Repayments Of Notes Payable us-gaap/2024 Payments on notes payable 1
0001641172-25-017196 6 30 CF 0 H Proceeds From Notes Payable us-gaap/2024 Proceeds from notes payable 0
0001641172-25-017196 6 31 CF 0 H Repayments Of Debt And Capital Lease Obligations us-gaap/2024 Payments on finance lease obligation 1
0001641172-25-017196 6 32 CF 0 H Net Cash Provided By Used In Financing Activities us-gaap/2024 Net cash provided in financing activities 0
0001641172-25-017196 6 33 CF 0 H Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect us-gaap/2024 Net increase (decrease) in cash 0
0001641172-25-017196 6 34 CF 0 H Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations us-gaap/2024 Cash, beginning of period 0
0001641172-25-017216 2 3 BS 0 H Cash us-gaap/2024 Cash 0
0001641172-25-017216 2 4 BS 0 H Accounts Receivable Net Current us-gaap/2024 Accounts receivable, net 0
0001641172-25-017216 2 5 BS 0 H Prepaid Expense And Other Assets Current us-gaap/2024 Prepaid expenses and other current assets 0
0001641172-25-017216 2 6 BS 0 H Accounts And Other Receivables Net Current us-gaap/2024 Note receivable, net 0
0001641172-25-017216 2 7 BS 0 H Assets Of Disposal Group Including Discontinued Operation Current us-gaap/2024 Assets of discontinued operations 0
0001641172-25-017216 2 8 BS 0 H Assets Current us-gaap/2024 Total current assets 0
0001641172-25-017216 2 9 BS 0 H Property Plant And Equipment Net us-gaap/2024 Property and equipment, net 0
0001641172-25-017216 2 10 BS 0 H Assets us-gaap/2024 Total assets 0
0001641172-25-017216 2 13 BS 0 H Accounts Payable And Accrued Liabilities Current us-gaap/2024 Accounts payable and accrued expenses 0
0001641172-25-017216 2 14 BS 0 H Dividends Payable Current us-gaap/2024 Dividends payable 0
0001641172-25-017216 2 15 BS 0 H Liabilities Of Disposal Group Including Discontinued Operation Current us-gaap/2024 Liabilities of discontinued operations 0
0001641172-25-017216 2 16 BS 0 H Liabilities Current us-gaap/2024 Total current liabilities 0
0001641172-25-017216 2 17 BS 0 H Liabilities us-gaap/2024 Total liabilities 0
0001641172-25-017216 2 18 BS 0 H Commitments And Contingencies us-gaap/2024 Commitment and Contingencies Note 14 0
0001641172-25-017216 2 20 BS 0 H Preferred Stock Value us-gaap/2024 Preferred stock - $0.001 par value, 5,000,000 authorized, 50,502 issued and outstanding at December 31, 2024 and 2,645 Series B-1 and 1,905 Series B-2 issued and outstanding at December 31, 2023 0
0001641172-25-017216 2 21 BS 0 H Common Stock Value us-gaap/2024 Common stock; $0.001 par value, 120,000,000 authorized; 2,029,864 and 1,148,321 shares issued and outstanding at December 31, 2024 and 2023, respectively. 0
0001641172-25-017216 2 22 BS 0 H Additional Paid In Capital us-gaap/2024 Additional paid-in capital 0
0001641172-25-017216 2 23 BS 0 H Retained Earnings Accumulated Deficit us-gaap/2024 Accumulated deficit 0
0001641172-25-017216 2 24 BS 0 H Stockholders Equity us-gaap/2024 Total stockholders equity (deficit) 0
0001641172-25-017216 2 25 BS 0 H Liabilities And Stockholders Equity us-gaap/2024 Total liabilities and stockholders equity (deficit) 0
0001641172-25-017216 3 7 BS 1 H Preferred Stock Par Or Stated Value Per Share us-gaap/2024 Preferred stock par value 0
0001641172-25-017216 3 8 BS 1 H Preferred Stock Shares Authorized us-gaap/2024 Preferred stock shares authorized 0
0001641172-25-017216 3 9 BS 1 H Preferred Stock Shares Issued us-gaap/2024 Preferred stock, shares issued 0
0001641172-25-017216 3 10 BS 1 H Preferred Stock Shares Outstanding us-gaap/2024 Preferred stock, shares outstanding 0
0001641172-25-017216 3 11 BS 1 H Common Stock Par Or Stated Value Per Share us-gaap/2024 Common Stock, Par or Stated Value Per Share 0
0001641172-25-017216 3 12 BS 1 H Common Stock Shares Authorized us-gaap/2024 Common Stock, Shares Authorized 0
0001641172-25-017216 3 13 BS 1 H Common Stock Shares Issued us-gaap/2024 Common stock, shares issued 0
0001641172-25-017216 3 14 BS 1 H Common Stock Shares Outstanding us-gaap/2024 Common stock, shares outstanding 0
0001641172-25-017216 4 1 IS 0 H Revenue From Contract With Customer Excluding Assessed Tax us-gaap/2024 Patient revenue, net 0
0001641172-25-017216 4 2 IS 0 H Cost Of Revenue us-gaap/2024 Cost of revenues 0
0001641172-25-017216 4 3 IS 0 H Gross Profit us-gaap/2024 Gross profit (loss) 0
0001641172-25-017216 4 5 IS 0 H General And Administrative Expense us-gaap/2024 General and administrative 0
0001641172-25-017216 4 6 IS 0 H Gain Loss On Disposition Of Assets us-gaap/2024 Loss on disposition or impairment 1
0001641172-25-017216 4 7 IS 0 H Operating Expenses us-gaap/2024 Total operating expenses 0
0001641172-25-017216 4 8 IS 0 H Operating Income Loss us-gaap/2024 Operating loss 0
0001641172-25-017216 4 10 IS 0 H Investment Income Interest us-gaap/2024 Interest income 0
0001641172-25-017216 4 11 IS 0 H Other Nonoperating Income Expense us-gaap/2024 Other income (expense) 0
0001641172-25-017216 4 12 IS 0 H Interest Expense Nonoperating us-gaap/2024 Interest expense 1
0001641172-25-017216 4 13 IS 0 H Nonoperating Income Expense us-gaap/2024 Total other income (expenses) 0
0001641172-25-017216 4 14 IS 0 H Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest us-gaap/2024 Net loss before income taxes 0
0001641172-25-017216 4 15 IS 0 H Income Tax Expense Benefit us-gaap/2024 Income taxes 0
0001641172-25-017216 4 16 IS 0 H Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interests 0001641172-25-017216 Net loss from continuing operations 0
0001641172-25-017216 4 17 IS 0 H Discontinued Operation Income Loss From Discontinued Operation Before Income Tax us-gaap/2024 Loss from operations of discontinued component 0
0001641172-25-017216 4 18 IS 0 H Discontinued Operation Gain Loss On Disposal Of Discontinued Operation Net Of Tax us-gaap/2024 Loss on disposal of discontinued operations 0
0001641172-25-017216 4 19 IS 0 H Income Loss From Discontinued Operations Net Of Tax us-gaap/2024 Net loss from discontinued operations 0
0001641172-25-017216 4 20 IS 0 H Net Income Loss us-gaap/2024 Net loss 0
0001641172-25-017216 4 21 IS 0 H Preferred Stock Dividends Income Statement Impact us-gaap/2024 Preferred dividends 1
0001641172-25-017216 4 22 IS 0 H Net Income Loss Available To Common Stockholders Basic us-gaap/2024 Net loss available to common stockholders 0
0001641172-25-017216 4 23 IS 0 H Income Loss From Continuing Operations Per Basic Share us-gaap/2024 Net loss per share from continuing operations basic 0
0001641172-25-017216 4 24 IS 0 H Income Loss From Continuing Operations Per Diluted Share us-gaap/2024 Net loss per share from continuing operations diluted 0
0001641172-25-017216 4 25 IS 0 H Income Loss From Discontinued Operations Net Of Tax Per Basic Share us-gaap/2024 Loss per share from discontinued operations - Basic 0
0001641172-25-017216 4 26 IS 0 H Income Loss From Discontinued Operations Net Of Tax Per Diluted Share us-gaap/2024 Loss per share from discontinued operations - diluted 0
0001641172-25-017216 4 27 IS 0 H Earnings Per Share Basic us-gaap/2024 Net loss per share basic 0
0001641172-25-017216 4 28 IS 0 H Earnings Per Share Diluted us-gaap/2024 Net loss per share diluted 0
0001641172-25-017216 4 29 IS 0 H Weighted Average Number Of Shares Outstanding Basic us-gaap/2024 Weighted average common shares outstanding, basic 0
0001641172-25-017216 4 30 IS 0 H Weighted Average Number Of Diluted Shares Outstanding us-gaap/2024 Weighted average common shares outstanding, diluted 0
0001641172-25-017216 5 9 EQ 0 H Stockholders Equity us-gaap/2024 Balance 0
0001641172-25-017216 5 10 EQ 0 H Shares Outstanding us-gaap/2024 Balance, shares 0
0001641172-25-017216 5 11 EQ 0 H Stock Issued During Period Value New Issues us-gaap/2024 Issuance of preferred stock for cash, net of issuance costs 0
0001641172-25-017216 5 12 EQ 0 H Stock Issued During Period Shares New Issues us-gaap/2024 Issuance of common stock for cash, shares 0
0001641172-25-017216 5 13 EQ 0 H Stock Issued During Period Value Reverse Stock Splits 0001641172-25-017216 Issuance of fractional shares with reverse stock split 0
0001641172-25-017216 5 14 EQ 0 H Stock Issued During Period Shares Reverse Stock Splits us-gaap/2024 Issuance of fractional shares with reverse stock split, shares 0
0001641172-25-017216 5 15 EQ 0 H Adjustments To Additional Paid In Capital Issuance Of Employee Stock Option 0001641172-25-017216 Issuance of employee stock options 0
0001641172-25-017216 5 16 EQ 0 H Stock Issued During Period Value Share Based Compensation Gross us-gaap/2024 Share based compensation expenses 0
0001641172-25-017216 5 17 EQ 0 H Stock Issued During Period Shares Share Based Compensation Gross us-gaap/2024 Share based compensation, shares 0
0001641172-25-017216 5 18 EQ 0 H Stock Issued During Period Preferred Stock Value 0001641172-25-017216 Issuance of preferred stock net of issuance costs 0
0001641172-25-017216 5 19 EQ 0 H Stock Issued During Period Preferred Stock Shares 0001641172-25-017216 Issuance of preferred stock net of issuance costs, shares 0
0001641172-25-017216 5 20 EQ 0 H Adjustments To Additional Paid In Capital Dividend In Excess Of Retained Earnings 0001641172-25-017216 Dividends declared 1
0001641172-25-017216 5 21 EQ 0 H Net Income Loss us-gaap/2024 Net loss 0
0001641172-25-017216 5 22 EQ 0 H Dividends Sharebased Compensation Paid In Kind us-gaap/2024 Capitalized dividends 0
0001641172-25-017216 5 23 EQ 0 H Stock Issued During Period Value Conversion Of Convertible Securities us-gaap/2024 Conversion of preferred stock into common shares 0
0001641172-25-017216 5 24 EQ 0 H Stock Issued During Period Shares Conversion Of Convertible Securities us-gaap/2024 Conversion of preferred stock into common shares, shares 0
0001641172-25-017216 5 25 EQ 0 H Stockholders Equity us-gaap/2024 Balance 0
0001641172-25-017216 5 26 EQ 0 H Shares Outstanding us-gaap/2024 Balance, shares 0
0001641172-25-017216 6 2 CF 0 H Net Income Losses 0001641172-25-017216 Net loss 0
0001641172-25-017216 6 3 CF 0 H Income Loss From Discontinued Operations Net Of Tax us-gaap/2024 Net loss from discontinuing operations 0
0001641172-25-017216 6 4 CF 0 H Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest us-gaap/2024 Net loss from continuing operations 0
0001641172-25-017216 6 6 CF 0 H Depreciation Depletion And Amortization us-gaap/2024 Depreciation and amortization 0
0001641172-25-017216 6 7 CF 0 H Interest Expense Debt us-gaap/2024 Interest expense - OID 0
0001641172-25-017216 6 8 CF 0 H Share Based Compensation us-gaap/2024 Share based compensation 0
0001641172-25-017216 6 9 CF 0 H Gain Loss On Disposition Of Assets1 us-gaap/2024 Loss on disposition of assets 1
0001641172-25-017216 6 10 CF 0 H Asset Impairment Charges us-gaap/2024 Loss on impairment 0
0001641172-25-017216 6 11 CF 0 H Provision For Doubtful Accounts us-gaap/2024 Bad debt expense 0
0001641172-25-017216 6 12 CF 0 H Gains Losses On Extinguishment Of Debt us-gaap/2024 Gain on extinguishment of debt 1
0001641172-25-017216 6 14 CF 0 H Increase Decrease In Accounts Receivable us-gaap/2024 Accounts receivable, net 1
0001641172-25-017216 6 15 CF 0 H Increase Decrease In Prepaid Deferred Expense And Other Assets us-gaap/2024 Prepaid expenses and other current assets 1
0001641172-25-017216 6 16 CF 0 H Increase Decrease In Deferred Compensation us-gaap/2024 Deferred compensation 0
0001641172-25-017216 6 17 CF 0 H Increase Decrease In Security Deposits us-gaap/2024 Security deposits 0
0001641172-25-017216 6 18 CF 0 H Increase Decrease In Liability To Issue Common Stock 0001641172-25-017216 Liability to issue common stock 1
0001641172-25-017216 6 19 CF 0 H Increase Decrease In Right Of Use Lease Liability 0001641172-25-017216 Right of use/lease liability 1
0001641172-25-017216 6 20 CF 0 H Increase Decrease In Accounts Payable And Accrued Liabilities us-gaap/2024 Accounts payable and accrued expenses 0
0001641172-25-017216 6 21 CF 0 H Increase Decrease In Patient Deposits 0001641172-25-017216 Patient deposits 0
0001641172-25-017216 6 22 CF 0 H Net Cash Provided By Used In Operating Activities Continuing Operations us-gaap/2024 Net cash used in operating activities from continuing operations 0
0001641172-25-017216 6 23 CF 0 H Cash Provided By Used In Operating Activities Discontinued Operations us-gaap/2024 Net cash used in operating activities from discontinued operations 0
0001641172-25-017216 6 24 CF 0 H Net Cash Provided By Used In Operating Activities us-gaap/2024 Net cash used in operating activities 0
0001641172-25-017216 6 26 CF 0 H Payments To Acquire Property Plant And Equipment us-gaap/2024 Purchase of property and equipment 1
0001641172-25-017216 6 27 CF 0 H Payments To Acquire Notes Receivable us-gaap/2024 Note receivable 1
0001641172-25-017216 6 28 CF 0 H Proceeds From Sale Of Practices 0001641172-25-017216 Proceeds from sale of practices 0
0001641172-25-017216 6 29 CF 0 H Proceeds From Sale Of Property Plant And Equipment us-gaap/2024 Proceeds from sale of property and equipment 0
0001641172-25-017216 6 30 CF 0 H Net Cash Provided By Used In Investing Activities us-gaap/2024 Net cash used in investing activities 0
0001641172-25-017216 6 32 CF 0 H Proceeds From Issuance Of Common Stock us-gaap/2024 Proceeds from issuance of common stock 0
0001641172-25-017216 6 33 CF 0 H Proceeds From Issuance Of Preferred Stock And Preference Stock us-gaap/2024 Proceeds from issuance of preferred stock, net of offering costs 0
0001641172-25-017216 6 34 CF 0 H Proceeds From Repayments Of Notes Payable us-gaap/2024 Payments on notes payable 0
0001641172-25-017216 6 35 CF 0 H Proceeds From Notes Payable us-gaap/2024 Proceeds from notes payable 0
0001641172-25-017216 6 36 CF 0 H Repayments Of Debt And Capital Lease Obligations us-gaap/2024 Payments on finance lease obligation 1
0001641172-25-017216 6 37 CF 0 H Net Cash Provided By Used In Financing Activities us-gaap/2024 Net cash from financing activities 0
0001641172-25-017216 6 38 CF 0 H Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect us-gaap/2024 Net increase (decrease) in cash 0
0001641172-25-017216 6 39 CF 0 H Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations us-gaap/2024 Cash, beginning of year 0
0001641172-25-017216 6 40 CF 0 H Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations us-gaap/2024 Cash, end of year 0
0001641172-25-017216 6 42 CF 0 H Interest Paid Net us-gaap/2024 Interest paid 0
0001641172-25-017216 6 43 CF 0 H Income Taxes Paid Net us-gaap/2024 Income Tax 0
0001641172-25-017216 6 45 CF 0 H Preferred Stock Converstion 0001641172-25-017216 Preferred stock conversion 0
0001641172-25-017216 6 46 CF 0 H Converted Accrued C1 Dividends 0001641172-25-017216 Converted accrued C-1 dividends 0
0001641172-25-017216 6 47 CF 0 H Preferred Dividends Accrued C1 And C2 0001641172-25-017216 Preferred dividends accrued C-1 & C-2 0
0001641172-25-017216 6 48 CF 0 H Preferred Dividends Accrued B1 0001641172-25-017216 Preferred dividends accrued B-1 0
0001641172-25-017216 6 49 CF 0 H Preferred Dividends Accrued Converted Into C1 0001641172-25-017216 Preferred dividends accrued converted into C-1 0
0001641172-25-017216 6 50 CF 0 H Capitalized Dividend 0001641172-25-017216 Capitalized dividends D, E, F & G 0
0001641172-25-017216 6 51 CF 0 H Settlement Of Notes Receivable In Connection With Asset Purchase Agreement 0001641172-25-017216 Settlement of notes receivable in connection with asset purchase agreement 0
0001641172-25-017196 6 35 CF 0 H Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations us-gaap/2024 Cash, end of period 0
0001641172-25-017196 6 37 CF 0 H Interest Paid Net us-gaap/2024 Interest paid 0
0001641172-25-017196 6 38 CF 0 H Income Taxes Paid Net us-gaap/2024 Income tax 0
0001641172-25-017196 6 39 CF 0 H Preferred Stock Conversion 0001641172-25-017196 Preferred stock conversion 0
0001641172-25-017196 6 40 CF 0 H Converted Accrued C1 Dividends 0001641172-25-017196 Converted accrued C-1 dividends 0
0001641172-25-017196 6 41 CF 0 H Preferred Dividends Accrued C1 And C2 0001641172-25-017196 Preferred dividends accrued C-1 & C-2 0
0001641172-25-017196 6 42 CF 0 H Preferred Dividends Accrued B1 0001641172-25-017196 Preferred dividends accrued B-1 0
0001641172-25-017196 6 43 CF 0 H Preferred Dividends Accrued Converted Into C1 0001641172-25-017196 Preferred dividends accrued converted into C-1 0
0001641172-25-017196 6 44 CF 0 H Capitalized Dividends D E F 0001641172-25-017196 Capitalized dividends D, E & F 0
0001641172-25-017196 6 45 CF 0 H Settlement Of Notes Receivable In Connection With Asset Purchase Agreement 0001641172-25-017196 Settlement of notes receivable in connection with asset purchase agreement 0
0001641172-25-004643 2 3 BS 0 H Cash us-gaap/2024 Cash 0
0001641172-25-004643 2 4 BS 0 H Accounts Receivable Net Current us-gaap/2024 Accounts receivable, net 0
0001641172-25-004643 2 5 BS 0 H Prepaid Expense And Other Assets Current us-gaap/2024 Prepaid expenses and other current assets 0
0001641172-25-004643 2 6 BS 0 H Accounts And Other Receivables Net Current us-gaap/2024 Note receivable, net 0
0001641172-25-004643 2 7 BS 0 H Assets Of Disposal Group Including Discontinued Operation Current us-gaap/2024 Assets of discontinued operations 0
0001641172-25-004643 2 8 BS 0 H Assets Current us-gaap/2024 Total current assets 0
0001641172-25-004643 2 9 BS 0 H Property Plant And Equipment Net us-gaap/2024 Property and equipment, net 0
0001641172-25-004643 2 10 BS 0 H Assets us-gaap/2024 Total assets 0
0001641172-25-004643 2 13 BS 0 H Accounts Payable And Accrued Liabilities Current us-gaap/2024 Accounts payable and accrued expenses 0
0001641172-25-004643 2 14 BS 0 H Dividends Payable Current us-gaap/2024 Dividends payable 0
0001641172-25-004643 2 15 BS 0 H Liabilities Of Disposal Group Including Discontinued Operation Current us-gaap/2024 Liabilities of discontinued operations 0
0001641172-25-004643 2 16 BS 0 H Liabilities Current us-gaap/2024 Total current liabilities 0
0001641172-25-004643 2 17 BS 0 H Liabilities us-gaap/2024 Total liabilities 0
0001641172-25-004643 2 18 BS 0 H Commitments And Contingencies us-gaap/2024 Commitment and Contingencies Note 13 0
0001641172-25-004643 2 20 BS 0 H Preferred Stock Value us-gaap/2024 Preferred stock - $0.001 par value, 5,000,000 authorized, 50,502 issued and outstanding at December 31, 2024 and 2,645 Series B-1 and 1,905 Series B-2 issued and outstanding at December 31, 2023 0
0001641172-25-004643 2 21 BS 0 H Common Stock Value us-gaap/2024 Common stock; $0.001 par value, 120,000,000 authorized; 2,029,864 and 1,148,321 shares issued and outstanding at December 31, 2024 and 2023, respectively. 0
0001641172-25-004643 2 22 BS 0 H Additional Paid In Capital us-gaap/2024 Additional paid-in capital 0
0001641172-25-004643 2 23 BS 0 H Retained Earnings Accumulated Deficit us-gaap/2024 Accumulated deficit 0
0001641172-25-004643 2 24 BS 0 H Stockholders Equity us-gaap/2024 Total stockholders equity (deficit) 0
0001641172-25-004643 2 25 BS 0 H Liabilities And Stockholders Equity us-gaap/2024 Total liabilities and stockholders equity (deficit) 0
0001641172-25-004643 3 7 BS 1 H Preferred Stock Par Or Stated Value Per Share us-gaap/2024 Preferred Stock, Par or Stated Value Per Share 0
0001641172-25-004643 3 8 BS 1 H Preferred Stock Shares Authorized us-gaap/2024 Preferred Stock, Shares Authorized 0
0001641172-25-004643 3 9 BS 1 H Preferred Stock Shares Issued us-gaap/2024 Preferred stock, shares issued 0
0001641172-25-004643 3 10 BS 1 H Preferred Stock Shares Outstanding us-gaap/2024 Preferred stock, shares outstanding 0
0001641172-25-004643 3 11 BS 1 H Common Stock Par Or Stated Value Per Share us-gaap/2024 Common Stock, Par or Stated Value Per Share 0
0001641172-25-004643 3 12 BS 1 H Common Stock Shares Authorized us-gaap/2024 Common Stock, Shares Authorized 0
0001641172-25-004643 3 13 BS 1 H Common Stock Shares Issued us-gaap/2024 Common stock, shares issued 0
0001641172-25-004643 3 14 BS 1 H Common Stock Shares Outstanding us-gaap/2024 Common stock, shares outstanding 0
0001641172-25-004643 4 1 IS 0 H Revenue From Contract With Customer Excluding Assessed Tax us-gaap/2024 Patient revenue, net 0
0001641172-25-004643 4 2 IS 0 H Cost Of Revenue us-gaap/2024 Cost of revenues 0
0001641172-25-004643 4 3 IS 0 H Gross Profit us-gaap/2024 Gross profit (loss) 0
0001641172-25-004643 4 5 IS 0 H General And Administrative Expense us-gaap/2024 General and administrative 0
0001641172-25-004643 4 6 IS 0 H Gain Loss On Disposition Of Assets us-gaap/2024 Loss on disposition or impairment 1
0001641172-25-004643 4 7 IS 0 H Operating Expenses us-gaap/2024 Total operating expenses 0
0001641172-25-004643 4 8 IS 0 H Operating Income Loss us-gaap/2024 Operating loss 0
0001641172-25-004643 4 10 IS 0 H Investment Income Interest us-gaap/2024 Interest income 0
0001641172-25-004643 4 11 IS 0 H Other Nonoperating Income Expense us-gaap/2024 Other income (expense) 0
0001641172-25-004643 4 12 IS 0 H Interest Expense Nonoperating us-gaap/2024 Interest expense 1
0001641172-25-004643 4 13 IS 0 H Nonoperating Income Expense us-gaap/2024 Total other income (expenses) 0
0001641172-25-004643 4 14 IS 0 H Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest us-gaap/2024 Net loss before income taxes 0
0001641172-25-004643 4 15 IS 0 H Income Tax Expense Benefit us-gaap/2024 Income taxes 0
0001641172-25-004643 4 16 IS 0 H Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interests 0001641172-25-004643 Net loss from continuing operations 0
0001641172-25-004643 4 17 IS 0 H Discontinued Operation Income Loss From Discontinued Operation Before Income Tax us-gaap/2024 Loss from operations of discontinued component 0
0001641172-25-004643 4 18 IS 0 H Discontinued Operation Gain Loss On Disposal Of Discontinued Operation Net Of Tax us-gaap/2024 Loss on disposal of discontinued operations 0
0001641172-25-004643 4 19 IS 0 H Income Loss From Discontinued Operations Net Of Tax us-gaap/2024 Net loss from discontinued operations 0
0001641172-25-004643 4 20 IS 0 H Net Income Loss us-gaap/2024 Net loss 0
0001641172-25-004643 4 21 IS 0 H Preferred Stock Dividends Income Statement Impact us-gaap/2024 Preferred dividends 1
0001641172-25-004643 4 22 IS 0 H Net Income Loss Available To Common Stockholders Basic us-gaap/2024 Net loss available to common stockholders 0
0001641172-25-004643 4 23 IS 0 H Income Loss From Continuing Operations Per Basic Share us-gaap/2024 Net loss per share from continuing operations basic 0
0001641172-25-004643 4 24 IS 0 H Income Loss From Continuing Operations Per Diluted Share us-gaap/2024 Net loss per share from continuing operations diluted 0
0001641172-25-004643 4 25 IS 0 H Income Loss From Discontinued Operations Net Of Tax Per Basic Share us-gaap/2024 Loss per share from discontinued operations - Basic 0
0001641172-25-004643 4 26 IS 0 H Income Loss From Discontinued Operations Net Of Tax Per Diluted Share us-gaap/2024 Loss per share from discontinued operations - diluted 0
0001641172-25-004643 4 27 IS 0 H Earnings Per Share Basic us-gaap/2024 Net loss per share basic 0
0001641172-25-004643 4 28 IS 0 H Earnings Per Share Diluted us-gaap/2024 Net loss per share diluted 0
0001641172-25-004643 4 29 IS 0 H Weighted Average Number Of Shares Outstanding Basic us-gaap/2024 Weighted average common shares outstanding, basic 0
0001641172-25-004643 4 30 IS 0 H Weighted Average Number Of Diluted Shares Outstanding us-gaap/2024 Weighted average common shares outstanding, diluted 0
0001641172-25-004643 5 9 EQ 0 H Stockholders Equity us-gaap/2024 Balance 0
0001641172-25-004643 5 10 EQ 0 H Shares Outstanding us-gaap/2024 Balance, shares 0
0001641172-25-004643 5 11 EQ 0 H Stock Issued During Period Value New Issues us-gaap/2024 Issuance of preferred stock for cash, net of issuance costs 0
0001641172-25-004643 5 12 EQ 0 H Stock Issued During Period Shares New Issues us-gaap/2024 Issuance of common stock for cash, shares 0
0001641172-25-004643 5 13 EQ 0 H Stock Issued During Period Value Reverse Stock Splits 0001641172-25-004643 Issuance of fractional shares with reverse stock split 0
0001641172-25-004643 5 14 EQ 0 H Stock Issued During Period Shares Reverse Stock Splits us-gaap/2024 Issuance of fractional shares with reverse stock split, shares 0
0001641172-25-004643 5 15 EQ 0 H Adjustments To Additional Paid In Capital Issuance Of Employee Stock Option 0001641172-25-004643 Issuance of employee stock options 0
0001641172-25-004643 5 16 EQ 0 H Stock Issued During Period Value Share Based Compensation Gross us-gaap/2024 Share based compensation expenses 0
0001641172-25-004643 5 17 EQ 0 H Stock Issued During Period Shares Share Based Compensation Gross us-gaap/2024 Share based compensation, shares 0
0001641172-25-004643 5 18 EQ 0 H Stock Issued During Period Preferred Stock Value 0001641172-25-004643 Issuance of preferred stock net of issuance costs 0
0001641172-25-004643 5 19 EQ 0 H Stock Issued During Period Preferred Stock Shares 0001641172-25-004643 Issuance of preferred stock net of issuance costs, shares 0
0001641172-25-004643 5 20 EQ 0 H Adjustments To Additional Paid In Capital Dividend In Excess Of Retained Earnings 0001641172-25-004643 Dividends declared 1
0001641172-25-004643 5 21 EQ 0 H Net Income Loss us-gaap/2024 Net loss 0
0001641172-25-004643 5 22 EQ 0 H Stock Issued During Period Value Conversion Of Convertible Securities us-gaap/2024 Conversion of preferred stock into common shares 0
0001641172-25-004643 5 23 EQ 0 H Stock Issued During Period Shares Conversion Of Convertible Securities us-gaap/2024 Conversion of preferred stock into common shares, shares 0
0001641172-25-004643 5 24 EQ 0 H Stockholders Equity us-gaap/2024 Balance 0
0001641172-25-004643 5 25 EQ 0 H Shares Outstanding us-gaap/2024 Balance, shares 0
0001641172-25-004643 6 2 CF 0 H Net Income Losses 0001641172-25-004643 Net loss 0
0001641172-25-004643 6 3 CF 0 H Income Loss From Discontinued Operations Net Of Tax us-gaap/2024 Net loss from discontinuing operations 0
0001641172-25-004643 6 4 CF 0 H Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest us-gaap/2024 Net loss from continuing operations 0
0001641172-25-004643 6 6 CF 0 H Depreciation Depletion And Amortization us-gaap/2024 Depreciation and amortization 0
0001641172-25-004643 6 7 CF 0 H Interest Expense Debt us-gaap/2024 Interest expense - OID 0
0001641172-25-004643 6 8 CF 0 H Share Based Compensation us-gaap/2024 Share based compensation 0
0001641172-25-004643 6 9 CF 0 H Gain Loss On Disposition Of Assets1 us-gaap/2024 Loss on disposition of assets 1
0001641172-25-004643 6 10 CF 0 H Asset Impairment Charges us-gaap/2024 Loss on impairment 0
0001641172-25-004643 6 11 CF 0 H Provision For Doubtful Accounts us-gaap/2024 Bad debt expense 0
0001641172-25-004643 6 12 CF 0 H Gains Losses On Extinguishment Of Debt us-gaap/2024 Gain on extinguishment of debt 1
0001641172-25-004643 6 14 CF 0 H Increase Decrease In Accounts Receivable us-gaap/2024 Accounts receivable, net 1
0001641172-25-004643 6 15 CF 0 H Increase Decrease In Prepaid Deferred Expense And Other Assets us-gaap/2024 Prepaid expenses and other current assets 1
0001641172-25-004643 6 16 CF 0 H Increase Decrease In Deferred Compensation us-gaap/2024 Deferred compensation 0
0001641172-25-004643 6 17 CF 0 H Increase Decrease In Security Deposits us-gaap/2024 Security deposits 0
0001641172-25-004643 6 18 CF 0 H Increase Decrease In Liability To Issue Common Stock 0001641172-25-004643 Liability to issue common stock 1
0001641172-25-004643 6 19 CF 0 H Increase Decrease In Right Of Use Lease Liability 0001641172-25-004643 Right of use/lease liability 1
0001641172-25-004643 6 20 CF 0 H Increase Decrease In Accounts Payable And Accrued Liabilities us-gaap/2024 Accounts payable and accrued expenses 0
0001641172-25-004643 6 21 CF 0 H Increase Decrease In Patient Deposits 0001641172-25-004643 Patient deposits 0
0001641172-25-004643 6 22 CF 0 H Net Cash Provided By Used In Operating Activities Continuing Operations us-gaap/2024 Net cash used in operating activities from continuing operations 0
0001641172-25-004643 6 23 CF 0 H Cash Provided By Used In Operating Activities Discontinued Operations us-gaap/2024 Net cash used in operating activities from discontinued operations 0
0001641172-25-004643 6 24 CF 0 H Net Cash Provided By Used In Operating Activities us-gaap/2024 Net cash used in operating activities 0
0001641172-25-004643 6 26 CF 0 H Payments To Acquire Property Plant And Equipment us-gaap/2024 Purchase of property and equipment 1
0001641172-25-004643 6 27 CF 0 H Payments To Acquire Notes Receivable us-gaap/2024 Note receivable 1
0001641172-25-004643 6 28 CF 0 H Proceeds From Sale Of Practices 0001641172-25-004643 Proceeds from sale of practices 0
0001641172-25-004643 6 29 CF 0 H Proceeds From Sale Of Property Plant And Equipment us-gaap/2024 Proceeds from sale of property and equipment 0
0001641172-25-004643 6 30 CF 0 H Net Cash Provided By Used In Investing Activities us-gaap/2024 Net cash used in investing activities 0
0001641172-25-004643 6 32 CF 0 H Proceeds From Issuance Of Common Stock us-gaap/2024 Proceeds from issuance of common stock 0
0001641172-25-004643 6 33 CF 0 H Proceeds From Issuance Of Preferred Stock And Preference Stock us-gaap/2024 Proceeds from issuance of preferred stock, net of offering costs 0
0001641172-25-004643 6 34 CF 0 H Proceeds From Repayments Of Notes Payable us-gaap/2024 Payments on notes payable 0
0001641172-25-004643 6 35 CF 0 H Proceeds From Notes Payable us-gaap/2024 Proceeds from notes payable 0
0001641172-25-004643 6 36 CF 0 H Repayments Of Debt And Capital Lease Obligations us-gaap/2024 Payments on finance lease obligation 1
0001641172-25-004643 6 37 CF 0 H Net Cash Provided By Used In Financing Activities us-gaap/2024 Net cash from financing activities 0
0001641172-25-004643 6 38 CF 0 H Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect us-gaap/2024 Net increase (decrease) in cash 0
0001641172-25-004643 6 39 CF 0 H Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations us-gaap/2024 Cash, beginning of year 0
0001641172-25-004643 6 40 CF 0 H Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations us-gaap/2024 Cash, end of year 0
0001641172-25-004643 6 42 CF 0 H Interest Paid Net us-gaap/2024 Interest paid 0
0001641172-25-004643 6 43 CF 0 H Income Taxes Paid Net us-gaap/2024 Income Tax 0
0001641172-25-004643 6 44 CF 0 H Preferred Stock Converstion 0001641172-25-004643 Preferred stock conversion 0
0001641172-25-004643 6 45 CF 0 H Accrued Dividends 0001641172-25-004643 Accrued dividends 0
0001641172-25-004643 6 46 CF 0 H Settlement Of Notes Receivable In Connection With Asset Purchase Agreement 0001641172-25-004643 Settlement of notes receivable in connection with asset purchase agreement 0

Description
Field Name Field Description
adsh Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission.
report Represents the report grouping. This field corresponds to the statement (stmt) field, which indicates the type of statement. The numeric value refers to the “R file” as posted on the EDGAR Web site.
line Represents the tag’s presentation line order for a given report. Together with the statement and report field, presentation location, order and grouping can be derived.
stmt The financial statement location to which the value of the “report” field pertains.
inpth Value was presented “parenthetically” instead of in columns within the financial statements. For example: Receivables (net of allowance for bad debts of $200 in 2012) $700.
rfile The type of interactive data file rendered on the EDGAR web site, H = .htm file, X = .xml file.
tag The tag chosen by the filer for this line item.
version The taxonomy identifier if the tag is a standard tag, otherwise adsh.
plabel The text presented on the line item, also known as a “preferred” label.
negating Flag to indicate whether the plabel is negating.